<?xml version="1.0" encoding="UTF-8"?><search-results xmlns="http://www.w3.org/2005/Atom" xmlns:cto="http://www.elsevier.com/xml/cto/dtd" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:opensearch="http://a9.com/-/spec/opensearch/1.1/" xmlns:dc="http://purl.org/dc/elements/1.1/"><opensearch:totalResults>2992343</opensearch:totalResults><opensearch:startIndex>1700</opensearch:startIndex><opensearch:itemsPerPage>100</opensearch:itemsPerPage><opensearch:Query role="request" searchTerms="heart" startPage="1700"/><link ref="self" href="http://api.elsevier.com:80/content/search/index:scopus?start=1700&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="first" href="http://api.elsevier.com:80/content/search/index:scopus?start=0&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="prev" href="http://api.elsevier.com:80/content/search/index:scopus?start=1600&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="next" href="http://api.elsevier.com:80/content/search/index:scopus?start=1800&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="last" href="http://api.elsevier.com:80/content/search/index:scopus?start=4900&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925625775"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925625775?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925625775&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925625775&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0928493115001861"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925625775</prism:url><dc:identifier>SCOPUS_ID:84925625775</dc:identifier><eid>2-s2.0-84925625775</eid><dc:title>Heat treatment mechanism and biodegradable characteristics of ZAX1330 Mg alloy</dc:title><dc:creator>Lin D.</dc:creator><prism:publicationName>Materials Science and Engineering C</prism:publicationName><prism:issn>09284931</prism:issn><prism:volume>51</prism:volume><prism:pageRange>300-308</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.msec.2015.03.004</prism:doi><pii>S0928493115001861</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. Heat treatments are key processes in the development of biodegradable magnesium implants. The aim of this study is to investigate the factors of microstructures and metallurgical segregation on the functionality of biodegradable magnesium alloy. The solid solution heat treatment and strain induced melting activation heat treatment were employed to alter the microstructures of ZAX1330 alloy in this study. Heat treatments caused a significant change on grain size and distribution of secondary phases. The fine-grained microstructure enhanced the mechanical strength, corrosion resistance and achieved the lowest degradation rate in simulated body fluid solution. In coarse-grained microstructure systems, grain growth followed liquid phase formation. The corrosion rate increased due to a larger cathodic region. The status of micro-alloyed calcium (in solid solution or segregated) influenced the microstructural evolution mechanisms, mechanical strength, and degradation properties. A cytotoxicity test and a live/dead assay showed that ZAX1330 had good cytocompatibility, which varied with heat treatment, and no cell toxicity. The results suggest that heat treatment should be controlled precisely in order to improve the cytocompatibility of magnesium alloys for application in orthopedic implants.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014982</affiliation-url><afid>60014982</afid><affilname>National Cheng Kung University</affilname><name-variant>National Cheng Kung University</name-variant><affiliation-city>Tainan</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014982</affiliation-url><afid>60014982</afid><affilname>National Cheng Kung University</affilname><name-variant>National Cheng Kung University</name-variant><affiliation-city>Tainan</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56571860500</author-url><authid>56571860500</authid><authname>Lin D.</authname><surname>Lin</surname><given-name>Da Jun</given-name><initials>D.J.</initials><afid>60014982</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7004572095</author-url><authid>7004572095</authid><authname>Hung F.</authname><surname>Hung</surname><given-name>Fei Yi</given-name><initials>F.Y.</initials><afid>60014982</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7005009564</author-url><authid>7005009564</authid><authname>Lui T.</authname><surname>Lui</surname><given-name>Truan Sheng</given-name><initials>T.S.</initials><afid>60014982</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56437886800</author-url><authid>56437886800</authid><authname>Yeh M.</authname><surname>Yeh</surname><given-name>Ming Long</given-name><initials>M.L.</initials><afid>60014982</afid></author><authkeywords>Biodegradable | Corrosion | Cytocompatibility | Heat treatment | Magnesium alloy | Mechanical properties</authkeywords><intid>1035323456</intid><source-id>17813</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925411087"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925411087?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925411087&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925411087&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0165032715001214"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925411087</prism:url><dc:identifier>SCOPUS_ID:84925411087</dc:identifier><eid>2-s2.0-84925411087</eid><dc:title>Mortality of subjects with mood disorders in the Lundby community cohort: A follow-up over 50 years</dc:title><dc:creator>Mattisson C.</dc:creator><prism:publicationName>Journal of Affective Disorders</prism:publicationName><prism:issn>01650327</prism:issn><prism:eIssn>15732517</prism:eIssn><prism:volume>178</prism:volume><prism:pageRange>98-106</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jad.2015.02.028</prism:doi><pii>S0165032715001214</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. Aims To compare causes of death and mortality among subjects with and without mood disorder in the Lundby Cohort and to analyse additional mental disorders as risk factors for mortality in subjects with mood disorders. Background The Lundby study is a longitudinal study that investigated mental health in an unselected population. The study commenced in 1947; the population was further investigated in 1957, 1972, and 1997. Methods Experienced psychiatrists performed semi-structured diagnostic interviews, and best estimate consensus diagnoses of mental disorders were assessed at each field investigation. Subjects with mood disorder (n=508, 195 males, 313 females) were identified until 1997. Causes and dates of death between 1947 and 2011 were obtained from the Swedish cause of death register and were compared between subjects diagnosed with mood disorder and other participants. Mortality was compared between those with mood disorders and the remaining cohort with Cox regression analyses. Other mental disorders were considered as risk factors for death for subjects with mood disorders. Results The hazard ratio for mortality in mood disorders was HR=1.18. However, the mortality was elevated only for males, HR=1.5. Comorbid anxiety disorders, organic disorders, dementia and psychotic disorders were significant risk factors for death. A total of 6.3% of the participants with mood disorder and 1.2% of the remaining participants committed suicide. Conclusions As expected, the suicide rate was higher among participants with mood disorders. Only males with mood disorders had elevated mortality. The impact on mortality from other mental disorders seems to vary between the genders.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014077</affiliation-url><afid>60014077</afid><affilname>Universitssjukhuset i Lund</affilname><name-variant>University Hospital</name-variant><affiliation-city>Lund</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029170</affiliation-url><afid>60029170</afid><affilname>Lunds Universitet</affilname><name-variant>University of Lund</name-variant><affiliation-city>Lund</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8717594100</author-url><authid>8717594100</authid><authname>Mattisson C.</authname><surname>Mattisson</surname><given-name>C.</given-name><initials>C.</initials><afid>60014077</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8717593700</author-url><authid>8717593700</authid><authname>Bogren M.</authname><surname>Bogren</surname><given-name>M.</given-name><initials>M.</initials><afid>60014077</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6603249040</author-url><authid>6603249040</authid><authname>Brådvik L.</authname><surname>Brådvik</surname><given-name>L.</given-name><initials>L.</initials><afid>60014077</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:16039057700</author-url><authid>16039057700</authid><authname>Horstmann V.</authname><surname>Horstmann</surname><given-name>V.</given-name><initials>V.</initials><afid>60029170</afid></author><authkeywords>Causes of death | Depression | Mood disorder | Mortality | Suicide</authkeywords><intid>35296403</intid><source-id>16245</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929175823"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929175823?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929175823&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929175823&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929175823</prism:url><dc:identifier>SCOPUS_ID:84929175823</dc:identifier><eid>2-s2.0-84929175823</eid><dc:title>Seedlings of two Acacia species from contrasting habitats show different photoprotective and antioxidative responses to drought and heatwaves</dc:title><dc:creator>Wujeska-Klause A.</dc:creator><prism:publicationName>Annals of Forest Science</prism:publicationName><prism:issn>12864560</prism:issn><prism:eIssn>1297966X</prism:eIssn><prism:volume>72</prism:volume><prism:issueIdentifier>4</prism:issueIdentifier><prism:pageRange>403-414</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s13595-014-0438-5</prism:doi><dc:description>© 2014, INRA and Springer-Verlag France. Results: Photosynthesis and quantum yield of photochemistry decreased significantly in both Acacia species, especially after water was withheld in combination with the second heatwave episode. In phyllodes, the concentration of antioxidants remained unchanged until exposure to severe drought and heatwave conditions (except for A. melanoxylon where changes in glutathione concentration were observed prior to exposure to severe stress), but after water was withheld and the second heatwave occurred, oxidised forms of glutathione increased. After exposure to the second heatwave, well-watered seedlings of A. melanoxylon but not A. aneura increased ascorbic acid concentration in phyllodes. Under well-watered conditions, Acacia species also showed increased concentration of antioxidants in roots following heatwaves. Conclusions: Both Acacia species showed photodamage to photosystem II (PSII) after water was withheld and the second heatwave imposed, but with more gradual response in A. aneura. Total concentration of investigated antioxidants increased in response to the first (A. melanoxylon) and second (A. aneura) heatwaves rather than drought stress alone. Key message: TwoAcaciaspecies adapted to contrasting habitats showed different response of photoprotective and antioxidative defence systems to imposed drought and heatwave. Context: Predicted increases in drought frequency and intense heatwaves are expected to lead to dieback of sensitive tree species. Stomatal closure restricts CO&lt;inf&gt;2&lt;/inf&gt; input into the leaf, resulting in imbalances between light energy-driven electron transport rate and electron consumption in the Calvin cycle. Reactive oxygen species formed under these circumstances have to be kept under control by photoprotective and antioxidative defence systems. Aims: We hypothesised that these defence systems behave differently in tree species from contrasting habitats. Methods: Acacia aneura (adapted to arid habitats) and Acacia melanoxylon (adapted to humid habitats) were exposed to two water treatments for 50 days including two short heatwave periods. Responses were assessed by gas exchange, chlorophyll fluorescence and concentrations of antioxidants (phyllodes, roots).</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026553</affiliation-url><afid>60026553</afid><affilname>University of Melbourne</affilname><name-variant>University of Melbourne</name-variant><affiliation-city>Parkville</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56641693700</author-url><authid>56641693700</authid><authname>Wujeska-Klause A.</authname><surname>Wujeska-Klause</surname><given-name>Agnieszka</given-name><initials>A.</initials><afid>60026553</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6506139853</author-url><authid>6506139853</authid><authname>Bossinger G.</authname><surname>Bossinger</surname><given-name>Gerd</given-name><initials>G.</initials><afid>60026553</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7003855900</author-url><authid>7003855900</authid><authname>Tausz M.</authname><surname>Tausz</surname><given-name>Michael</given-name><initials>M.</initials><afid>60026553</afid></author><authkeywords>Acacia aneura | Acacia melanoxylon | Arid | ASC | GSH | Humid | Phyllodes | Roots</authkeywords><intid>1035913817</intid><source-id>25557</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84922654338"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84922654338?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84922654338&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84922654338&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1096495915000160"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84922654338</prism:url><dc:identifier>SCOPUS_ID:84922654338</dc:identifier><eid>2-s2.0-84922654338</eid><dc:title>Molecular cloning and sequence analysis of selenoprotein W gene and its mRNA expression patterns in response to metabolic status and cadmium exposure in goldfish, Carassius auratus</dc:title><dc:creator>Chen W.</dc:creator><prism:publicationName>Comparative Biochemistry and Physiology Part - B: Biochemistry and Molecular Biology</prism:publicationName><prism:issn>10964959</prism:issn><prism:eIssn>18791107</prism:eIssn><prism:volume>184</prism:volume><prism:pageRange>1-9</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cbpb.2015.01.005</prism:doi><pii>S1096495915000160</pii><dc:description>© 2015 Elsevier Inc. Selenoprotein W (SelW) is a low molecular weight and selenocysteine containing protein with redox activity involved in the antioxidant response. In the present study, the full-length cDNA of goldfish (. Carassius auratus) selenoprotein W (gfSelW) was successfully cloned from the liver tissue by rapid amplification of cDNA ends technique. The obtained gfSelW cDNA was 730. bp long with a 79. bp 5'-untranslated region (UTR), a 390. bp 3'-UTR containing the consensus polyadenylation signal AATAAA and a 261. bp open reading frame coding a protein of 86 amino acid residues. gfSelW mRNA was observed in all regions of brain and peripheral tissues by semi-quantitative RT-PCR, and the most abundant was detected in testis. After fasting for 1. week, gfSelW mRNA expression levels were significantly decreased compared to the fed group in hypothalamus and liver. After refeeding for 7. days, gfSelW mRNA expression levels were increased back. Furthermore, the mRNA expressions of gfSelW in hypothalamus and liver were varied in periprandial changes and significantly up-regulated after meal 2. h and 4. h, respectively. With cadmium exposure for 24. h, gfSelW mRNA expression levels in gill and leucocytes were significantly decreased at different cadmium concentrations changing from 0.5. ppm to 10. ppm. However, the gfSelW mRNA expression level was sharply increased in liver, relatively to the control about 4.98-fold at 0.5. ppm. The results in this study provide molecular characterization of SelW in goldfish and imply that SelW mRNA expression may be associated with metabolic status and oxidative stress and regulated by metabolic factors and cadmium in fish.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025881</affiliation-url><afid>60025881</afid><affilname>Henan Polytechnic University</affilname><name-variant>Henan Polytechnic University</name-variant><affiliation-city>Jiaozuo</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60073558</affiliation-url><afid>60073558</afid><affilname>Huzhou University</affilname><name-variant>Huzhou University</name-variant><affiliation-city>Huzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56512587400</author-url><authid>56512587400</authid><authname>Chen W.</authname><surname>Chen</surname><given-name>Wenbo</given-name><initials>W.</initials><afid>60025881</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56512911100</author-url><authid>56512911100</authid><authname>Zhang Z.</authname><surname>Zhang</surname><given-name>Zhen</given-name><initials>Z.</initials><afid>60025881</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55460765300</author-url><authid>55460765300</authid><authname>Dong H.</authname><surname>Dong</surname><given-name>Haiyan</given-name><initials>H.</initials><afid>60073558</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56512799900</author-url><authid>56512799900</authid><authname>Jiang X.</authname><surname>Jiang</surname><given-name>Xiaoxue</given-name><initials>X.</initials><afid>60025881</afid></author><authkeywords>Cadmium | Carassius auratus | Fasting | Periprandial change | Selenoprotein W</authkeywords><intid>1784844692</intid><source-id>9700153210</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84923592416"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84923592416?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84923592416&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84923592416&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84923592416</prism:url><dc:identifier>SCOPUS_ID:84923592416</dc:identifier><eid>2-s2.0-84923592416</eid><dc:title>DNS and LES of turbulent flow in a closed channel featuring a pattern of hemispherical roughness elements</dc:title><dc:creator>Chatzikyriakou D.</dc:creator><prism:publicationName>International Journal of Heat and Fluid Flow</prism:publicationName><prism:issn>0142727X</prism:issn><prism:volume>53</prism:volume><prism:pageRange>29-43</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijheatfluidflow.2015.01.002</prism:doi><pii>S0142727X1500003X</pii><dc:description>© 2015 Elsevier Inc. Direct Numerical Simulations (DNS) and Large Eddy Simulations (LES) were performed for fully-developed turbulent flow in channels with smooth walls and walls featuring hemispherical roughness elements at shear Reynolds numbers Reτ=180 and 400, with the goal of studying the effect of these roughness elements on the wall-layer structure and on the friction factor. The LES and DNS approaches were verified first by comparison with existing DNS databases for smooth walls. Then, a parametric study for the hemispherical roughness elements was conducted, including the effects of shear Reynolds number, normalized roughness height (k+=10-20) and relative roughness spacing (s+/k+=2-6). The sensitivity study also included the effect of distribution pattern (regular square lattice vs. random pattern) of the roughness elements on the walls. The hemispherical roughness elements generate turbulence, thus increasing the friction factor with respect to the smooth-wall case, and causing a downward shift in the mean velocity profiles. The simulations revealed that the friction factor decreases with increasing Reynolds number and roughness spacing, and increases strongly with increasing roughness height. The effect of random element distribution on friction factor and mean velocities is however weak. In all cases, there is a clear cut between the inner layer near the wall, which is affected by the presence of the roughness elements, and the outer layer, which remains relatively unaffected. The study reveals that the presence of roughness elements of this shape promotes locally the instantaneous flow motion in the lateral direction in the wall layer, causing a transfer of energy from the streamwise Reynolds stress to the lateral component. The study indicates also that the coherent structures developing in the wall layer are rather similar to the smooth case but are lifted up by almost a constant wall-unit shift y+ (~10-15), which, interestingly, corresponds to the relative roughness k+=10.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022195</affiliation-url><afid>60022195</afid><affilname>Massachusetts Institute of Technology</affilname><name-variant>Massachusetts Inst. of Technology</name-variant><affiliation-city>Cambridge</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60099353</affiliation-url><afid>60099353</afid><affilname>ASCOMP GmbH</affilname><name-variant>ASCOMP GmbH</name-variant><affiliation-city>Zurich</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:23979611700</author-url><authid>23979611700</authid><authname>Chatzikyriakou D.</authname><surname>Chatzikyriakou</surname><given-name>D.</given-name><initials>D.</initials><afid>60022195</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7006297540</author-url><authid>7006297540</authid><authname>Buongiorno J.</authname><surname>Buongiorno</surname><given-name>J.</given-name><initials>J.</initials><afid>60022195</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:23468503300</author-url><authid>23468503300</authid><authname>Caviezel D.</authname><surname>Caviezel</surname><given-name>D.</given-name><initials>D.</initials><afid>60099353</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7003880934</author-url><authid>7003880934</authid><authname>Lakehal D.</authname><surname>Lakehal</surname><given-name>D.</given-name><initials>D.</initials><afid>60022195</afid><afid>60099353</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7003880934</author-url><authid>7003880934</authid><authname>Lakehal D.</authname><surname>Lakehal</surname><given-name>D.</given-name><initials>D.</initials><afid>60022195</afid><afid>60099353</afid></author><authkeywords>DNS | LES | Roughness elements | Turbulent flow</authkeywords><intid>35003323</intid><source-id>13759</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928890328"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928890328?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928890328&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928890328&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1874391915001372"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928890328</prism:url><dc:identifier>SCOPUS_ID:84928890328</dc:identifier><eid>2-s2.0-84928890328</eid><dc:title>Human monocyte-derived macrophages are heterogenous: Proteomic profile of different phenotypes</dc:title><dc:creator>Eligini S.</dc:creator><prism:publicationName>Journal of Proteomics</prism:publicationName><prism:issn>18743919</prism:issn><prism:eIssn>18767737</prism:eIssn><prism:volume>124</prism:volume><prism:pageRange>112-123</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jprot.2015.03.026</prism:doi><pii>S1874391915001372</pii><dc:description>© 2015 Elsevier B.V. Tissue macrophages play a key role in many aspects of human physiology and pathology. These cells are heterogeneous both in term of morphology and function. As an example, heterogeneity has been reported within the atherosclerotic lesions where distinct populations exert opposite functions driving plaque progression or stability. Tissue macrophages are not easily obtained and differentiated blood-derived monocytes are largely used as surrogate model. We previously reported that human macrophages spontaneously differentiated from adherent monocytes show two dominant subsets, distinct for morphology (spindle and round) and functions. The aim of this study was to evaluate the intracellular proteome of these two macrophage subsets by means of a microproteomic workflow properly set up to simultaneously identify and quantify proteins from a minimal number of morphotypically heterogeneous cells in culture. We report two distinct proteomic profiles that distinguish round from spindle macrophages. In particular, differential abundances were observed for proteins involved in membrane traffic regulation, lipid handling, efferocytosis, and protection against stress conditions. Results reinforce and extend previous data on the functional and antigenic profile of these macrophage phenotypes strengthening the suitability of our model to focus on macrophage heterogeneity. Biological significance: Tissue macrophages patrol homeostatic functions, immune surveillance, and resolution of inflammation. The spectrum of macrophage activation states is, therefore, wide and gives ground for the heterogeneity of these cells, documented in health and disease. This study provides knowledge of the distinct proteome that characterises the two dominant morphotypes (round and spindle) of human macrophages that, in our culture condition, are generated by spontaneous differentiation from blood-derived monocytes. Results extend previous data about the different antigenic, transcriptional, and functional profiles of these morphotypes and further strengthen the suitability of this in vitro model to study macrophage heterogeneity and to address the effects of environmental challenges and drugs.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60073816</affiliation-url><afid>60073816</afid><affilname>IRCCS Centro Cardiologico Monzino</affilname><name-variant>Centro Cardiologico Monzino</name-variant><affiliation-city>Milan</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030318</affiliation-url><afid>60030318</afid><affilname>Universita degli Studi di Milano</affilname><name-variant>University of Milan</name-variant><affiliation-city>Milan</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6602730831</author-url><authid>6602730831</authid><authname>Eligini S.</authname><surname>Eligini</surname><given-name>S.</given-name><initials>S.</initials><afid>60073816</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55237102700</author-url><authid>55237102700</authid><authname>Brioschi M.</authname><surname>Brioschi</surname><given-name>M.</given-name><initials>M.</initials><afid>60073816</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56063899400</author-url><authid>56063899400</authid><authname>Fiorelli S.</authname><surname>Fiorelli</surname><given-name>S.</given-name><initials>S.</initials><afid>60073816</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7006057885</author-url><authid>7006057885</authid><authname>Tremoli E.</authname><surname>Tremoli</surname><given-name>E.</given-name><initials>E.</initials><afid>60073816</afid><afid>60030318</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7006057885</author-url><authid>7006057885</authid><authname>Tremoli E.</authname><surname>Tremoli</surname><given-name>E.</given-name><initials>E.</initials><afid>60073816</afid><afid>60030318</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6603951888</author-url><authid>6603951888</authid><authname>Banfi C.</authname><surname>Banfi</surname><given-name>C.</given-name><initials>C.</initials><afid>60073816</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:23495207900</author-url><authid>23495207900</authid><authname>Colli S.</authname><surname>Colli</surname><given-name>S.</given-name><initials>S.</initials><afid>60030318</afid></author><authkeywords>Fatty acid-binding protein4 | Label-free quantitative mass spectrometry | Laser capture microdissection | Macrophage heterogeneity | Rab GTPases | Transglutaminase-2</authkeywords><intid>1535861480</intid><source-id>11700154304</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928168794"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928168794?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928168794&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928168794&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0149763415000883"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928168794</prism:url><dc:identifier>SCOPUS_ID:84928168794</dc:identifier><eid>2-s2.0-84928168794</eid><dc:title>The hippocampus and TNF: Common links between chronic pain and depression</dc:title><dc:creator>Fasick V.</dc:creator><prism:publicationName>Neuroscience and Biobehavioral Reviews</prism:publicationName><prism:issn>01497634</prism:issn><prism:eIssn>18737528</prism:eIssn><prism:volume>53</prism:volume><prism:pageRange>139-159</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.neubiorev.2015.03.014</prism:doi><pii>S0149763415000883</pii><dc:description>© 2015 Elsevier Ltd. Major depression and chronic pain are significant health problems that seriously impact the quality of life of affected individuals. These diseases that individually are difficult to treat often co-exist, thereby compounding the patient's disability and impairment as well as the challenge of successful treatment. The development of efficacious treatments for these comorbid disorders requires a more comprehensive understanding of their linked associations through common neuromodulators, such as tumor necrosis factor-α (TNFα), and various neurotransmitters, as well as common neuroanatomical pathways and structures, including the hippocampal brain region. This review discusses the interaction between depression and chronic pain, emphasizing the fundamental role of the hippocampus in the development and maintenance of both disorders. The focus of this review addresses the hypothesis that hippocampal expressed TNFα serves as a therapeutic target for management of chronic pain and major depressive disorder (MDD).</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032083</affiliation-url><afid>60032083</afid><affilname>University at Buffalo State University of New York</affilname><name-variant>State University of New York at Buffalo</name-variant><affiliation-city>Buffalo</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114427557</affiliation-url><afid>114427557</afid><affilname>NanoAxis, LLC</affilname><name-variant>NanoAxis, LLC</name-variant><affiliation-city>Clarence</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032083</affiliation-url><afid>60032083</afid><affilname>University at Buffalo State University of New York</affilname><name-variant>State University of New York at Buffalo</name-variant><affiliation-city>Buffalo</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032083</affiliation-url><afid>60032083</afid><affilname>University at Buffalo State University of New York</affilname><name-variant>State University of New York at Buffalo</name-variant><affiliation-city>Buffalo</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56600632400</author-url><authid>56600632400</authid><authname>Fasick V.</authname><surname>Fasick</surname><given-name>Victoria</given-name><initials>V.</initials><afid>60032083</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7004849190</author-url><authid>7004849190</authid><authname>Spengler R.</authname><surname>Spengler</surname><given-name>Robert N.</given-name><initials>R.N.</initials><afid>114427557</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55453446000</author-url><authid>55453446000</authid><authname>Samankan S.</authname><surname>Samankan</surname><given-name>Shabnam</given-name><initials>S.</initials><afid>60032083</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56600192200</author-url><authid>56600192200</authid><authname>Nader N.</authname><surname>Nader</surname><given-name>Nader D.</given-name><initials>N.D.</initials><afid>60032083</afid><afid>60032083</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56600192200</author-url><authid>56600192200</authid><authname>Nader N.</authname><surname>Nader</surname><given-name>Nader D.</given-name><initials>N.D.</initials><afid>60032083</afid><afid>60032083</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6701378617</author-url><authid>6701378617</authid><authname>Ignatowski T.</authname><surname>Ignatowski</surname><given-name>Tracey A.</given-name><initials>T.A.</initials><afid>60032083</afid><afid>114427557</afid><afid>60032083</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6701378617</author-url><authid>6701378617</authid><authname>Ignatowski T.</authname><surname>Ignatowski</surname><given-name>Tracey A.</given-name><initials>T.A.</initials><afid>60032083</afid><afid>114427557</afid><afid>60032083</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6701378617</author-url><authid>6701378617</authid><authname>Ignatowski T.</authname><surname>Ignatowski</surname><given-name>Tracey A.</given-name><initials>T.A.</initials><afid>60032083</afid><afid>114427557</afid><afid>60032083</afid></author><authkeywords>Brain | Chronic pain | Comorbid | Depression | Hippocampus | Tumor necrosis factor-α</authkeywords><intid>35732558</intid><source-id>18045</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928963355"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928963355?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928963355&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928963355&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928963355</prism:url><dc:identifier>SCOPUS_ID:84928963355</dc:identifier><eid>2-s2.0-84928963355</eid><dc:title>Graft Patency in Long-term Survivors after Renovisceral Debranching with VORTEC</dc:title><dc:creator>Winklehner A.</dc:creator><prism:publicationName>CardioVascular and Interventional Radiology</prism:publicationName><prism:issn>01741551</prism:issn><prism:eIssn>1432086X</prism:eIssn><prism:volume>38</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:pageRange>606-612</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s00270-014-0977-z</prism:doi><dc:description>© 2014, Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE). Purpose: This study was designed to evaluate retrospectively the long-term stent-graft patency after renovisceral revascularization with Viabahn Open Revascularization Technique (VORTEC) using computed tomography angiography (CTA) and magnetic resonance angiography (MRA). Methods: In 34 patients (seven women; mean age 72 ± 8 years) with aortic aneurysm, 63 renovisceral vessels (i.e., 54 renal, nine visceral arteries) were revascularized with VORTEC between 2004 and 2009. All patients obtained a pre- and postinterventional CTA and at least one follow-up CTA or MRA after 6 or more months following intervention (median follow up: 43 months). Detection of bypass occlusion, bypass stenosis, infolding, stent-graft fractures and dislocations, and kidney shrinkage were noted by two readers in consensus. Furthermore, mortality during follow-up was assessed using the medical report. Results: During follow-up, 12.6 % of stent-grafts occluded. Cumulative patency rate was 95.2 ± 2.7 % at 12 months, 87.7 ± 4.4 % at 24 and 36 months, and 84.7 ± 5.2 % at 48, 60, 72, 84, and 89 months, respectively. Overall, 19 % of stent-grafts (12/63) developed bypass stenosis (&lt;50 %, 10 stent-grafts; &gt; 50 %, 2 stent-grafts), in one case stenosis (&gt;70 %) was suspected to be hemodynamically significant. No secondary dislocation, no infolding of renovisceral stent-grafts, and no stent-graft fracture occurred. Kidney shrinkage occurred in nine patients, primarily in patients with an occluded Viabahn (n = 7). Eleven patients (32.3 %) died within the follow-up time period. Conclusions: In long-term survivors after VORTEC cumulative patency rate remained high, and no stent-graft fractures or secondary dislocations occurred.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019619</affiliation-url><afid>60019619</afid><affilname>UniversitatsSpital Zurich</affilname><name-variant>University Hospital Zurich</name-variant><affiliation-city>Zurich</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019619</affiliation-url><afid>60019619</afid><affilname>UniversitatsSpital Zurich</affilname><name-variant>University Hospital Zurich</name-variant><affiliation-city>Zurich</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:42162334700</author-url><authid>42162334700</authid><authname>Winklehner A.</authname><surname>Winklehner</surname><given-name>Anna</given-name><initials>A.</initials><afid>60019619</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55945147200</author-url><authid>55945147200</authid><authname>Nguyen-Kim T.</authname><surname>Nguyen-Kim</surname><given-name>Thi Dan Linh</given-name><initials>T.D.L.</initials><afid>60019619</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7006497116</author-url><authid>7006497116</authid><authname>Pfammatter T.</authname><surname>Pfammatter</surname><given-name>Thomas</given-name><initials>T.</initials><afid>60019619</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6508236457</author-url><authid>6508236457</authid><authname>Rancic Z.</authname><surname>Rancic</surname><given-name>Zoran</given-name><initials>Z.</initials><afid>60019619</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7202303371</author-url><authid>7202303371</authid><authname>Mayer D.</authname><surname>Mayer</surname><given-name>Dieter</given-name><initials>D.</initials><afid>60019619</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35452698800</author-url><authid>35452698800</authid><authname>Lachat M.</authname><surname>Lachat</surname><given-name>Mario</given-name><initials>M.</initials><afid>60019619</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6507832349</author-url><authid>6507832349</authid><authname>Frauenfelder T.</authname><surname>Frauenfelder</surname><given-name>Thomas</given-name><initials>T.</initials><afid>60019619</afid></author><authkeywords>Aortic aneurysm | Computed tomography angiography | VORTEC</authkeywords><intid>1035872923</intid><source-id>16597</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925431344"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925431344?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925431344&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925431344&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925431344</prism:url><dc:identifier>SCOPUS_ID:84925431344</dc:identifier><eid>2-s2.0-84925431344</eid><dc:title>Ultra-trace arsenic and mercury speciation and determination in blood samples by ionic liquid-based dispersive liquid-liquid microextraction combined with flow injection-hydride generation/cold vapor atomic absorption spectroscopy</dc:title><dc:creator>Shirkhanloo H.</dc:creator><prism:publicationName>Chemical Papers</prism:publicationName><prism:issn>03666352</prism:issn><prism:eIssn>13369075</prism:eIssn><prism:volume>69</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>779-790</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1515/chempap-2015-0086</prism:doi><dc:description>© 2015 Institute of Chemistry, Slovak Academy of Sciences. A simple, fast, and sensitive method for speciation and determination of As (III, V) and Hg (II, R) in human blood samples based on ionic liquid-dispersive liquid-liquid microextraction (IL-DLLME) and flow injection hydride generation/cold vapor atomic absorption spectrometry (FI-HG/CV-AAS) has been developed. Tetraethylthiuram disulfide, mixed ionic liquids (hydrophobic and hydrophilic ILs) and acetone were used in the DLLME step as the chelating agent, extraction and dispersive solvents, respectively. Using a microwave assisted-UV system, organic mercury (R-Hg) was converted to Hg(II) and total mercury amount was measured in blood samples by the presented method. Total arsenic content was determined by reducing As(V) to As(III) with potassium iodide and ascorbic acid in a hydrochloric acid solution. Finally, As(V) and R-Hg were determined by mathematically subtracting the As(III) and Hg(II) content from the total arsenic and mercury, respectively. Under optimum conditions, linear range and detection limit (3σ) of 0.1-5.0 μg L-1 and 0.02 μg L-1 for As(III) and 0.15-8.50 μg L-1 and 0.03 μg L-1 for Hg(II) were achieved, respectively, at low RSD values of &lt; 4 % (N = 10). The developed method was successfully applied to determine the ultratrace amounts of arsenic and mercury species in blood samples; the validation of the method was performed using standard reference materials.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113136297</affiliation-url><afid>113136297</afid><affilname>Iranian Petroleum Industry Health Research Institute</affilname><name-variant>Iranian Petroleum Industry Health Research Institute</name-variant><affiliation-city>Tehran</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018870</affiliation-url><afid>60018870</afid><affilname>Semnan University</affilname><name-variant>Semnan University</name-variant><affiliation-city>Semnan</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003215</affiliation-url><afid>60003215</afid><affilname>Research Institute of Petroleum Industry, Tehran</affilname><name-variant>Research Institute of Petroleum Industry</name-variant><affiliation-city>Tehran</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:25230864100</author-url><authid>25230864100</authid><authname>Shirkhanloo H.</authname><surname>Shirkhanloo</surname><given-name>Hamid</given-name><initials>H.</initials><afid>113136297</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56462413400</author-url><authid>56462413400</authid><authname>Khaligh A.</authname><surname>Khaligh</surname><given-name>Aisan</given-name><initials>A.</initials><afid>60018870</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55666739100</author-url><authid>55666739100</authid><authname>Mousavi H.</authname><surname>Mousavi</surname><given-name>Hassan Zavvar</given-name><initials>H.Z.</initials><afid>60018870</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7006674053</author-url><authid>7006674053</authid><authname>Eskandari M.</authname><surname>Eskandari</surname><given-name>Mohammad Mehdi</given-name><initials>M.M.</initials><afid>60003215</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55998341700</author-url><authid>55998341700</authid><authname>Miran-Beigi A.</authname><surname>Miran-Beigi</surname><given-name>Ali Akbar</given-name><initials>A.A.</initials><afid>60003215</afid></author><authkeywords>arsenic | hydride generation/cold vapor atomic absorption spectrometry | ionic liquid-based dispersive liquid- liquid microextraction | mercury | microwave assisted-UV system</authkeywords><intid>35295349</intid><source-id>22804</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924872617"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924872617?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924872617&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924872617&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S000632071500097X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924872617</prism:url><dc:identifier>SCOPUS_ID:84924872617</dc:identifier><eid>2-s2.0-84924872617</eid><dc:title>Environmental and anthropogenic factors structuring waterbird habitats of tropical coastal lagoons: Implications for management</dc:title><dc:creator>Tavares D.</dc:creator><prism:publicationName>Biological Conservation</prism:publicationName><prism:issn>00063207</prism:issn><prism:volume>186</prism:volume><prism:pageRange>12-21</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.biocon.2015.02.027</prism:doi><pii>S000632071500097X</pii><dc:description>© 2015 Published by Elsevier Ltd. Tropical coastal lagoons are among the most threatened ecosystems on Earth due to multiple factors. The loss and degradation of coastal lagoons can adversely affect waterbirds, which depend crucially on wetland habitats. This study investigates the effects of a number of environmental variables on waterbird habitat use. Specifically, we assessed the abundances of six waterbird guilds in relation to hydrochemical, structural, and anthropogenic factors in 351 survey blocks of 22 tropical coastal lagoons of southeastern Brazil. Patterns of habitat use were analyzed using generalized mixed models. We found that water depth was the most important variable influencing the waterbird assemblage. Increasing water depth reduced the abundance of small and large wading birds, dabbling ducks, and diving birds. Extreme values of salinity negatively affected diving birds and large wading birds. Vegetation height influenced shorebirds negatively, while it influenced vegetation gleaners positively. Anthropogenic factors played an important role in structuring the habitat of small wading birds, dabbling ducks, diving birds and fishing birds. Our study indicates that the various guilds showed specific responses to different habitat variables. We conclude that the maintenance of water depths in the range of 0-20. cm, the preservation of a mosaic of vegetation heights, and the reduction of livestock grazing pressure are among the most important aspects for supporting high avian abundance and biodiversity in tropical coastal lagoons. Management strategies should therefore address a specific number of structural and hydrochemical attributes of coastal lagoons and should carefully consider the effects of land use practices.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025875</affiliation-url><afid>60025875</afid><affilname>Universidade Estadual do Norte Fluminense</affilname><name-variant>Universidade Estadual do Norte Fluminense</name-variant><affiliation-city>Campos dos Goitacazes</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115060510</affiliation-url><afid>115060510</afid><affilname>Universidade Federal do</affilname><name-variant>Universidade Federal do</name-variant><affiliation-city/><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60072176</affiliation-url><afid>60072176</afid><affilname>Zentrum fur Marine Tropenokologie Bremen</affilname><name-variant>Center for Tropical Marine Ecology</name-variant><affiliation-city>Bremen</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026004</affiliation-url><afid>60026004</afid><affilname>Fundacao Oswaldo Cruz</affilname><name-variant>Fundacao Oswaldo Cruz</name-variant><affiliation-city>Rio de Janeiro</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016458</affiliation-url><afid>60016458</afid><affilname>Jacobs University Bremen</affilname><name-variant>Jacobs University Bremen</name-variant><affiliation-city>Bremen</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55325830400</author-url><authid>55325830400</authid><authname>Tavares D.</authname><surname>Tavares</surname><given-name>Davi Castro</given-name><initials>D.C.</initials><afid>60025875</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8945202700</author-url><authid>8945202700</authid><authname>Guadagnin D.</authname><surname>Guadagnin</surname><given-name>Demétrio Luis</given-name><initials>D.L.</initials><afid>115060510</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:37661243600</author-url><authid>37661243600</authid><authname>de Moura J.</authname><surname>de Moura</surname><given-name>Jailson Fulgencio</given-name><initials>J.F.</initials><afid>60072176</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35301053500</author-url><authid>35301053500</authid><authname>Siciliano S.</authname><surname>Siciliano</surname><given-name>Salvatore</given-name><initials>S.</initials><afid>60026004</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6603349643</author-url><authid>6603349643</authid><authname>Merico A.</authname><surname>Merico</surname><given-name>Agostino</given-name><initials>A.</initials><afid>60072176</afid><afid>60016458</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6603349643</author-url><authid>6603349643</authid><authname>Merico A.</authname><surname>Merico</surname><given-name>Agostino</given-name><initials>A.</initials><afid>60072176</afid><afid>60016458</afid></author><authkeywords>Aquatic birds | Conservation | Generalized linear mixed models | Human-induced changes | Management | Tropical biology | Water depth | Waterfowl | Wetlands</authkeywords><intid>535218371</intid><source-id>17244</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84923332636"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84923332636?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84923332636&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84923332636&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0889157515000563"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84923332636</prism:url><dc:identifier>SCOPUS_ID:84923332636</dc:identifier><eid>2-s2.0-84923332636</eid><dc:title>Changes in fatty acid composition, atherogenic and thrombogenic health lipid indices and lipid stability of bogue (Boops boops Linnaeus, 1758) during storage on ice: Effect of fish farming activities</dc:title><dc:creator>Šimat V.</dc:creator><prism:publicationName>Journal of Food Composition and Analysis</prism:publicationName><prism:issn>08891575</prism:issn><prism:volume>40</prism:volume><prism:pageRange>120-125</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jfca.2014.12.026</prism:doi><pii>S0889157515000563</pii><dc:description>© 2015 Elsevier Inc. In this study the fatty acid (FA) composition and lipid stability of wild and farm-affected wild bogues (Boops boops Linnaeus, 1758) during storage on ice were compared. The main saturated and unsaturated FAs were C16:0 and C18:1(n-9) in both bogue samples. Levels of eicosapentaenoic acid (EPA, 20:5n-3) and docosahexaenoic acid (DHA, 22:6n-3), and n-3/n-6 ratios, as well as atherogenic and thrombogenic indices, were significantly higher in wild samples. Over a period of 16 days on ice, the polyunsaturated fatty acids (PUFAs) were reduced by 9.4% in wild and by 11.7% in farm-affected wild bogues; however, lipid damage during storage on ice was low. The total free fatty acid content of wild and farm-affected wild bogues at three different stages during storage on ice was small, &lt;3% over 16 days. Peroxide values changed from 1.05 to 5.73 and from 2.98 to 5.25milliequivalents (meq)/kg of O2 in wild and farm-affected wild bogues, respectively, while thiobarbituric acid index stayed under 5mg of malondialdehyde/kg in all samples. This work provides important information about the effect of farming activities on changes in lipid and nutritive properties of fish oil from wild and farm-affected wild bogue.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006948</affiliation-url><afid>60006948</afid><affilname>University of Split</affilname><name-variant>University of Split</name-variant><affiliation-city>Split</affiliation-city><affiliation-country>Croatia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60077676</affiliation-url><afid>60077676</afid><affilname>Hrvatski veterinarski institut - Zagreb</affilname><name-variant>Croatian Veterinary Institute</name-variant><affiliation-city>Zagreb</affiliation-city><affiliation-country>Croatia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018171</affiliation-url><afid>60018171</afid><affilname>Croatian National Institute of Public Health</affilname><name-variant>Hrvatski Zavod za Javno Zdravstvo</name-variant><affiliation-city>Zagreb</affiliation-city><affiliation-country>Croatia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35186349300</author-url><authid>35186349300</authid><authname>Šimat V.</authname><surname>Šimat</surname><given-name>Vida</given-name><initials>V.</initials><afid>60006948</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35218617600</author-url><authid>35218617600</authid><authname>Bogdanović T.</authname><surname>Bogdanović</surname><given-name>Tanja</given-name><initials>T.</initials><afid>60077676</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:16317609100</author-url><authid>16317609100</authid><authname>Poljak V.</authname><surname>Poljak</surname><given-name>Vedran</given-name><initials>V.</initials><afid>60018171</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:20434566500</author-url><authid>20434566500</authid><authname>Petričević S.</authname><surname>Petričević</surname><given-name>Sandra</given-name><initials>S.</initials><afid>60077676</afid></author><authkeywords>Aquaculture and nutrition | Bogue | Boops boops linnaeus, 1758 | Farmed fish | Fish lipids | Food analysis | Food composition | Free fatty acids | Peroxide value | Polyene index | Proximate composition | Thiobarbituric acid</authkeywords><intid>34960169</intid><source-id>20582</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929301105"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929301105?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929301105&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929301105&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929301105</prism:url><dc:identifier>SCOPUS_ID:84929301105</dc:identifier><eid>2-s2.0-84929301105</eid><dc:title>Acute Shrinkage of the Pulmonary Vein Ensuing From Radiofrequency and Cryoablations</dc:title><dc:creator>Quallich S.</dc:creator><prism:publicationName>Journal of Medical Devices, Transactions of the ASME</prism:publicationName><prism:issn>19326181</prism:issn><prism:eIssn>1932619X</prism:eIssn><prism:volume>9</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>1-2</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1115/1.4030121</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005745</affiliation-url><afid>60005745</afid><affilname>University of Minnesota System</affilname><name-variant>University of Minnesota</name-variant><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55930246500</author-url><authid>55930246500</authid><authname>Quallich S.</authname><surname>Quallich</surname><given-name>Stephen G.</given-name><initials>S.G.</initials><afid>60005745</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7005561758</author-url><authid>7005561758</authid><authname>Iaizzo P.</authname><surname>Iaizzo</surname><given-name>Paul A.</given-name><initials>P.A.</initials><afid>60005745</afid></author><intid>1785947010</intid><source-id>11700154387</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930226318"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930226318?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930226318&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930226318&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930226318</prism:url><dc:identifier>SCOPUS_ID:84930226318</dc:identifier><eid>2-s2.0-84930226318</eid><dc:title>HuR mediates the synergistic effects of angiotensin II and IL-1β on vascular COX-2 expression and cell migration</dc:title><dc:creator>Aguado A.</dc:creator><prism:publicationName>British Journal of Pharmacology</prism:publicationName><prism:issn>00071188</prism:issn><prism:eIssn>14765381</prism:eIssn><prism:volume>172</prism:volume><prism:issueIdentifier>12</prism:issueIdentifier><prism:pageRange>3028-3042</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1111/bph.13103</prism:doi><dc:description>© 2015 The British Pharmacological Society. Background and Purpose Angiotensin II (AngII) and IL-1β are involved in cardiovascular diseases through the induction of inflammatory pathways. HuR is an adenylate- and uridylate-rich element (ARE)-binding protein involved in the mRNA stabilization of many genes. This study investigated the contribution of HuR to the increased expression of COX-2 induced by AngII and IL-1β and its consequences on VSMC migration and remodelling. Experimental Approach Rat and human VSMCs were stimulated with AngII (0.1 μM) and/or IL-1β (10 ng·mL&lt;sup&gt;-1&lt;/sup&gt;). Mice were infused with AngII or subjected to carotid artery ligation. mRNA and protein levels were assayed by quantitative PCR, Western blot, immunohistochemistry and immunofluorescence. Cell migration was measured by wound healing and transwell assays. Key Results In VSMCs, AngII potentiated COX-2 and tenascin-C expressions and cell migration induced by IL-1β. This effect of AngII on IL-1β-induced COX-2 expression was accompanied by increased COX-2 3′ untranslated region reporter activity and mRNA stability, mediated through cytoplasmic HuR translocation and COX-2 mRNA binding. These effects were blocked by ERK1/2 and HuR inhibitors. VSMC migration was reduced by blockade of ERK1/2, HuR, COX-2, TXAS, TP and EP receptors. HuR, COX-2, mPGES-1 and TXAS expressions were increased in AngII-infused mouse aortas and in carotid-ligated arteries. AngII-induced tenascin-C expression and vascular remodelling were abolished by celecoxib and by mPGES-1 deletion. Conclusions and Implications The synergistic induction of COX-2 by AngII and IL-1β in VSMCs involves HuR through an ERK1/2-dependent mechanism. The HuR/COX-2 axis participates in cell migration and vascular damage. HuR might be a novel target to modulate vascular remodelling.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026796</affiliation-url><afid>60026796</afid><affilname>Universidad Autonoma de Madrid</affilname><name-variant>Universidad Autónoma de Madrid</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60103750</affiliation-url><afid>60103750</afid><affilname>CSIC-ICCC - Centro de Investigacion Cardiovascular (CIC)</affilname><name-variant>Cardiovascular Research Center</name-variant><affiliation-city>Barcelona</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018940</affiliation-url><afid>60018940</afid><affilname>Universidad Rey Juan Carlos</affilname><name-variant>Rey Juan Carlos University</name-variant><affiliation-city>Mostoles</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007828</affiliation-url><afid>60007828</afid><affilname>University of Kansas Medical Center</affilname><name-variant>University of Kansas Medical Center</name-variant><affiliation-city>Kansas City</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35083136100</author-url><authid>35083136100</authid><authname>Aguado A.</authname><surname>Aguado</surname><given-name>A.</given-name><initials>A.</initials><afid>60026796</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55574197855</author-url><authid>55574197855</authid><authname>Rodríguez C.</authname><surname>Rodríguez</surname><given-name>C.</given-name><initials>C.</initials><afid>60103750</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:9037327900</author-url><authid>9037327900</authid><authname>Martínez-Revelles S.</authname><surname>Martínez-Revelles</surname><given-name>S.</given-name><initials>S.</initials><afid>60026796</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35363537300</author-url><authid>35363537300</authid><authname>Avendaño M.</authname><surname>Avendaño</surname><given-name>M. S.</given-name><initials>M.S.</initials><afid>60026796</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55625145500</author-url><authid>55625145500</authid><authname>Zhenyukh O.</authname><surname>Zhenyukh</surname><given-name>O.</given-name><initials>O.</initials><afid>60026796</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:37063355900</author-url><authid>37063355900</authid><authname>Orriols M.</authname><surname>Orriols</surname><given-name>M.</given-name><initials>M.</initials><afid>60103750</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:35550552700</author-url><authid>35550552700</authid><authname>Martínez-González J.</authname><surname>Martínez-González</surname><given-name>J.</given-name><initials>J.</initials><afid>60103750</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7401659495</author-url><authid>7401659495</authid><authname>Alonso M.</authname><surname>Alonso</surname><given-name>M. J.</given-name><initials>M.J.</initials><afid>60018940</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7004606732</author-url><authid>7004606732</authid><authname>Briones A.</authname><surname>Briones</surname><given-name>A. M.</given-name><initials>A.M.</initials><afid>60026796</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7401748076</author-url><authid>7401748076</authid><authname>Dixon D.</authname><surname>Dixon</surname><given-name>D. A.</given-name><initials>D.A.</initials><afid>60007828</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7005739080</author-url><authid>7005739080</authid><authname>Salaices M.</authname><surname>Salaices</surname><given-name>M.</given-name><initials>M.</initials><afid>60026796</afid></author><intid>2036082629</intid><source-id>20084</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929326114"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929326114?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929326114&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929326114&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929326114</prism:url><dc:identifier>SCOPUS_ID:84929326114</dc:identifier><eid>2-s2.0-84929326114</eid><dc:title>Investigational agents for treatment of traumatic brain injury</dc:title><dc:creator>Xiong Y.</dc:creator><prism:publicationName>Expert Opinion on Investigational Drugs</prism:publicationName><prism:issn>13543784</prism:issn><prism:eIssn>17447658</prism:eIssn><prism:volume>24</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>743-760</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1517/13543784.2015.1021919</prism:doi><dc:description>© 2015 Informa UK, Ltd. Introduction: Traumatic brain injury (TBI) is a major cause of death and disability worldwide. To date, there are no pharmacologic agents proven to improve outcomes from TBI because all the Phase III clinical trials in TBI have failed. Thus, there is a compelling need to develop treatments for TBI. Areas covered: The following article provides an overview of select cell-based and pharmacological therapies under early development for the treatment of TBI. These therapies seek to enhance cognitive and neurological functional recovery through neuroprotective and neurorestorative strategies. Expert opinion: TBI elicits both complex degenerative and regenerative tissue responses in the brain. TBI can lead to cognitive, behavioral, and motor deficits. Although numerous promising neuroprotective treatment options have emerged from preclinical studies that mainly target the lesion, translation of preclinical effective neuroprotective drugs to clinical trials has proven challenging. Accumulating evidence indicates that the mammalian brain has a significant, albeit limited, capacity for both structural and functional plasticity, as well as regeneration essential for spontaneous functional recovery after injury. A new therapeutic approach is to stimulate neurovascular remodeling by enhancing angiogenesis, neurogenesis, oligodendrogenesis, and axonal sprouting, which in concert, may improve neurological functional recovery after TBI.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008578</affiliation-url><afid>60008578</afid><affilname>Henry Ford Hospital</affilname><name-variant>Henry Ford Hospital</name-variant><affiliation-city>Detroit</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008578</affiliation-url><afid>60008578</afid><affilname>Henry Ford Hospital</affilname><name-variant>Henry Ford Hospital</name-variant><affiliation-city>Detroit</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008578</affiliation-url><afid>60008578</afid><affilname>Henry Ford Hospital</affilname><name-variant>Henry Ford Hospital</name-variant><affiliation-city>Detroit</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011873</affiliation-url><afid>60011873</afid><affilname>Oakland University</affilname><name-variant>Oakland University</name-variant><affiliation-city>Rochester Hills</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7402194530</author-url><authid>7402194530</authid><authname>Xiong Y.</authname><surname>Xiong</surname><given-name>Ye</given-name><initials>Y.</initials><afid>60008578</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35338253200</author-url><authid>35338253200</authid><authname>Zhang Y.</authname><surname>Zhang</surname><given-name>Yanlu</given-name><initials>Y.</initials><afid>60008578</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56644026500</author-url><authid>56644026500</authid><authname>Mahmood A.</authname><surname>Mahmood</surname><given-name>Asim</given-name><initials>A.</initials><afid>60008578</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35450613600</author-url><authid>35450613600</authid><authname>Chopp M.</authname><surname>Chopp</surname><given-name>Michael</given-name><initials>M.</initials><afid>60008578</afid><afid>60011873</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35450613600</author-url><authid>35450613600</authid><authname>Chopp M.</authname><surname>Chopp</surname><given-name>Michael</given-name><initials>M.</initials><afid>60008578</afid><afid>60011873</afid></author><authkeywords>Angiogenesis | Cell therapy | Exosomes | MicroRNAs | Neurogenesis | Neuroprotection | Neurorestoration | Traumatic brain injury</authkeywords><intid>1535943183</intid><source-id>21351</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930194947"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930194947?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930194947&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930194947&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1521661615000315"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930194947</prism:url><dc:identifier>SCOPUS_ID:84930194947</dc:identifier><eid>2-s2.0-84930194947</eid><dc:title>Monocyte and plasma expression of TAM ligand and receptor in renal failure: Links to unregulated immunity and chronic inflammation</dc:title><dc:creator>Lee I.</dc:creator><prism:publicationName>Clinical Immunology</prism:publicationName><prism:issn>15216616</prism:issn><prism:eIssn>15217035</prism:eIssn><prism:volume>158</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>231-241</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.clim.2015.01.012</prism:doi><pii>S1521661615000315</pii><dc:description>© 2015 Elsevier Inc. Chronic inflammation is increased in patients with chronic kidney disease (CKD) and contributes to cardiovascular morbidity and mortality. Specific immune mechanisms and pathways that drive and maintain chronic inflammation in CKD are not well described. The TAM ligands (Gas6 and protein S) and receptors (Axl and Mer) have been recently recognized as playing a prominent role in immune regulation. The receptors exist in both soluble and cell-bound forms; the soluble receptors (sAxl and sMer) are believed to compete with the bound receptors and thus inhibit their function. In this study, we determined the expression of cell-bound and soluble TAM proteins in patients with CKD. CKD patients had significantly lower expression of Mer in monocytes, yet increased expression of soluble TAM receptors sAxl and sMer in plasma compared to controls. The metalloproteinase ADAM 17, responsible for cleavage of Mer to its soluble form, was increased in patient monocytes. Elevated levels of soluble TAM receptors were more evident in patients with progressive renal failure. These observations suggest that functional deficiency of TAM receptor-mediated regulation of inflammation may contribute to chronic inflammation in patients with CKD.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030398</affiliation-url><afid>60030398</afid><affilname>Temple University</affilname><name-variant>Temple University</name-variant><affiliation-city>Philadelphia</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030398</affiliation-url><afid>60030398</afid><affilname>Temple University</affilname><name-variant>Temple University</name-variant><affiliation-city>Philadelphia</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030398</affiliation-url><afid>60030398</afid><affilname>Temple University</affilname><name-variant>Temple University</name-variant><affiliation-city>Philadelphia</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030398</affiliation-url><afid>60030398</afid><affilname>Temple University</affilname><name-variant>Temple University</name-variant><affiliation-city>Philadelphia</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:26659996300</author-url><authid>26659996300</authid><authname>Lee I.</authname><surname>Lee</surname><given-name>Iris J.</given-name><initials>I.J.</initials><afid>60030398</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603809259</author-url><authid>6603809259</authid><authname>Hilliard B.</authname><surname>Hilliard</surname><given-name>Brendan A.</given-name><initials>B.A.</initials><afid>60030398</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56095937100</author-url><authid>56095937100</authid><authname>Ulas M.</authname><surname>Ulas</surname><given-name>Mehriban</given-name><initials>M.</initials><afid>60030398</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56662618400</author-url><authid>56662618400</authid><authname>Yu D.</authname><surname>Yu</surname><given-name>Daohai</given-name><initials>D.</initials><afid>60030398</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56663218500</author-url><authid>56663218500</authid><authname>Vangala C.</authname><surname>Vangala</surname><given-name>Chandan</given-name><initials>C.</initials><afid>60030398</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55488864200</author-url><authid>55488864200</authid><authname>Rao S.</authname><surname>Rao</surname><given-name>Swati</given-name><initials>S.</initials><afid>60030398</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55490593100</author-url><authid>55490593100</authid><authname>Lee J.</authname><surname>Lee</surname><given-name>Jean</given-name><initials>J.</initials><afid>60030398</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56664769700</author-url><authid>56664769700</authid><authname>Gadegbeku C.</authname><surname>Gadegbeku</surname><given-name>Crystal A.</given-name><initials>C.A.</initials><afid>60030398</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56664763400</author-url><authid>56664763400</authid><authname>Cohen P.</authname><surname>Cohen</surname><given-name>Philip L.</given-name><initials>P.L.</initials><afid>60030398</afid></author><authkeywords>Axl | Chronic kidney disease | Inflammation | Mer | Monocytes | TAM receptors</authkeywords><intid>1786087413</intid><source-id>20740</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926157136"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926157136?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926157136&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926157136&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S089158491500091X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926157136</prism:url><dc:identifier>SCOPUS_ID:84926157136</dc:identifier><eid>2-s2.0-84926157136</eid><dc:title>Efficacy of methuselah gene mutation toward tolerance of dichlorvos exposure in Drosophila melanogaster</dc:title><dc:creator>Pandey A.</dc:creator><prism:publicationName>Free Radical Biology and Medicine</prism:publicationName><prism:issn>08915849</prism:issn><prism:eIssn>18734596</prism:eIssn><prism:volume>83</prism:volume><prism:pageRange>54-65</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.freeradbiomed.2015.02.025</prism:doi><pii>S089158491500091X</pii><dc:description>© 2015 Elsevier Inc. Adverse reports on the exposure of organisms to dichlorvos (DDVP; an organophosphate insecticide) necessitate studies of organismal resistance/tolerance by way of pharmacological or genetic means. In the context of genetic modulation, a mutation in methuselah (mth; encodes a class II G-protein-coupled receptor (GPCR)) is reported to extend (~35%) the life span of Drosophila melanogaster and enhance their resistance to oxidative stress induced by paraquat exposure (short term, high level). A lack of studies on organismal tolerance of DDVP by genetic modulation prompted us to examine the protective efficacy of mth mutation in exposed Drosophila. Flies were exposed to 1.5 and 15.0 ng/ml DDVP for 12-48 h to examine oxidative stress endpoints and chemical resistance. After prolonged exposure of flies to DDVP, antioxidant enzyme activities, oxidative stress, glutathione content, and locomotor performance were assayed at various days (0, 10, 20, 30, 40, 50) of age. Flies with the mth mutation (mth&lt;sup&gt;1&lt;/sup&gt;) showed improved chemical resistance and rescued redox impairment after acute DDVP exposure. Exposed mth&lt;sup&gt;1&lt;/sup&gt; flies exhibited improved life span along with enhanced antioxidant enzyme activities and rescued oxidative perturbations and locomotor insufficiency up to middle age (~20 days) over similarly exposed w&lt;sup&gt;1118&lt;/sup&gt; flies. However, at late (=30 days) age, these benefits were undermined. Further, similarly exposed mth-knockdown flies showed effects similar to those observed in mth&lt;sup&gt;1&lt;/sup&gt; flies. This study provides evidence of tolerance in organisms carrying a mth mutation against prolonged DDVP exposure and further warrants examination of similar class II GPCR signaling facets toward better organismal health.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60101552</affiliation-url><afid>60101552</afid><affilname>Indian Institute of Toxicology Research</affilname><name-variant>Indian Institute of Toxicology Research</name-variant><affiliation-city>Lucknow</affiliation-city><affiliation-country>India</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008721</affiliation-url><afid>60008721</afid><affilname>Banaras Hindu University</affilname><name-variant>Banaras Hindu University</name-variant><affiliation-city>Varanasi</affiliation-city><affiliation-country>India</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114071236</affiliation-url><afid>114071236</afid><affilname>Academy of Scientific and Innovative Research</affilname><name-variant>Academy of Scientific and Innovative Research (AcSIR)</name-variant><affiliation-city>Lucknow</affiliation-city><affiliation-country>India</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60101552</affiliation-url><afid>60101552</afid><affilname>Indian Institute of Toxicology Research</affilname><name-variant>Indian Institute of Toxicology Research</name-variant><affiliation-city>Lucknow</affiliation-city><affiliation-country>India</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:37097834500</author-url><authid>37097834500</authid><authname>Pandey A.</authname><surname>Pandey</surname><given-name>Ashutosh</given-name><initials>A.</initials><afid>60101552</afid><afid>60008721</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:37097834500</author-url><authid>37097834500</authid><authname>Pandey A.</authname><surname>Pandey</surname><given-name>Ashutosh</given-name><initials>A.</initials><afid>60101552</afid><afid>60008721</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56580155200</author-url><authid>56580155200</authid><authname>Khatoon R.</authname><surname>Khatoon</surname><given-name>Rehana</given-name><initials>R.</initials><afid>60101552</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56032170600</author-url><authid>56032170600</authid><authname>Saini S.</authname><surname>Saini</surname><given-name>Sanjay</given-name><initials>S.</initials><afid>60101552</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56032241400</author-url><authid>56032241400</authid><authname>Vimal D.</authname><surname>Vimal</surname><given-name>Divya</given-name><initials>D.</initials><afid>60101552</afid><afid>114071236</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56032241400</author-url><authid>56032241400</authid><authname>Vimal D.</authname><surname>Vimal</surname><given-name>Divya</given-name><initials>D.</initials><afid>60101552</afid><afid>114071236</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:12041256600</author-url><authid>12041256600</authid><authname>Patel D.</authname><surname>Patel</surname><given-name>Devendra Kumar</given-name><initials>D.K.</initials><afid>114071236</afid><afid>60101552</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:12041256600</author-url><authid>12041256600</authid><authname>Patel D.</authname><surname>Patel</surname><given-name>Devendra Kumar</given-name><initials>D.K.</initials><afid>114071236</afid><afid>60101552</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7004870735</author-url><authid>7004870735</authid><authname>Narayan G.</authname><surname>Narayan</surname><given-name>Gopeshwar</given-name><initials>G.</initials><afid>60008721</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6601985892</author-url><authid>6601985892</authid><authname>Chowdhuri D.</authname><surname>Chowdhuri</surname><given-name>Debapratim Kar</given-name><initials>D.K.</initials><afid>60101552</afid><afid>114071236</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6601985892</author-url><authid>6601985892</authid><authname>Chowdhuri D.</authname><surname>Chowdhuri</surname><given-name>Debapratim Kar</given-name><initials>D.K.</initials><afid>60101552</afid><afid>114071236</afid></author><authkeywords>Dichlorvos | Drosophila | Freeradicals | Life span | Long-term exposure | Methuselah | Oxidativestress</authkeywords><intid>1035677797</intid><source-id>15095</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925354033"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925354033?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925354033&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925354033&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0958166915000373"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925354033</prism:url><dc:identifier>SCOPUS_ID:84925354033</dc:identifier><eid>2-s2.0-84925354033</eid><dc:title>Metagenomics for the discovery of novel biosurfactants of environmental interest from marine ecosystems</dc:title><dc:creator>Jackson S.</dc:creator><prism:publicationName>Current Opinion in Biotechnology</prism:publicationName><prism:issn>09581669</prism:issn><prism:eIssn>18790429</prism:eIssn><prism:volume>33</prism:volume><prism:pageRange>176-182</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.copbio.2015.03.004</prism:doi><pii>S0958166915000373</pii><dc:description>© 2015 Elsevier Ltd. cerevisiae. coli. Research focused on the search for new biosurfactants aims to replace chemical surfactants, which while being cost-effective are ecologically undesirable. Metagenomics can lead to discovery of novel biosurfactants, tackling issues of low production yields. Recent successes include the heterologous production of biosurfactants. The dearth of biosurfactants discovered to date through metagenomics is puzzling given that good screening systems and heterologous host systems are available.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025160</affiliation-url><afid>60025160</afid><affilname>University College Cork</affilname><name-variant>University College Cork</name-variant><affiliation-city>Cork</affiliation-city><affiliation-country>Ireland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025160</affiliation-url><afid>60025160</afid><affilname>University College Cork</affilname><name-variant>University College Cork</name-variant><affiliation-city>Cork</affiliation-city><affiliation-country>Ireland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025160</affiliation-url><afid>60025160</afid><affilname>University College Cork</affilname><name-variant>University College Cork</name-variant><affiliation-city>Cork</affiliation-city><affiliation-country>Ireland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55419800600</author-url><authid>55419800600</authid><authname>Jackson S.</authname><surname>Jackson</surname><given-name>Stephen A.</given-name><initials>S.A.</initials><afid>60025160</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56566643200</author-url><authid>56566643200</authid><authname>Borchert E.</authname><surname>Borchert</surname><given-name>Erik</given-name><initials>E.</initials><afid>60025160</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7005240529</author-url><authid>7005240529</authid><authname>O'Gara F.</authname><surname>O'Gara</surname><given-name>Fergal</given-name><initials>F.</initials><afid>60025160</afid><afid>60025160</afid><afid>60025160</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7005240529</author-url><authid>7005240529</authid><authname>O'Gara F.</authname><surname>O'Gara</surname><given-name>Fergal</given-name><initials>F.</initials><afid>60025160</afid><afid>60025160</afid><afid>60025160</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7005240529</author-url><authid>7005240529</authid><authname>O'Gara F.</authname><surname>O'Gara</surname><given-name>Fergal</given-name><initials>F.</initials><afid>60025160</afid><afid>60025160</afid><afid>60025160</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56017141900</author-url><authid>56017141900</authid><authname>Dobson A.</authname><surname>Dobson</surname><given-name>Alan D W</given-name><initials>A.D.W.</initials><afid>60025160</afid><afid>60025160</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56017141900</author-url><authid>56017141900</authid><authname>Dobson A.</authname><surname>Dobson</surname><given-name>Alan D W</given-name><initials>A.D.W.</initials><afid>60025160</afid><afid>60025160</afid></author><intid>2035284742</intid><source-id>15579</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925712577"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925712577?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925712577&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925712577&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0891584915000908"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925712577</prism:url><dc:identifier>SCOPUS_ID:84925712577</dc:identifier><eid>2-s2.0-84925712577</eid><dc:title>Overproduction of nitric oxide by endothelial cells and macrophages contributes to mitochondrial oxidative stress in adrenocortical cells and adrenal insufficiency during endotoxemia</dc:title><dc:creator>Wang C.</dc:creator><prism:publicationName>Free Radical Biology and Medicine</prism:publicationName><prism:issn>08915849</prism:issn><prism:eIssn>18734596</prism:eIssn><prism:volume>83</prism:volume><prism:pageRange>31-40</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.freeradbiomed.2015.02.024</prism:doi><pii>S0891584915000908</pii><dc:description>© 2015 Elsevier Inc. All rights reserved. We have recently demonstrated that lipopolysaccharide (LPS) causes mitochondrial oxidative stress and dysfunction in adrenal glands, thereby leading to adrenocortical insufficiency. Since nitric oxide (NO) produced by inducible nitric oxide synthase (iNOS) leads to mitochondrial damage in various tissues, the present study aims to investigate whether NO contributes to mitochondrial oxidative stress in adrenal cortex and adrenocortical insufficiency during endotoxemia. Systemic administration of LPS increased iNOS expression and NO production in adrenal glands of mice. The specific iNOS inhibitor 1400 W significantly attenuated the LPS-induced mitochondrial superoxide production and dysfunction in adrenal glands, and reversed the LPS-induced adrenocortical hyporesponsiveness to adrenocorticotropic hormone (ACTH). In contrast, administration of the NO donor sodium nitroprusside (SNP) led to mitochondrial oxidative stress and dysfunction in adrenal glands, which resulted in a blunted corticosterone response to ACTH. Using double immunofluorescence staining for iNOS with the vascular endothelial cell marker CD31 or the macrophage marker CD68, we found that increased iNOS expression was found in vascular endothelial cells and macrophages, but not adrenocortical cells in the adrenal gland during endotoxemia. Administration of the hydrogen sulfide (H2S) donor GYY4137 inhibited NO production and reversed LPS-induced adrenocortical hyporesponsiveness. Our data suggest that overproduction of NO, which is mainly generated by endothelial cells and macrophages during endotoxemia, contributes to mitochondrial oxidative stress in adrenocortical cells and subsequently leads to adrenal insufficiency.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001604</affiliation-url><afid>60001604</afid><affilname>Ministry of Education China</affilname><name-variant>Ministry of Education</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60069758</affiliation-url><afid>60069758</afid><affilname>Changhai Hospital</affilname><name-variant>Second Military Medical University</name-variant><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023813</affiliation-url><afid>60023813</afid><affilname>Shanghai University</affilname><name-variant>Shanghai University</name-variant><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55643976200</author-url><authid>55643976200</authid><authname>Wang C.</authname><surname>Wang</surname><given-name>Chang Nan</given-name><initials>C.N.</initials><afid>60001604</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56063716800</author-url><authid>56063716800</authid><authname>Duan G.</authname><surname>Duan</surname><given-name>Guo Li</given-name><initials>G.L.</initials><afid>60001604</afid><afid>60069758</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56063716800</author-url><authid>56063716800</authid><authname>Duan G.</authname><surname>Duan</surname><given-name>Guo Li</given-name><initials>G.L.</initials><afid>60001604</afid><afid>60069758</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56376874600</author-url><authid>56376874600</authid><authname>Liu Y.</authname><surname>Liu</surname><given-name>Yu Jian</given-name><initials>Y.J.</initials><afid>60023813</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56573192000</author-url><authid>56573192000</authid><authname>Yu Q.</authname><surname>Yu</surname><given-name>Qing</given-name><initials>Q.</initials><afid>60001604</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56573120900</author-url><authid>56573120900</authid><authname>Tang X.</authname><surname>Tang</surname><given-name>Xiao Lu</given-name><initials>X.L.</initials><afid>60001604</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55574199179</author-url><authid>55574199179</authid><authname>Zhao W.</authname><surname>Zhao</surname><given-name>Wei</given-name><initials>W.</initials><afid>60001604</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55870158200</author-url><authid>55870158200</authid><authname>Li X.</authname><surname>Li</surname><given-name>Xiao Han</given-name><initials>X.H.</initials><afid>60001604</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:55696608200</author-url><authid>55696608200</authid><authname>Zhu X.</authname><surname>Zhu</surname><given-name>Xiao Yan</given-name><initials>X.Y.</initials><afid>60001604</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7202075942</author-url><authid>7202075942</authid><authname>Ni X.</authname><surname>Ni</surname><given-name>Xin</given-name><initials>X.</initials><afid>60001604</afid></author><authkeywords>Adrenalinsufficiency | Hydrogensulfide | Lipopolysaccharide | Mitochondria | Nitric oxide</authkeywords><intid>535351560</intid><source-id>15095</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927755459"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927755459?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927755459&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927755459&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0143622815000776"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927755459</prism:url><dc:identifier>SCOPUS_ID:84927755459</dc:identifier><eid>2-s2.0-84927755459</eid><dc:title>Spatial distribution of unconventional gas wells and human populations in the Marcellus Shale in the United States: Vulnerability analysis</dc:title><dc:creator>Ogneva-Himmelberger Y.</dc:creator><prism:publicationName>Applied Geography</prism:publicationName><prism:issn>01436228</prism:issn><prism:volume>60</prism:volume><prism:pageRange>165-174</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.apgeog.2015.03.011</prism:doi><pii>S0143622815000776</pii><dc:description>© 2015 Elsevier Ltd. Modern forms of drilling and extraction have recently led to a boom in oil and gas production in the U.S. and stimulated a controversy around its economic benefits and environmental and human health impacts. Using an environmental justice paradigm this study applies Geographic Information Systems (GIS) and spatial analysis to determine whether certain vulnerable human populations are unequally exposed to pollution from unconventional gas wells in Pennsylvania, West Virginia, and Ohio. Several GIS-based approaches were used to identify exposed areas, and a t-test was used to find statistically significant differences between rural populations living close to wells and rural populations living farther away. Sociodemographic indicators include age (children and the elderly), poverty level, education level, and race at the census tract level. Local Indicators of Spatial Autocorrelation (LISA) technique was applied to find spatial clusters where both high well density and high proportions of vulnerable populations occur. The results demonstrate that the environmental injustice occurs in areas with unconventional wells in Pennsylvania with respect to the poor population. There are also localized clusters of vulnerable populations in exposed areas in all three states: Pennsylvania (for poverty and elderly population), West Virginia (for poverty, elderly population, and education level) and Ohio (for children).</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026910</affiliation-url><afid>60026910</afid><affilname>Clark University</affilname><name-variant>Clark University</name-variant><affiliation-city>Worcester</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6505992197</author-url><authid>6505992197</authid><authname>Ogneva-Himmelberger Y.</authname><surname>Ogneva-Himmelberger</surname><given-name>Yelena</given-name><initials>Y.</initials><afid>60026910</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56593893200</author-url><authid>56593893200</authid><authname>Huang L.</authname><surname>Huang</surname><given-name>Liyao</given-name><initials>L.</initials><afid>60026910</afid></author><authkeywords>Environmental justice | Hydraulic fracturing | LISA | Vulnerability</authkeywords><intid>35666309</intid><source-id>27471</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929994248"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929994248?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929994248&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929994248&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929994248</prism:url><dc:identifier>SCOPUS_ID:84929994248</dc:identifier><eid>2-s2.0-84929994248</eid><dc:title>Elucidation of hydroxyl groups-antioxidant relationship in mono- and dihydroxyflavones based on O-H bond dissociation enthalpies</dc:title><dc:creator>Treesuwan W.</dc:creator><prism:publicationName>Journal of Molecular Modeling</prism:publicationName><prism:issn>16102940</prism:issn><prism:eIssn>09485023</prism:eIssn><prism:volume>21</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s00894-015-2669-2</prism:doi><dc:description>© 2015, Springer-Verlag Berlin Heidelberg. Radical scavenging potential is the key to anti-oxidation of hydroxyflavones which generally found in fruits and vegetables. The objective of this work was to investigate the influence of hydroxyl group on the O-H bond dissociation enthalpies (BDE) from a series of mono- and dihydroxyflavones. Calculation at the B3LYP/6-31G(d,p) level reveals the important roles of an additional one hydroxyl group to boost the BDE of hydroxyflavones that were a stabilization of the generated radicals through attractive H-bond interactions, an ortho- and para-dihydroxyl effect, and a presence of the 3-OH in dihydroxyflavones. On the other hand, the meta-dihydroxyl effect and range-hydroxyl effect especially associated with the either 5-OH or 8-OH promoted greater BDE. Results did not only confirm that dihydroxyflavones had lower BDE than monohydroxyflavones but also suggest the selective potent hydroxyflavone molecules that are the 6′-hydroxyflavone (for monohydroxyflavone) and the 5′,6′-, 7,8- and 3′,4′-dihydroxyflavone which the corresponding radical preferable generated at C6′-O•, C8-O• and C4′-O•, respectively. Electron distribution was limited only over the two connected rings of hydroxyflavones while the expansion distribution into C-ring could be enhanced if the radical was formed especially for the 2′,3′- and 5′,6′dihydroxyflavone radicals. The delocalized bonds were strengthened after radical was generated. However the 5-O• in 5,6-dihydroxyflavone and the 3-O• in 3,6′-dihydroxyflavone increased the bond order at C4-O11 which might interrupt the conjugated delocalized bonds at the keto group. [Figure not available: see fulltext.]</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021944</affiliation-url><afid>60021944</afid><affilname>Kasetsart University</affilname><name-variant>Kasetsart University</name-variant><affiliation-city>Bangkok</affiliation-city><affiliation-country>Thailand</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021944</affiliation-url><afid>60021944</afid><affilname>Kasetsart University</affilname><name-variant>Kasetsart University</name-variant><affiliation-city>Bangkok</affiliation-city><affiliation-country>Thailand</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021944</affiliation-url><afid>60021944</afid><affilname>Kasetsart University</affilname><name-variant>Kasetsart University</name-variant><affiliation-city>Bangkok</affiliation-city><affiliation-country>Thailand</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:15840460500</author-url><authid>15840460500</authid><authname>Treesuwan W.</authname><surname>Treesuwan</surname><given-name>Witcha</given-name><initials>W.</initials><afid>60021944</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:9240339500</author-url><authid>9240339500</authid><authname>Suramitr S.</authname><surname>Suramitr</surname><given-name>Songwut</given-name><initials>S.</initials><afid>60021944</afid><afid>60021944</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:9240339500</author-url><authid>9240339500</authid><authname>Suramitr S.</authname><surname>Suramitr</surname><given-name>Songwut</given-name><initials>S.</initials><afid>60021944</afid><afid>60021944</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55401484200</author-url><authid>55401484200</authid><authname>Hannongbua S.</authname><surname>Hannongbua</surname><given-name>Supa</given-name><initials>S.</initials><afid>60021944</afid><afid>60021944</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55401484200</author-url><authid>55401484200</authid><authname>Hannongbua S.</authname><surname>Hannongbua</surname><given-name>Supa</given-name><initials>S.</initials><afid>60021944</afid><afid>60021944</afid></author><authkeywords>Antioxidant | Bond dissociation enthalpy | DFT | Functional food | Hydroxyflavone</authkeywords><intid>36048711</intid><source-id>57844</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930216279"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930216279?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930216279&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930216279&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S2352431615000425"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930216279</prism:url><dc:identifier>SCOPUS_ID:84930216279</dc:identifier><eid>2-s2.0-84930216279</eid><dc:title>Oxidation stiffening of PDMS microposts</dc:title><dc:creator>Sim J.</dc:creator><prism:publicationName>Extreme Mechanics Letters</prism:publicationName><prism:eIssn>23524316</prism:eIssn><prism:volume>3</prism:volume><prism:pageRange>17-23</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.eml.2015.02.003</prism:doi><pii>S2352431615000425</pii><dc:description>© 2015 Elsevier Ltd. This paper presents guidance for analyzing the stiffness changes of micropost arrays after oxidation. Numerous mechanobiology studies exploit micropost arrays to quantify cell-generated micropost displacements and traction forces. Cell adhesion requires surface functionalization typically facilitated by an oxidation step, which can form a glassy skin. We estimate the material properties of this skin, analytically calculate the stiffness of oxidized microposts and compare it with direct measurements. We find correction factors increase exponentially with decreasing micropost diameter. Ignoring this oxidation stiffening of microposts results in more than 200% underestimation in micropost stiffness as well as the cellular traction forces extracted from micropost deflections.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012708</affiliation-url><afid>60012708</afid><affilname>Stanford University</affilname><name-variant>Stanford University</name-variant><affiliation-city>Palo Alto</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001558</affiliation-url><afid>60001558</afid><affilname>Electronics and Telecommunications Research Institute</affilname><name-variant>Electronics and Telecommunications Research Institute (ETRI)</name-variant><affiliation-city>Daejeon</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:38562023300</author-url><authid>38562023300</authid><authname>Sim J.</authname><surname>Sim</surname><given-name>Joo Yong</given-name><initials>J.Y.</initials><afid>60012708</afid><afid>60001558</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:38562023300</author-url><authid>38562023300</authid><authname>Sim J.</authname><surname>Sim</surname><given-name>Joo Yong</given-name><initials>J.Y.</initials><afid>60012708</afid><afid>60001558</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56302118500</author-url><authid>56302118500</authid><authname>Taylor R.</authname><surname>Taylor</surname><given-name>Rebecca E.</given-name><initials>R.E.</initials><afid>60012708</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56662742300</author-url><authid>56662742300</authid><authname>Larsen T.</authname><surname>Larsen</surname><given-name>Tom</given-name><initials>T.</initials><afid>60012708</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7102121044</author-url><authid>7102121044</authid><authname>Pruitt B.</authname><surname>Pruitt</surname><given-name>Beth L.</given-name><initials>B.L.</initials><afid>60012708</afid></author><authkeywords>Mechanotransduction | Rigidity sensing | Traction force</authkeywords><intid>1786088012</intid><source-id>21100376821</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930178577"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930178577?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930178577&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930178577&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1878540915000274"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930178577</prism:url><dc:identifier>SCOPUS_ID:84930178577</dc:identifier><eid>2-s2.0-84930178577</eid><dc:title>Editorial: Anomalous aortic origin of coronary arteries: What we know, what we need to know</dc:title><dc:creator>Fujii K.</dc:creator><prism:publicationName>Journal of Cardiology Cases</prism:publicationName><prism:issn>18785409</prism:issn><prism:eIssn>18785409</prism:eIssn><prism:volume>11</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>181-182</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jccase.2015.03.006</prism:doi><pii>S1878540915000274</pii><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030873</affiliation-url><afid>60030873</afid><affilname>Hyogo College of Medicine</affilname><name-variant>Hyogo College of Medicine</name-variant><affiliation-city>Nishinomiya</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ed</subtype><subtypeDescription>Editorial</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7403359586</author-url><authid>7403359586</authid><authname>Fujii K.</authname><surname>Fujii</surname><given-name>Kenichi</given-name><initials>K.</initials><afid>60030873</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56385212000</author-url><authid>56385212000</authid><authname>Masuyama T.</authname><surname>Masuyama</surname><given-name>Tohru</given-name><initials>T.</initials><afid>60030873</afid></author><authkeywords>Atherosclerosis | Coronary anomaly | Intravascular ultrasound</authkeywords><intid>1786079679</intid><source-id>19600156852</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929340310"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929340310?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929340310&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929340310&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929340310</prism:url><dc:identifier>SCOPUS_ID:84929340310</dc:identifier><eid>2-s2.0-84929340310</eid><dc:title>The evaluation of blood damage in a left Ventricular assist device</dc:title><dc:creator>Myagmar O.</dc:creator><prism:publicationName>Journal of Medical Devices, Transactions of the ASME</prism:publicationName><prism:issn>19326181</prism:issn><prism:eIssn>1932619X</prism:eIssn><prism:volume>9</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1115/1.4030122</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001777</affiliation-url><afid>60001777</afid><affilname>Rochester Institute of Technology</affilname><name-variant>Rochester Institute of Technology</name-variant><affiliation-city>Rochester</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56644879100</author-url><authid>56644879100</authid><authname>Myagmar O.</authname><surname>Myagmar</surname><given-name>Oyungerel</given-name><initials>O.</initials><afid>60001777</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56566083200</author-url><authid>56566083200</authid><authname>Day S.</authname><surname>Day</surname><given-name>Steven W.</given-name><initials>S.W.</initials><afid>60001777</afid></author><intid>35945341</intid><article-number>020914</article-number><source-id>11700154387</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924156242"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924156242?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924156242&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924156242&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0160412015000355"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924156242</prism:url><dc:identifier>SCOPUS_ID:84924156242</dc:identifier><eid>2-s2.0-84924156242</eid><dc:title>Lower placental telomere length may be attributed to maternal residential traffic exposure; a twin study</dc:title><dc:creator>Bijnens E.</dc:creator><prism:publicationName>Environment International</prism:publicationName><prism:issn>01604120</prism:issn><prism:eIssn>18736750</prism:eIssn><prism:volume>79</prism:volume><prism:pageRange>1-7</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.envint.2015.02.008</prism:doi><pii>S0160412015000355</pii><dc:description>© 2015 . Background: High variation in telomere length between individuals is already present before birth and is as wide among newborns as in adults. Environmental exposures likely have an impact on this observation, but remain largely unidentified. We hypothesize that placental telomere length in twins is associated with residential traffic exposure, an important environmental source of free radicals that might accelerate aging. Next, we intend to unravel the nature-nurture contribution to placental telomere length by estimating the heritability of placental telomere length. Methods: We measured the telomere length in placental tissues of 211 twins in the East Flanders Prospective Twin Survey. Maternal traffic exposure was determined using a geographic information system. Additionally, we estimated the relative importance of genetic and environmental sources of variance. Results: In this twin study, a variation in telomere length in the placental tissue was mainly determined by the common environment. Maternal residential proximity to a major road was associated with placental telomere length: a doubling in the distance to the nearest major road was associated with a 5.32% (95% CI: 1.90 to 8.86%; p. =. 0.003) longer placental telomere length at birth. In addition, an interquartile increase (22%) in maternal residential surrounding greenness (5. km buffer) was associated with an increase of 3.62% (95% CI: 0.20 to 7.15%; p. =. 0.04) in placental telomere length. Conclusions: In conclusion, we showed that maternal residential proximity to traffic and lower residential surrounding greenness is associated with shorter placental telomere length at birth. This may explain a significant proportion of air pollution-related adverse health outcomes starting from early life, since shortened telomeres accelerate the progression of many diseases.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010413</affiliation-url><afid>60010413</afid><affilname>Universiteit Hasselt</affilname><name-variant>Limburgs Universitair Centrum</name-variant><affiliation-city>Diepenbeek</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018869</affiliation-url><afid>60018869</afid><affilname>Maastricht University</affilname><name-variant>University of Limburg</name-variant><affiliation-city>Maastricht</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018869</affiliation-url><afid>60018869</afid><affilname>Maastricht University</affilname><name-variant>University of Limburg</name-variant><affiliation-city>Maastricht</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031069</affiliation-url><afid>60031069</afid><affilname>University Hospital Leuven</affilname><name-variant>University Hospitals Leuven</name-variant><affiliation-city>Leuven</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025063</affiliation-url><afid>60025063</afid><affilname>Katholieke Universiteit Leuven</affilname><name-variant>University of Leuven</name-variant><affiliation-city>Leuven</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55969785700</author-url><authid>55969785700</authid><authname>Bijnens E.</authname><surname>Bijnens</surname><given-name>Esmée</given-name><initials>E.</initials><afid>60010413</afid><afid>60018869</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55969785700</author-url><authid>55969785700</authid><authname>Bijnens E.</authname><surname>Bijnens</surname><given-name>Esmée</given-name><initials>E.</initials><afid>60010413</afid><afid>60018869</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7003691618</author-url><authid>7003691618</authid><authname>Zeegers M.</authname><surname>Zeegers</surname><given-name>Maurice P.</given-name><initials>M.P.</initials><afid>60018869</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:9737867600</author-url><authid>9737867600</authid><authname>Gielen M.</authname><surname>Gielen</surname><given-name>Marij</given-name><initials>M.</initials><afid>60018869</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:53982775000</author-url><authid>53982775000</authid><authname>Kicinski M.</authname><surname>Kicinski</surname><given-name>Michal</given-name><initials>M.</initials><afid>60010413</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56305212500</author-url><authid>56305212500</authid><authname>Hageman G.</authname><surname>Hageman</surname><given-name>Geja J.</given-name><initials>G.J.</initials><afid>60018869</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6602445057</author-url><authid>6602445057</authid><authname>Pachen D.</authname><surname>Pachen</surname><given-name>Daniëlle</given-name><initials>D.</initials><afid>60018869</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7003348389</author-url><authid>7003348389</authid><authname>Derom C.</authname><surname>Derom</surname><given-name>Catherine</given-name><initials>C.</initials><afid>60031069</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7005040487</author-url><authid>7005040487</authid><authname>Vlietinck R.</authname><surname>Vlietinck</surname><given-name>Robert</given-name><initials>R.</initials><afid>60031069</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:6701621197</author-url><authid>6701621197</authid><authname>Nawrot T.</authname><surname>Nawrot</surname><given-name>Tim S.</given-name><initials>T.S.</initials><afid>60010413</afid><afid>60025063</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:6701621197</author-url><authid>6701621197</authid><authname>Nawrot T.</authname><surname>Nawrot</surname><given-name>Tim S.</given-name><initials>T.S.</initials><afid>60010413</afid><afid>60025063</afid></author><authkeywords>Placenta | Telomeres | Traffic | Twin</authkeywords><intid>1535083464</intid><source-id>20912</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929178273"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929178273?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929178273&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929178273&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929178273</prism:url><dc:identifier>SCOPUS_ID:84929178273</dc:identifier><eid>2-s2.0-84929178273</eid><dc:title>Evaluation and management of back pain in the elderly</dc:title><dc:creator>Ulane C.</dc:creator><prism:publicationName>Current Geriatrics Reports</prism:publicationName><prism:eIssn>21967865</prism:eIssn><prism:volume>4</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>117-123</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s13670-015-0122-0</prism:doi><dc:description>© 2015 Springer Science+Business Media New York. Back pain is common in the elderly. Most back pain is uncomplicated but identifying back pain due to serious systemic disease is essential. History and physical exam are critical to this distinction and guide further diagnostic evaluation. There are numerous treatments available for acute and chronic back pain, yet there are special considerations when treating the elderly. Treatment is comprehensive with pharmacotherapy, physical therapy, and alternative methods. Pharmacologic therapy for back pain is targeted at reducing inflammation and providing analgesia. Physical therapy is a necessary part of any treatment plan. Non-pharmacologic treatments are broad in scope and consist of activity-based modalities and alternative therapies. Acute back pain generally has a good prognosis, while chronic back pain can be associated with significant morbidity. This update will review the epidemiology, pathophysiology, evaluation, and treatment of back pain with a particular emphasis on issues unique to the geriatric population.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027565</affiliation-url><afid>60027565</afid><affilname>Columbia University Medical Center</affilname><name-variant>Columbia University</name-variant><affiliation-city>New York</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36855341600</author-url><authid>36855341600</authid><authname>Ulane C.</authname><surname>Ulane</surname><given-name>Christina M.</given-name><initials>C.M.</initials><afid>60027565</afid></author><authkeywords>Back pain | Degenerative spine disease | Elderly | Herniated disc | Muscle relaxant | NSAIDs | Spinal stenosis</authkeywords><intid>1785918703</intid><source-id>21100358312</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926334825"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926334825?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926334825&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926334825&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0141813015002044"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926334825</prism:url><dc:identifier>SCOPUS_ID:84926334825</dc:identifier><eid>2-s2.0-84926334825</eid><dc:title>Spectroscopy study and co-administration effect on the interaction of mycophenolic acid and human serum albumin</dc:title><dc:creator>Ma X.</dc:creator><prism:publicationName>International Journal of Biological Macromolecules</prism:publicationName><prism:issn>01418130</prism:issn><prism:eIssn>18790003</prism:eIssn><prism:volume>77</prism:volume><prism:pageRange>280-286</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijbiomac.2015.03.052</prism:doi><pii>S0141813015002044</pii><dc:description>© 2015 Elsevier B.V. Mycophenolic acid (MPA), an immunosuppressor, is always administered in combination with several drugs in clinical therapy, which may alter the binding of MPA to human serum albumin (HSA) and could influence its pharmacological activities. Thus, this study evaluated the interaction between HSA and MPA, as well as investigated the effect of co-administrated drugs on the MPA-protein binary system using fluorescence spectroscopy. Results revealed that MPA has a strong capability to quench the fluorescence of HSA, and the acting forces for the binding are hydrogen bonds and van der Waals forces. Competition on combined administration showed that balofloxacin significantly affects the MPA-HSA interaction, as reflected by the remarkable decrease in fluorescence intensity. Furthermore, cefminox sodium has competitive capability with MPA to some extent, whereas methyl prednisone and amlodipine besylate have a minor influence on the binary system. However, simvastatin has no appreciable effect on the MPA-HSA interaction. In addition, three-dimensional fluorescence spectra and circular dichroism spectroscopy, which were employed to determine the conformation, showed that the binding of MPA with HSA can induce conformation changes in HSA.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016521</affiliation-url><afid>60016521</afid><affilname>Sichuan University</affilname><name-variant>Sichuan University</name-variant><affiliation-city>Chengdu</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56580750300</author-url><authid>56580750300</authid><authname>Ma X.</authname><surname>Ma</surname><given-name>Xiaoli</given-name><initials>X.</initials><afid>60016521</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55595559200</author-url><authid>55595559200</authid><authname>Yan J.</authname><surname>Yan</surname><given-name>Jin</given-name><initials>J.</initials><afid>60016521</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55555450900</author-url><authid>55555450900</authid><authname>Wang Q.</authname><surname>Wang</surname><given-name>Qing</given-name><initials>Q.</initials><afid>60016521</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56291791400</author-url><authid>56291791400</authid><authname>Wu D.</authname><surname>Wu</surname><given-name>Di</given-name><initials>D.</initials><afid>60016521</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56002811300</author-url><authid>56002811300</authid><authname>Li H.</authname><surname>Li</surname><given-name>Hui</given-name><initials>H.</initials><afid>60016521</afid></author><authkeywords>Co-administration | Human serum albumin (HSA) | Interaction | Mycophenolic acid (MPA) | Spectroscopy</authkeywords><intid>1035427572</intid><source-id>17544</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924989314"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924989314?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924989314&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924989314&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1751616115000703"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924989314</prism:url><dc:identifier>SCOPUS_ID:84924989314</dc:identifier><eid>2-s2.0-84924989314</eid><dc:title>Novel methodology for assessing biomaterial-biofluid interaction in cancellous bone</dc:title><dc:creator>Bou-Francis A.</dc:creator><prism:publicationName>Journal of the Mechanical Behavior of Biomedical Materials</prism:publicationName><prism:issn>17516161</prism:issn><prism:eIssn>18780180</prism:eIssn><prism:volume>46</prism:volume><prism:pageRange>158-167</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jmbbm.2015.02.027</prism:doi><pii>S1751616115000703</pii><dc:description>© 2015 Elsevier Ltd. Understanding the cement flow behaviour and accurately predicting the cement placement within the vertebral body is extremely challenging. Vertebral cancellous bone displays highly complex geometrical structures and architectural inhomogeneities over a range of length scales, thus making the scientific understanding of the cement injection behaviour difficult in clinical or cadaveric studies. Previous experimental studies on cement flow have used open-porous aluminum foam to represent osteoporotic bone. Although the porosity was well controlled, the geometrical structure of each of the foams was inherently unique. This paper presents novel methodology using customized, reproducible and pathologically representative three-dimensional bone surrogates to help study biomaterial-biofluid interaction. The aim was to provide a robust tool for comprehensive assessment of biomaterial injection behaviour through controlling the bone surrogate morphology and the injection parameters (i.e. needle gauge, needle placement, flow rate and injected volume), measuring the injection pressure, and allowing the visualization and quantitative analysis of the spreading distribution. This methodology provides a clinically relevant representation of cement flow patterns and a tool for validating computational simulations.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012070</affiliation-url><afid>60012070</afid><affilname>University of Leeds</affilname><name-variant>University of Leeds</name-variant><affiliation-city>Leeds</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012070</affiliation-url><afid>60012070</afid><affilname>University of Leeds</affilname><name-variant>University of Leeds</name-variant><affiliation-city>Leeds</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025858</affiliation-url><afid>60025858</afid><affilname>Eidgenossische Technische Hochschule Zurich</affilname><name-variant>ETH Zurich</name-variant><affiliation-city>Zurich</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56362508600</author-url><authid>56362508600</authid><authname>Bou-Francis A.</authname><surname>Bou-Francis</surname><given-name>Antony</given-name><initials>A.</initials><afid>60012070</afid><afid>60012070</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56362508600</author-url><authid>56362508600</authid><authname>Bou-Francis A.</authname><surname>Bou-Francis</surname><given-name>Antony</given-name><initials>A.</initials><afid>60012070</afid><afid>60012070</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55790794300</author-url><authid>55790794300</authid><authname>Widmer Soyka R.</authname><surname>Widmer Soyka</surname><given-name>René P.</given-name><initials>R.P.</initials><afid>60025858</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56417126700</author-url><authid>56417126700</authid><authname>Ferguson S.</authname><surname>Ferguson</surname><given-name>Stephen J.</given-name><initials>S.J.</initials><afid>60025858</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56480994800</author-url><authid>56480994800</authid><authname>Hall R.</authname><surname>Hall</surname><given-name>Richard M.</given-name><initials>R.M.</initials><afid>60012070</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56460941400</author-url><authid>56460941400</authid><authname>Kapur N.</authname><surname>Kapur</surname><given-name>Nikil</given-name><initials>N.</initials><afid>60012070</afid></author><authkeywords>Bone cement | Bone surrogates | Cement injection behavior | Cement leakage | Experimental computational cross-validation | Vertebral augmentation</authkeywords><intid>35232297</intid><source-id>8000153139</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927168986"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927168986?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927168986&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927168986&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0039128X15001129"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927168986</prism:url><dc:identifier>SCOPUS_ID:84927168986</dc:identifier><eid>2-s2.0-84927168986</eid><dc:title>Synthesis and radical scavenger properties of novel spirochromenes derived from steroid sapogenins</dc:title><dc:creator>Ramos-Enríquez M.</dc:creator><prism:publicationName>Steroids</prism:publicationName><prism:issn>0039128X</prism:issn><prism:eIssn>18785867</prism:eIssn><prism:volume>98</prism:volume><prism:pageRange>132-137</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.steroids.2015.03.013</prism:doi><pii>S0039128X15001129</pii><dc:description>© 2015 Elsevier Inc. All rights reserved. Abstract Tandem aldol condensation between steroid sapogenins and hydroxylated benzaldehydes afforded steroidal spirochromenes. Compounds that bear a phenolic hydroxyl group at position C-6′, obtained by a reaction with 2,5-dihydroxybenzaldehyde, showed approximately 80% of maximal radical scavenging activity in the 1,1-diphenyl-2-picrylhydrazyl radical (DPPH) assay at 288 nM. In contrast, the starting steroid sapogenins and the spirochromenes without a phenolic group in the side chain proved to be inactive.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005847</affiliation-url><afid>60005847</afid><affilname>Universidad Nacional Autonoma de Mexico, Facultad de Quimica</affilname><name-variant>UNAM</name-variant><affiliation-city>Mexico City</affiliation-city><affiliation-country>Mexico</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55776287300</author-url><authid>55776287300</authid><authname>Ramos-Enríquez M.</authname><surname>Ramos-Enríquez</surname><given-name>Manuel A.</given-name><initials>M.A.</initials><afid>60005847</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6602200343</author-url><authid>6602200343</authid><authname>Medina-Campos O.</authname><surname>Medina-Campos</surname><given-name>Omar N.</given-name><initials>O.N.</initials><afid>60005847</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7007015511</author-url><authid>7007015511</authid><authname>Pedraza-Chaverri J.</authname><surname>Pedraza-Chaverri</surname><given-name>José</given-name><initials>J.</initials><afid>60005847</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6701580186</author-url><authid>6701580186</authid><authname>Iglesias-Arteaga M.</authname><surname>Iglesias-Arteaga</surname><given-name>Martín A.</given-name><initials>M.A.</initials><afid>60005847</afid></author><authkeywords>Antioxidant activity | DPPH test | Radical scavengers | Spirochromenes | Steroid sapogenins</authkeywords><intid>535571699</intid><article-number>7767</article-number><source-id>14805</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929492691"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929492691?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929492691&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929492691&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929492691</prism:url><dc:identifier>SCOPUS_ID:84929492691</dc:identifier><eid>2-s2.0-84929492691</eid><dc:title>Detection of an amphiphilic biosample in a paper microchannel based on length</dc:title><dc:creator>Chen Y.</dc:creator><prism:publicationName>Biomedical Microdevices</prism:publicationName><prism:issn>13872176</prism:issn><prism:eIssn>15728781</prism:eIssn><prism:volume>17</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s10544-015-9954-9</prism:doi><dc:description>© 2015, Springer Science+Business Media New York. We developed a simple method to achieve semiquantitative detection of an amphiphilic biosample through measuring the length of flow on a microfluidic analytical device (μPAD) based on paper. When an amphiphilic sample was dripped into a straight microchannel defined with a printed wax barrier (hydrophobic) on filter paper (hydrophilic), the length of flow was affected by the reciprocal effect between the sample, the filter-paper channel and the wax barrier. The flow length decreased with increasing concentration of an amphiphilic sample because of adsorption of the sample on the hydrophobic barrier. Measurement of the flow length enabled a determination of the concentration of the amphiphilic sample. The several tested samples included surfactants (Tween 20 and Triton X-100), oligonucleotides (DNA), bovine serum albumin (BSA), human albumin, nitrite, glucose and low-density lipoprotein (LDL). The results show that the measurement of the flow length determined directly the concentration of an amphiphilic sample, whereas a non-amphiphilic sample was not amenable to this method. The proposed method features the advantages of small cost, simplicity, convenience, directness, rapidity (&lt;5 min) and requirement of only a small volume (5 μL) of sample, with prospective applications in developing areas and sites near patients for testing at a point of care (POCT).</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005429</affiliation-url><afid>60005429</afid><affilname>National Taiwan University</affilname><name-variant>National Taiwan University</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36058470500</author-url><authid>36058470500</authid><authname>Chen Y.</authname><surname>Chen</surname><given-name>Yu Tzu</given-name><initials>Y.T.</initials><afid>60005429</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35323156500</author-url><authid>35323156500</authid><authname>Yang J.</authname><surname>Yang</surname><given-name>Jing Tang</given-name><initials>J.T.</initials><afid>60005429</afid></author><authkeywords>Amphiphilic | Length-based measurement | Microfluidic paper-based analytical device (μPAD) | Protein | Semiquantitative analysis</authkeywords><intid>1535963570</intid><source-id>28590</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924767753"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924767753?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924767753&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924767753&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0168945215000527"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924767753</prism:url><dc:identifier>SCOPUS_ID:84924767753</dc:identifier><eid>2-s2.0-84924767753</eid><dc:title>Stress responsive miRNAs and isomiRs in cereals</dc:title><dc:creator>Budak H.</dc:creator><prism:publicationName>Plant Science</prism:publicationName><prism:issn>01689452</prism:issn><prism:eIssn>18732259</prism:eIssn><prism:volume>235</prism:volume><prism:pageRange>1-13</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.plantsci.2015.02.008</prism:doi><pii>S0168945215000527</pii><dc:description>© 2015 Elsevier Ireland Ltd. Abiotic and biotic stress conditions are vital determinants in the production of cereals, the major caloric source in human nutrition. Small RNAs, miRNAs and isomiRs are central to post-transcriptional regulation of gene expression in a variety of cellular processes including development and stress responses. Several miRNAs have been identified using new technologies and have roles in stress responses in plants, including cereals. The overall knowledge about the cereal miRNA repertoire, as well as an understanding of complex miRNA mediated mechanisms of target regulation in response to stress conditions, is far from complete. Ongoing efforts that add to our understanding of complex miRNA machinery have implications in plant response to stress conditions. Additionally, sequence variants of miRNAs (isomiRNAs or isomiRs), regulation of their expression through dissection of upstream regulatory elements, the role of Processing-bodies (P-bodies) in miRNA exerted gene regulation and yet unveiled organellar plant miRNAs are newly emerging topics, which will contribute to the elucidation of the miRNA machinery and its role in cereal tolerance against abiotic and biotic stresses.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008991</affiliation-url><afid>60008991</afid><affilname>Sabanci Universitesi</affilname><name-variant>Sabanci University</name-variant><affiliation-city>Istanbul</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8681535200</author-url><authid>8681535200</authid><authname>Budak H.</authname><surname>Budak</surname><given-name>Hikmet</given-name><initials>H.</initials><afid>60008991</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36188351700</author-url><authid>36188351700</authid><authname>Kantar M.</authname><surname>Kantar</surname><given-name>Melda</given-name><initials>M.</initials><afid>60008991</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56549836100</author-url><authid>56549836100</authid><authname>Bulut R.</authname><surname>Bulut</surname><given-name>Reyyan</given-name><initials>R.</initials><afid>60008991</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55205912300</author-url><authid>55205912300</authid><authname>Akpinar B.</authname><surname>Akpinar</surname><given-name>Bala Ani</given-name><initials>B.A.</initials><afid>60008991</afid></author><authkeywords>CipomiRs | IsomiRs | MiRNA | MitomiRs | P-bodies | Plants</authkeywords><intid>1535197663</intid><source-id>16620</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84922366909"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84922366909?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84922366909&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84922366909&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1877343515000123"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84922366909</prism:url><dc:identifier>SCOPUS_ID:84922366909</dc:identifier><eid>2-s2.0-84922366909</eid><dc:title>REDD+ framework with integrated measurement, reporting and verification system for Community Based Forest Management Systems (CBFMS) in Nepal</dc:title><dc:creator>Sharma S.</dc:creator><prism:publicationName>Current Opinion in Environmental Sustainability</prism:publicationName><prism:issn>18773435</prism:issn><prism:volume>14</prism:volume><prism:pageRange>17-27</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cosust.2015.01.003</prism:doi><pii>S1877343515000123</pii><dc:description>© 2015 Elsevier B.V. Reducing Emissions from Deforestation and Forest Degradation+ (REDD+) has been accepted as a new paradigm for climate change mitigation. A country like Nepal could benefit from REDD+ and make a difference to the livelihoods of communities, including poor and marginalised families, from the positive incentives realized by establishing a MRV inclusive REDD+ framework that assures net GHG emission reductions at the local, landscape or sub-national levels. This paper presents a MRV inclusive REDD+ framework for Community Based Forest Management System and guides all stakeholders to accelerate REDD+ initiatives. This proposed REDD+ framework with MRV System draws on Nepal's in-country institutional structures and technical capabilities, and thus enables Nepal to participate early in the REDD+ mechanism.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:110075539</affiliation-url><afid>110075539</afid><affilname>Carbon Planet</affilname><name-variant>Carbon Planet Ltd.</name-variant><affiliation-city>Adelaide</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020828</affiliation-url><afid>60020828</afid><affilname>Flinders University of South Australia</affilname><name-variant>Flinders University of South Australia</name-variant><affiliation-city>Adelaide</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114967657</affiliation-url><afid>114967657</afid><affilname>Environmental Resources Institute Pvt. Ltd.</affilname><name-variant>Environmental Resources Institute Pvt. Ltd.</name-variant><affiliation-city/><affiliation-country>Nepal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114968715</affiliation-url><afid>114968715</afid><affilname>COOE Pty. Ltd.</affilname><name-variant>COOE Pty. Ltd.</name-variant><affiliation-city>Adelaide</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56505887300</author-url><authid>56505887300</authid><authname>Sharma S.</authname><surname>Sharma</surname><given-name>Sunil Kumar</given-name><initials>S.K.</initials><afid>110075539</afid><afid>60020828</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56505887300</author-url><authid>56505887300</authid><authname>Sharma S.</authname><surname>Sharma</surname><given-name>Sunil Kumar</given-name><initials>S.K.</initials><afid>110075539</afid><afid>60020828</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56507219300</author-url><authid>56507219300</authid><authname>Deml K.</authname><surname>Deml</surname><given-name>Kassandra</given-name><initials>K.</initials><afid>110075539</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56507315400</author-url><authid>56507315400</authid><authname>Dangal S.</authname><surname>Dangal</surname><given-name>Shambhu</given-name><initials>S.</initials><afid>114967657</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56507377200</author-url><authid>56507377200</authid><authname>Rana E.</authname><surname>Rana</surname><given-name>Eak</given-name><initials>E.</initials><afid>114968715</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56506864800</author-url><authid>56506864800</authid><authname>Madigan S.</authname><surname>Madigan</surname><given-name>Stephen</given-name><initials>S.</initials><afid>114968715</afid></author><intid>534797546</intid><source-id>19400158343</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930196459"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930196459?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930196459&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930196459&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930196459</prism:url><dc:identifier>SCOPUS_ID:84930196459</dc:identifier><eid>2-s2.0-84930196459</eid><dc:title>Re-conceptualising the Clan Structure and Migration Pattern of the Tarok People</dc:title><dc:creator>Lamle E.</dc:creator><prism:publicationName>International Migration</prism:publicationName><prism:issn>00207985</prism:issn><prism:eIssn>14682435</prism:eIssn><prism:volume>53</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:pageRange>168-192</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1111/j.1468-2435.2011.00684.x</prism:doi><dc:description>© 2011 The Author. International Migration © 2011 IOM. This study analyses the migration pattern of the Tarok people to their contemporary homeland, Langtang, in the Middle Belt of Nigeria. The framework is that the Tarok people are part of the Benue-Congo ethno-linguistic phylum. This conclusion is based on the assertion that the contemporary language that the Tarok people speak is of the Benue-Congo phylum. However, others of the Chadic ethno-linguistic phyla such as the Ngas, Boghom, Tel (Montol) and Yiwom joined the Benue-Congo Phylum and are given the full status of Tarokness. Also, Jukun, which are of the Benue Congo group, joined the Tarok and are given the same status as that of the Chadic. The study concludes that what is called the Tarok people are actually a consortium of many ethno-linguistic groups that mongrelized and gave birth to the Tarok people. This is because even though the cognate of the Tarok language is of the Benue-Congo phylum, their morphemes are a combination of the Benue Congo and Chadic ethno linguistic phylum.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028601</affiliation-url><afid>60028601</afid><affilname>University of Jos</affilname><name-variant>University of Jos</name-variant><affiliation-city>Jos</affiliation-city><affiliation-country>Nigeria</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:37081115500</author-url><authid>37081115500</authid><authname>Lamle E.</authname><surname>Lamle</surname><given-name>Elias Nankap</given-name><initials>E.N.</initials><afid>60028601</afid></author><intid>1536088309</intid><source-id>26855</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928890447"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928890447?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928890447&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928890447&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928890447</prism:url><dc:identifier>SCOPUS_ID:84928890447</dc:identifier><eid>2-s2.0-84928890447</eid><dc:title>Lack of effect of multiple doses of vortioxetine on the pharmacokinetics and pharmacodynamics of aspirin and warfarin</dc:title><dc:creator>Chen G.</dc:creator><prism:publicationName>Journal of Clinical Pharmacology</prism:publicationName><prism:issn>00912700</prism:issn><prism:eIssn>15524604</prism:eIssn><prism:volume>55</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>671-679</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1002/jcph.456</prism:doi><dc:description>© 2014, The American College of Clinical Pharmacology. Vortioxetine is an antidepressant with multimodal activity approved for the treatment of major depressive disorder. Two separate randomized, placebo-controlled trials evaluated the effects of multiple doses of vortioxetine (10 mg/day) on the pharmacokinetics and pharmacodynamics of aspirin and warfarin in healthy volunteers. In the aspirin study, subjects received vortioxetine 10 mg or placebo once daily for 14 days, followed by coadministration with aspirin 150 mg once daily for 6 days, in 2 periods with a crossover design. In the warfarin study, subjects were randomized after reaching target international normalized ratio (INR) values on warfarin to receive vortioxetine 10 mg or matching placebo once daily for 14 days, with all subjects receiving a maintenance dose of warfarin (1-10 mg). Vortioxetine had no effect on the steady-state pharmacokinetic parameters of aspirin or its metabolite salicylic acid, and no statistically significant effect on the inhibition of arachidonic acid-, adenosine-5′-diphosphate-, or collagen-induced platelet aggregation at any time points. Coadministration of vortioxetine did not alter the pharmacokinetics of (R)- and (S)-warfarin enantiomers, or the mean coagulation parameters of warfarin treatment alone. Coadministration of vortioxetine doses in healthy volunteers had no effect on aspirin or warfarin pharmacokinetics or pharmacodynamics. Vortioxetine was well tolerated when coadministered with aspirin or warfarin.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113906147</affiliation-url><afid>113906147</afid><affilname>Takeda Development Center Americas</affilname><name-variant>Takeda Development Center Americas</name-variant><affiliation-city>Deerfield</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55875800100</author-url><authid>55875800100</authid><authname>Chen G.</authname><surname>Chen</surname><given-name>Grace</given-name><initials>G.</initials><afid>113906147</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56510477700</author-url><authid>56510477700</authid><authname>Zhang W.</authname><surname>Zhang</surname><given-name>Wencan</given-name><initials>W.</initials><afid>113906147</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55874826400</author-url><authid>55874826400</authid><authname>Serenko M.</authname><surname>Serenko</surname><given-name>Michael</given-name><initials>M.</initials><afid>113906147</afid></author><authkeywords>bleeding | coagulation | drug-drug interaction | pharmacokinetics | platelet | vortioxetine</authkeywords><intid>535862554</intid><source-id>22983</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929336193"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929336193?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929336193&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929336193&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929336193</prism:url><dc:identifier>SCOPUS_ID:84929336193</dc:identifier><eid>2-s2.0-84929336193</eid><dc:title>Design of Bioimpedance Spectroscopy Instrument With Compensation Techniques for Soft Tissue Characterization</dc:title><dc:creator>Dodde R.</dc:creator><prism:publicationName>Journal of Medical Devices, Transactions of the ASME</prism:publicationName><prism:issn>19326181</prism:issn><prism:eIssn>1932619X</prism:eIssn><prism:volume>9</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>1-8</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1115/1.4029706</prism:doi><dc:description>© 2015 by ASME. Bioimpedance spectroscopy (BIS) has shown significant potential in many areas of medicine to provide new physiologic markers. Several acute and chronic diseases are accompanied by changes in intra- and extracellular fluid within various areas of the human body. The estimation of fluid in various body compartments is therefore a simple and convenient method to monitor certain disease states. In this work, the design and evaluation of a BIS instrument are presented and three key areas of the development process investigated facilitating the BIS measurement of tissue hydration state. First, the benefit of incorporating DC-stabilizing circuitry to the standard modified Howland current pump (MHCP) is investigated to minimize the effect of DC offsets limiting the dynamic range of the system. Second, the influence of the distance between the bioimpedance probe and a high impedance material is investigated using finite element analysis (FEA). Third, an analytic compensation technique is presented to minimize the influence of parasitic capacitance. Finally, the overall experimental setup is evaluated through ex vivo BIS measurements of porcine spleen tissue and compared to published results. The DC-stabilizing circuit demonstrated its ability to maintain DC offsets at less than 650 lV through 100 kHz while maintaining an output impedance of 1 MX from 100 Hz to 100 kHz. The proximity of a bioimpedance probe to a high impedance material such as acrylic was shown to increase measured impedance readings by a factor of 4x as the ratio of the distance between the sensing electrodes to the distance between the bioimpedance probe and acrylic reached 1:3. The average parasitic capacitance for the circuit presented was found to be 7126128 pF, and the analytic compensation method was shown to be able to minimize this effect on the BIS measurements. Measurements of porcine spleen tissue showed close correlation with experimental results reported in published articles. This research presents the successful design and evaluation of a BIS instrument. Specifically, robust measurements were obtained by implementing a DC-stabilized current source, investigating probe-material proximity issues and compensating for parasitic capacitance. These strategies were shown to provide tissue measurements comparable with published literature.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:107273215</affiliation-url><afid>107273215</afid><affilname>Stryker Corporation</affilname><name-variant>Stryker Corporation</name-variant><affiliation-city>Cambridge</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025778</affiliation-url><afid>60025778</afid><affilname>University Michigan Ann Arbor</affilname><name-variant>University of Michigan</name-variant><affiliation-city>Ann Arbor</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025778</affiliation-url><afid>60025778</afid><affilname>University Michigan Ann Arbor</affilname><name-variant>University of Michigan</name-variant><affiliation-city>Ann Arbor</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:23093567400</author-url><authid>23093567400</authid><authname>Dodde R.</authname><surname>Dodde</surname><given-name>Robert E.</given-name><initials>R.E.</initials><afid>107273215</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:25623687000</author-url><authid>25623687000</authid><authname>Kruger G.</authname><surname>Kruger</surname><given-name>Grant H.</given-name><initials>G.H.</initials><afid>60025778</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7103260452</author-url><authid>7103260452</authid><authname>Shih A.</authname><surname>Shih</surname><given-name>Albert J.</given-name><initials>A.J.</initials><afid>60025778</afid></author><authkeywords>bioimpedance | Current source | Soft-tissue | Spectroscopy</authkeywords><intid>2035940723</intid><source-id>11700154387</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928536616"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928536616?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928536616&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928536616&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S093964111500171X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928536616</prism:url><dc:identifier>SCOPUS_ID:84928536616</dc:identifier><eid>2-s2.0-84928536616</eid><dc:title>Retinol encapsulated into amorphous Ca&lt;sup&gt;2+&lt;/sup&gt; polyphosphate nanospheres acts synergistically in MC3T3-E1 cells</dc:title><dc:creator>Müller W.</dc:creator><prism:publicationName>European Journal of Pharmaceutics and Biopharmaceutics</prism:publicationName><prism:issn>09396411</prism:issn><prism:eIssn>18733441</prism:eIssn><prism:volume>93</prism:volume><prism:pageRange>214-223</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ejpb.2015.04.005</prism:doi><pii>S093964111500171X</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. Both the quality and quantity of collagen, the major structural component of the skin, decrease in aging skin. We succeeded to encapsulate retinol into amorphous inorganic polyphosphate (polyP) nanoparticles together with calcium ions ("aCa-polyP-NP"), under formation of amorphous Ca-polyP/retinol nanospheres ("retinol/aCa-polyP-NS"). The globular nanospheres are not cytotoxic, show an almost uniform size of 45 nm and have a retinol content of around 25%. Both components of those nanospheres, retinol and the aCa-polyP-NP, if administered together, caused a strong increase in proliferation of mouse calvaria MC3T3 cells. The expressions of collagen types I, II and III genes, but not the expression of collagen type V gene, were significantly enhanced if retinol is added together with aCa-polyP-NP. This synergistic effect was especially pronounced for the expression of the collagen type III gene. We propose that the synergistic effect of the retinol/aCa-polyP-NS on cell growth and collagen type III expression is induced via two routes, first through cellular uptake of the 45 nm nanospheres by clathrin-mediated endocytosis and second through extracellular disintegration of the nanospheres resulting in the release of retinol which is then taken up into the cells after binding to the retinal binding protein receptor.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031216</affiliation-url><afid>60031216</afid><affilname>Johannes Gutenberg Universitat Mainz</affilname><name-variant>University of Mainz</name-variant><affiliation-city>Mainz</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014618</affiliation-url><afid>60014618</afid><affilname>National Research Centre</affilname><name-variant>National Research Centre</name-variant><affiliation-city>Cairo</affiliation-city><affiliation-country>Egypt</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114097425</affiliation-url><afid>114097425</afid><affilname>NanotecMARIN GmbH</affilname><name-variant>NanotecMARIN</name-variant><affiliation-city>Mainz</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35374468500</author-url><authid>35374468500</authid><authname>Müller W.</authname><surname>Müller</surname><given-name>Werner E G</given-name><initials>W.E.G.</initials><afid>60031216</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56327133700</author-url><authid>56327133700</authid><authname>Tolba E.</authname><surname>Tolba</surname><given-name>Emad</given-name><initials>E.</initials><afid>60031216</afid><afid>60014618</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56327133700</author-url><authid>56327133700</authid><authname>Tolba E.</authname><surname>Tolba</surname><given-name>Emad</given-name><initials>E.</initials><afid>60031216</afid><afid>60014618</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56400080800</author-url><authid>56400080800</authid><authname>Schröder H.</authname><surname>Schröder</surname><given-name>Heinz C.</given-name><initials>H.C.</initials><afid>60031216</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6603333933</author-url><authid>6603333933</authid><authname>Diehl-Seifert B.</authname><surname>Diehl-Seifert</surname><given-name>Bärbel</given-name><initials>B.</initials><afid>114097425</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55736920800</author-url><authid>55736920800</authid><authname>Wang X.</authname><surname>Wang</surname><given-name>Xiaohong</given-name><initials>X.</initials><afid>60031216</afid></author><authkeywords>Collagen type III | Polyphosphate | Retinol | Skin damage | Synergistic action</authkeywords><intid>1035798414</intid><source-id>21332</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928998042"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928998042?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928998042&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928998042&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928998042</prism:url><dc:identifier>SCOPUS_ID:84928998042</dc:identifier><eid>2-s2.0-84928998042</eid><dc:title>Female PAPP-A knockout mice are resistant to metabolic dysfunction induced by high-fat/high-sucrose feeding at middle age</dc:title><dc:creator>Hill C.</dc:creator><prism:publicationName>Age</prism:publicationName><prism:issn>01619152</prism:issn><prism:eIssn>15744647</prism:eIssn><prism:volume>37</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:pageRange>1-14</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s11357-015-9765-1</prism:doi><dc:description>© 2015, American Aging Association. Longevity and aging are influenced by common intracellular signals of the insulin/insulin-like growth factor (IGF)-1 pathway. Abnormally high levels of bioactive IGF-1 increase the development of various cancers and may contribute to metabolic diseases such as insulin resistance. Enhanced availability of IGF-1 is promoted by cleavage of IGF binding proteins (IGFBPs) by proteases, including the pregnancy-associated plasma protein-A (PAPPA). In vitro, PAPP-A is regulated by pro-inflammatory cytokines (PICs) such as interleukin (IL)-6 and tumor necrosis factor (TNF). Mice born with deficiency of the Papp-a gene (PAPP-A knockout (KO) mice) live ∼30–40 % longer than their normal littermates and have decreased bioactive IGF-1 on standard diets. Our objective was to elucidate how the effects of high-fat, high-sucrose diet (HFHS) promote obesity, induce metabolic dysfunction, and alter systemic cytokine expression in PAPP-A KO and normal mice. PAPP-A KO mice fed HFHS diet for 10 weeks were more glucose tolerant and had enhanced insulin sensitivity compared to normal mice fed HFHS diet. PAPP-A KO mice fed HFHS diet had lower levels of pro-inflammatory cytokines (IL-2, IL-6, and TNF-α) compared to normal mice fed the same diet. However, anti-inflammatory cytokine levels (IL-4 and adiponectin) were higher in PAPP-A KO mice fed HFHS diet compared to normal mice fed HFHS. Circulating PAPP-A levels were elevated in normal mice fed an HFHS diet compared to normal mice fed a standard, low-fat, low-sucrose (LFLS) diet. Indirect calorimetry showed, at 10 weeks of feeding HFHS diet, significantly increased oxygen consumption (VO&lt;inf&gt;2&lt;/inf&gt;) in PAPP-A KO mice fed HFHS diet compared to normal mice fed the same diet. Furthermore, respiratory quotient (RQ) was significantly lower in PAPP-A KO mice fed HFHS diet compared to normal (N) mice fed HFHS diet indicating PAPP-A KO mice fed HFHS diet are able to rely on fat as their primary source of energy more so than normal controls. We conclude that PAPP-A KO mice are resistant to the HFHS diet induction of metabolic dysfunction associated with higher levels of anti-inflammatory cytokines and a remarkably metabolic flexible phenotype and that some of the effects of HFHS diet in normal animals may be due to increased levels of PAPP-A.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021399</affiliation-url><afid>60021399</afid><affilname>Southern Illinois University School of Medicine</affilname><name-variant>Southern Illinois University School of Medicine</name-variant><affiliation-city>Springfield</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022144</affiliation-url><afid>60022144</afid><affilname>University of Central Florida</affilname><name-variant>University of Central Florida</name-variant><affiliation-city>Orlando</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021399</affiliation-url><afid>60021399</afid><affilname>Southern Illinois University School of Medicine</affilname><name-variant>Southern Illinois University School of Medicine</name-variant><affiliation-city>Springfield</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname/><affiliation-city>Springfield</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55631121000</author-url><authid>55631121000</authid><authname>Hill C.</authname><surname>Hill</surname><given-name>Cristal M.</given-name><initials>C.M.</initials><afid>60021399</afid><afid>60021399</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55631121000</author-url><authid>55631121000</authid><authname>Hill C.</authname><surname>Hill</surname><given-name>Cristal M.</given-name><initials>C.M.</initials><afid>60021399</afid><afid>60021399</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:22233716900</author-url><authid>22233716900</authid><authname>Arum O.</authname><surname>Arum</surname><given-name>Oge</given-name><initials>O.</initials><afid>60021399</afid><afid/></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:22233716900</author-url><authid>22233716900</authid><authname>Arum O.</authname><surname>Arum</surname><given-name>Oge</given-name><initials>O.</initials><afid>60021399</afid><afid/></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7801602815</author-url><authid>7801602815</authid><authname>Boparai R.</authname><surname>Boparai</surname><given-name>Ravneet K.</given-name><initials>R.K.</initials><afid>60021399</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:15726963500</author-url><authid>15726963500</authid><authname>Wang F.</authname><surname>Wang</surname><given-name>Feiya</given-name><initials>F.</initials><afid>60021399</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55469336900</author-url><authid>55469336900</authid><authname>Fang Y.</authname><surname>Fang</surname><given-name>Yimin</given-name><initials>Y.</initials><afid>60021399</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35485730000</author-url><authid>35485730000</authid><authname>Sun L.</authname><surname>Sun</surname><given-name>Liou Y.</given-name><initials>L.Y.</initials><afid>60021399</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6508205666</author-url><authid>6508205666</authid><authname>Masternak M.</authname><surname>Masternak</surname><given-name>Michal M.</given-name><initials>M.M.</initials><afid>60022144</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:36044638400</author-url><authid>36044638400</authid><authname>Bartke A.</authname><surname>Bartke</surname><given-name>Andrzej</given-name><initials>A.</initials><afid>60021399</afid><afid>60021399</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:36044638400</author-url><authid>36044638400</authid><authname>Bartke A.</authname><surname>Bartke</surname><given-name>Andrzej</given-name><initials>A.</initials><afid>60021399</afid><afid>60021399</afid></author><authkeywords>High-fat/high-sucrose diet | Immune response | Insulin/IGF-1 signaling | Longevity | Metabolic flexibility | PAPP-A KO mice</authkeywords><intid>1035879212</intid><source-id>40283</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929444208"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929444208?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929444208&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929444208&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1874391915001487"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929444208</prism:url><dc:identifier>SCOPUS_ID:84929444208</dc:identifier><eid>2-s2.0-84929444208</eid><dc:title>Important mitochondrial proteins in human omental adipose tissue show reduced expression in obesity</dc:title><dc:creator>Lindinger P.</dc:creator><prism:publicationName>Journal of Proteomics</prism:publicationName><prism:issn>18743919</prism:issn><prism:eIssn>18767737</prism:eIssn><prism:volume>124</prism:volume><prism:pageRange>79-87</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jprot.2015.03.037</prism:doi><pii>S1874391915001487</pii><dc:description>© 2015 Elsevier B.V. Impaired mitochondrial function is important in obesity and the development of insulin resistance and diabetes. The aim of this study was to identify human adipocyte-derived mitochondrial proteins associated with obesity. Mitochondrial proteins from 20 abdominal omental adipose tissue biopsies (13 obese and 7 control subjects) were separated by anion-exchange chromatography coupled to SDS-PAGE. Protein contents were compared and identified by MALDI-TOF-TOF mass spectrometry. Proteins of interest were validated, verified and quantified using immuno dot blot assays in a total of 76 mitochondrial preparations from both obese and non-obese patients. Mass spectrometric comparison of 20 mitochondrial proteomes yielded 62 proteins that were differentially expressed in adipose tissue of obese subjects. The immunological quantification of 12 mitochondrial proteins from 76 omental adipose tissue biopsies revealed four proteins, citrate synthase, HADHA, LETM1 and mitofilin inversely being associated with BMI, and mitofilin being inversely correlated with gender. Biological significance: The finding that obese human subjects have reduced levels of important mitochondrial proteins in adipocytes of omental adipose tissue as compared to non-obese controls gives new insights in the impairment of mitochondrial function in this specialized compartment of human adipose tissue in obesity and may eventually lead to the definition of valuable obesity markers.</dc:description><citedby-count>1</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006655</affiliation-url><afid>60006655</afid><affilname>Universitats-Kinderspital beider Basel</affilname><name-variant>University Children's Hospital</name-variant><affiliation-city>Basel</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023588</affiliation-url><afid>60023588</afid><affilname>Universitat Basel</affilname><name-variant>University of Basel</name-variant><affiliation-city>Basel</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100700453</affiliation-url><afid>100700453</afid><affilname>Interdisciplinary Center of Nutritional and Metabolic Diseases</affilname><name-variant>Interdisciplinary Center of Nutritional and Metabolic Diseases</name-variant><affiliation-city>Basel</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000368</affiliation-url><afid>60000368</afid><affilname>MRC Mitochondrial Biology Unit</affilname><name-variant>MRC Dunn Human Nutrition Unit</name-variant><affiliation-city>Cambridge</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60099404</affiliation-url><afid>60099404</afid><affilname>Swiss Federal Institute of Technology, Collegium Helveticum</affilname><name-variant>University of Zurich</name-variant><affiliation-city>Zurich</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6603261708</author-url><authid>6603261708</authid><authname>Lindinger P.</authname><surname>Lindinger</surname><given-name>Peter W.</given-name><initials>P.W.</initials><afid>60006655</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36932616700</author-url><authid>36932616700</authid><authname>Christe M.</authname><surname>Christe</surname><given-name>Martine</given-name><initials>M.</initials><afid>60006655</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7103331111</author-url><authid>7103331111</authid><authname>Eberle A.</authname><surname>Eberle</surname><given-name>Alex N.</given-name><initials>A.N.</initials><afid>60006655</afid><afid>60099404</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7103331111</author-url><authid>7103331111</authid><authname>Eberle A.</authname><surname>Eberle</surname><given-name>Alex N.</given-name><initials>A.N.</initials><afid>60006655</afid><afid>60099404</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:34770601800</author-url><authid>34770601800</authid><authname>Kern B.</authname><surname>Kern</surname><given-name>Beatrice</given-name><initials>B.</initials><afid>60023588</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7003952988</author-url><authid>7003952988</authid><authname>Peterli R.</authname><surname>Peterli</surname><given-name>Ralph</given-name><initials>R.</initials><afid>60023588</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35300275300</author-url><authid>35300275300</authid><authname>Peters T.</authname><surname>Peters</surname><given-name>Thomas</given-name><initials>T.</initials><afid>100700453</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56646380200</author-url><authid>56646380200</authid><authname>Jayawardene K.</authname><surname>Jayawardene</surname><given-name>Kamburapola J I</given-name><initials>K.J.I.</initials><afid>60000368</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7004282077</author-url><authid>7004282077</authid><authname>Fearnley I.</authname><surname>Fearnley</surname><given-name>Ian M.</given-name><initials>I.M.</initials><afid>60000368</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:35513086500</author-url><authid>35513086500</authid><authname>Walker J.</authname><surname>Walker</surname><given-name>John E.</given-name><initials>J.E.</initials><afid>60000368</afid></author><authkeywords>Adipocytes | Mitochondrial proteome | Obesity | Omental adipose tissue</authkeywords><intid>35952191</intid><source-id>11700154304</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925660157"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925660157?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925660157&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925660157&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S009174351500078X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925660157</prism:url><dc:identifier>SCOPUS_ID:84925660157</dc:identifier><eid>2-s2.0-84925660157</eid><dc:title>The associations between overweight, weight change and health related quality of life: Longitudinal data from the Stockholm Public Health Cohort 2002-2010</dc:title><dc:creator>Döring N.</dc:creator><prism:publicationName>Preventive Medicine</prism:publicationName><prism:issn>00917435</prism:issn><prism:eIssn>10960260</prism:eIssn><prism:volume>75</prism:volume><prism:pageRange>12-17</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ypmed.2015.03.007</prism:doi><pii>S009174351500078X</pii><dc:description>© 2015 Elsevier Inc. Objective: Cross-sectional studies have shown that people with obesity and overweight report lower health related quality of life (HRQoL). With a lack of longitudinal studies, this study aims to assess the association between eight-year weight change and HRQoL measured by the EQ-5D instrument and to investigate whether the association differs with regard to baseline body mass index (BMI). Method: A population-based survey was conducted among a random sample of 31,182 individuals from Stockholm County aged 18-84. years in 2002 and reassessed in 2010 and supplemented by record linkage with regional and national registers. Multivariate Poisson regression and linear regression were conducted with adjustments for socio-demographic and health-related variables and baseline BMI category as effect modifier for the association between weight change and HRQoL. Results: Individuals with overweight and obesity respectively have 0.014 and 0.039 lower EQ-5D indexes compared to those being normal weight. Over the eight-year follow-up, 17.6% gained moderately (≥. 5% body weight) and 13.9% gained heavily (≥. 10% body weight) in weight. In the fully adjusted analysis, heavy weight gain was associated with a significantly lower overall EQ-5D index and an increased risk of reporting impairment in all but one EQ-5D dimensions irrespective of baseline BMI category. Weight reduction had no significant preventive effect. Conclusion: Next to obesity status itself, weight gain leads to impairment in HRQoL irrespective of BMI category at baseline while eight year weight loss seems not to have the reversed effect on HRQoL, emphasizing the importance of primary prevention of weight gain.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012311</affiliation-url><afid>60012311</afid><affilname>Karolinska Institutet</affilname><name-variant>Karolinska Institutet</name-variant><affiliation-city>Stockholm</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017615</affiliation-url><afid>60017615</afid><affilname>Stockholms Ians Landsting</affilname><name-variant>Stockholm County Council</name-variant><affiliation-city>Stockholm</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56124489300</author-url><authid>56124489300</authid><authname>Döring N.</authname><surname>Döring</surname><given-name>N.</given-name><initials>N.</initials><afid>60012311</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:24460468500</author-url><authid>24460468500</authid><authname>de Munter J.</authname><surname>de Munter</surname><given-name>J.</given-name><initials>J.</initials><afid>60012311</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7102356137</author-url><authid>7102356137</authid><authname>Rasmussen F.</authname><surname>Rasmussen</surname><given-name>F.</given-name><initials>F.</initials><afid>60012311</afid><afid>60017615</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7102356137</author-url><authid>7102356137</authid><authname>Rasmussen F.</authname><surname>Rasmussen</surname><given-name>F.</given-name><initials>F.</initials><afid>60012311</afid><afid>60017615</afid></author><authkeywords>Body mass index | EQ-5D | Obesity | Weight gain</authkeywords><intid>1535327848</intid><source-id>17665</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929944775"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929944775?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929944775&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929944775&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929944775</prism:url><dc:identifier>SCOPUS_ID:84929944775</dc:identifier><eid>2-s2.0-84929944775</eid><dc:title>Lung infarction following pulmonary embolism: A comparative study on clinical conditions and CT findings to identify predisposing factors</dc:title><dc:creator>Kirchner J.</dc:creator><prism:publicationName>RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren</prism:publicationName><prism:issn>14389029</prism:issn><prism:eIssn>14389010</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>440-444</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1055/s-0034-1399006</prism:doi><dc:description>Purpose: The aim of this study was to identify factors predisposing to lung infarction in patients with pulmonary embolism (PE). Materials and Methods: We performed a retrospective analysis on 154 patients with the final diagnosis of PE being examined between January 2009 and December 2012 by means of a Toshiba Aquilion 64 CT scanner. The severity of clinical symptoms was defined by means of a clinical index with 4 classes. The pulmonary clot load was quantified using a modified severity index of PE as proposed by Miller. We correlated several potential predictors of pulmonary infarction such as demographic data, pulmonary clot burden, distance of total vascular obstruction and pleura, the presence of cardiac congestion, signs of chronic bronchitis or emphysema with the occurrence of pulmonary infarction. Results: Computed tomography revealed 78 areas of pulmonary infarction in 45/154 (29.2%) patients. The presence of infarction was significantly higher in the right lung than in the left lung (p&lt;0.001). We found no correlation between pulmonary infarction and the presence of accompanying malignant diseases (r=-0.069), signs of chronic bronchitis (r=-0.109), cardiac congestion (r=-0.076), the quantified clot burden score (r=0.176), and the severity of symptoms (r=-0.024). Only a very weak negative correlation between the presence of infarction and age (r=-0.199) was seen. However, we could demonstrate a moderate negative correlation between the distance of total vascular occlusion and the occurrence of infarction (r=-0.504). Conclusion: Neither cardiac congestion nor the degree of pulmonary vascular obstruction are main factors predisposing to pulmonary infarction in patients with PE. It seems that a peripheral total vascular obstruction more often results in infarction than even massive central clot burden. Key points: •A peripheral location of vascular occlusion is the main factor predisposing to pulmonary infarction. Citation Format: •Kirchner J, Obermann A, Stückradt S etal. Lung Infarction Following Pulmonary Embolism: A Comparative Study on Clinical Conditions and CT Findings to Identify Predisposing Factors. Fortschr Röntgenstr 2015; 187: 440-444.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100996916</affiliation-url><afid>100996916</afid><affilname>General Hospital Hagen</affilname><name-variant>General Hospital Hagen</name-variant><affiliation-city>Hagen</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032515</affiliation-url><afid>60032515</afid><affilname>Universitatsklinikum Wurzburg und Medizinische Fakultat</affilname><affiliation-city>Wurzburg</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115043501</affiliation-url><afid>115043501</afid><affilname>University Hospital Marienhospital Herne</affilname><name-variant>University Hospital Marienhospital Herne</name-variant><affiliation-city/><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7201671618</author-url><authid>7201671618</authid><authname>Kirchner J.</authname><surname>Kirchner</surname><given-name>J.</given-name><initials>J.</initials><afid>100996916</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:37026825700</author-url><authid>37026825700</authid><authname>Obermann A.</authname><surname>Obermann</surname><given-name>A.</given-name><initials>A.</initials><afid>100996916</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56029210600</author-url><authid>56029210600</authid><authname>Stückradt S.</authname><surname>Stückradt</surname><given-name>S.</given-name><initials>S.</initials><afid>100996916</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56543585500</author-url><authid>56543585500</authid><authname>Tüshaus C.</authname><surname>Tüshaus</surname><given-name>C.</given-name><initials>C.</initials><afid>100996916</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:35233418500</author-url><authid>35233418500</authid><authname>Goltz J.</authname><surname>Goltz</surname><given-name>J.</given-name><initials>J.</initials><afid>60032515</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7003315936</author-url><authid>7003315936</authid><authname>Liermann D.</authname><surname>Liermann</surname><given-name>D.</given-name><initials>D.</initials><afid>115043501</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:8961506100</author-url><authid>8961506100</authid><authname>Kickuth R.</authname><surname>Kickuth</surname><given-name>R.</given-name><initials>R.</initials><afid>60032515</afid></author><authkeywords>cardiac | computed tomography | CT spiral | mediastinum | pathogenesis | pulmonary embolism | pulmonary infarction | thorax</authkeywords><intid>36041499</intid><source-id>110346</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929315022"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929315022?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929315022&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929315022&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929315022</prism:url><dc:identifier>SCOPUS_ID:84929315022</dc:identifier><eid>2-s2.0-84929315022</eid><dc:title>Effect of Turbulent Flow on Hemolysis Utilizing a Turbulent Free Jet</dc:title><dc:creator>Stauffer M.</dc:creator><prism:publicationName>Journal of Medical Devices, Transactions of the ASME</prism:publicationName><prism:issn>19326181</prism:issn><prism:eIssn>1932619X</prism:eIssn><prism:volume>9</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>1-2</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1115/1.4030117</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027671</affiliation-url><afid>60027671</afid><affilname>Penn State College of Medicine</affilname><name-variant>Pennsylvania State University College of Medicine</name-variant><affiliation-city>Hershey</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56644367500</author-url><authid>56644367500</authid><authname>Stauffer M.</authname><surname>Stauffer</surname><given-name>Megan A.</given-name><initials>M.A.</initials><afid>60027671</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7801487644</author-url><authid>7801487644</authid><authname>Reibson J.</authname><surname>Reibson</surname><given-name>John D.</given-name><initials>J.D.</initials><afid>60027671</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:54586356300</author-url><authid>54586356300</authid><authname>Yeager E.</authname><surname>Yeager</surname><given-name>Eric E.</given-name><initials>E.E.</initials><afid>60027671</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56249813500</author-url><authid>56249813500</authid><authname>Jhun C.</authname><surname>Jhun</surname><given-name>Choon Sik</given-name><initials>C.S.</initials><afid>60027671</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:35300599400</author-url><authid>35300599400</authid><authname>Newswanger R.</authname><surname>Newswanger</surname><given-name>Raymond K.</given-name><initials>R.K.</initials><afid>60027671</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:22952644900</author-url><authid>22952644900</authid><authname>Cysyk J.</authname><surname>Cysyk</surname><given-name>Joshua P.</given-name><initials>J.P.</initials><afid>60027671</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:35276481200</author-url><authid>35276481200</authid><authname>Weiss W.</authname><surname>Weiss</surname><given-name>William J.</given-name><initials>W.J.</initials><afid>60027671</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56644163500</author-url><authid>56644163500</authid><authname>Rosenberg G.</authname><surname>Rosenberg</surname><given-name>Gerson</given-name><initials>G.</initials><afid>60027671</afid></author><intid>1035941658</intid><source-id>11700154387</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930196180"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930196180?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930196180&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930196180&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930196180</prism:url><dc:identifier>SCOPUS_ID:84930196180</dc:identifier><eid>2-s2.0-84930196180</eid><dc:title>Vasopressin V1a and V1b receptor modulators: A patent review (2012-2014)</dc:title><dc:creator>͆lusarz M.</dc:creator><prism:publicationName>Expert Opinion on Therapeutic Patents</prism:publicationName><prism:issn>13543776</prism:issn><prism:eIssn>17447674</prism:eIssn><prism:volume>25</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>711-722</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1517/13543776.2015.1026257</prism:doi><dc:description>© 2015 Informa UK, Ltd. Introduction: The vasopressin V1a and V1b receptors are involved in many crucial physiological, reproductive, behavioral and social functions. Consequently, they are also involved in several pathological conditions, thus the ligands capable of selective stimulation/inhibition of these receptors may present therapeutic benefit in a variety of diseases.Areas covered: In this review, the author focuses on the vasopressin V1a and V1b receptors, their biological functions and agonists and antagonists patented in the years 2012-2014. This paper is divided according to both the target receptor and the applicant and describes the compounds from the patents along with their biological activity.Expert opinion: In the recent years, pharmaceutical companies have discovered and patented new compounds which act through vasopressin V1a and/or V1b receptors, both peptide and non-peptide. Among the V1bR antagonists published in the last years, the oxindole derivatives appear to be the most promising drug candidates.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026000</affiliation-url><afid>60026000</afid><affilname>Uniwersytet Gdanski</affilname><name-variant>University of Gdansk</name-variant><affiliation-city>Gdansk</affiliation-city><affiliation-country>Poland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56663241300</author-url><authid>56663241300</authid><authname>͆lusarz M.</authname><surname>͆lusarz</surname><given-name>Magdalena J.</given-name><initials>M.J.</initials><afid>60026000</afid></author><authkeywords>Agonist | Antagonist | Vasopressin | Vasopressin receptor</authkeywords><intid>36086102</intid><source-id>21353</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926433946"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926433946?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926433946&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926433946&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0005272815000407"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926433946</prism:url><dc:identifier>SCOPUS_ID:84926433946</dc:identifier><eid>2-s2.0-84926433946</eid><dc:title>The a subunit of the A&lt;inf&gt;1&lt;/inf&gt;A&lt;inf&gt;O&lt;/inf&gt; ATP synthase of Methanosarcina mazei Gö1 contains two conserved arginine residues that are crucial for ATP synthesis</dc:title><dc:creator>Gloger C.</dc:creator><prism:publicationName>Biochimica et Biophysica Acta - Bioenergetics</prism:publicationName><prism:issn>00052728</prism:issn><prism:eIssn>18792650</prism:eIssn><prism:volume>1847</prism:volume><prism:issueIdentifier>6-7</prism:issueIdentifier><prism:pageRange>505-513</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbabio.2015.02.015</prism:doi><pii>S0005272815000407</pii><dc:description>© 2015 Elsevier B.V. Like the evolutionary related F&lt;inf&gt;1&lt;/inf&gt;F&lt;inf&gt;O&lt;/inf&gt; ATP synthases and V&lt;inf&gt;1&lt;/inf&gt;V&lt;inf&gt;O&lt;/inf&gt; ATPases, the A&lt;inf&gt;1&lt;/inf&gt;A&lt;inf&gt;O&lt;/inf&gt; ATP synthases from archaea are multisubunit, membrane-bound transport machines that couple ion flow to the synthesis of ATP. Although the subunit composition is known for at least two species, nothing is known so far with respect to the function of individual subunits or amino acid residues. To pave the road for a functional analysis of A&lt;inf&gt;1&lt;/inf&gt;A&lt;inf&gt;O&lt;/inf&gt; ATP synthases, we have cloned the entire operon from Methanosarcina mazei into an expression vector and produced the enzyme in Escherichia coli. Inverted membrane vesicles of the recombinants catalyzed ATP synthesis driven by NADH oxidation as well as artificial driving forces. Δμ&lt;inf&gt;&lt;sup&gt;H+&lt;/sup&gt;&lt;/inf&gt; as well as ΔpH were used as driving forces which is consistent with the inhibition of NADH-driven ATP synthesis by protonophores. Exchange of the conserved glutamate in subunit c led to a complete loss of ATP synthesis, proving that this residue is essential for H&lt;sup&gt;+&lt;/sup&gt; translocation. Exchange of two conserved arginine residues in subunit a has different effects on ATP synthesis. The role of these residues in ion translocation is discussed.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007762</affiliation-url><afid>60007762</afid><affilname>Johann Wolfgang Goethe Universitat Frankfurt am Main</affilname><affiliation-city>Frankfurt am Main</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56584259300</author-url><authid>56584259300</authid><authname>Gloger C.</authname><surname>Gloger</surname><given-name>Carolin</given-name><initials>C.</initials><afid>60007762</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56583906100</author-url><authid>56583906100</authid><authname>Born A.</authname><surname>Born</surname><given-name>Anna Katharina</given-name><initials>A.K.</initials><afid>60007762</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:40361038700</author-url><authid>40361038700</authid><authname>Antosch M.</authname><surname>Antosch</surname><given-name>Martin</given-name><initials>M.</initials><afid>60007762</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7102893063</author-url><authid>7102893063</authid><authname>Müller V.</authname><surname>Müller</surname><given-name>Volker</given-name><initials>V.</initials><afid>60007762</afid></author><authkeywords>Archaea | Energy conservation | Ion translocation | Methanogens | Site directed mutagenesis</authkeywords><intid>2035449751</intid><source-id>16791</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926337785"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926337785?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926337785&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926337785&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0091743515000870"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926337785</prism:url><dc:identifier>SCOPUS_ID:84926337785</dc:identifier><eid>2-s2.0-84926337785</eid><dc:title>Individual and area-level factors correlated with death by suicide in older adults</dc:title><dc:creator>Ngamini Ngui A.</dc:creator><prism:publicationName>Preventive Medicine</prism:publicationName><prism:issn>00917435</prism:issn><prism:eIssn>10960260</prism:eIssn><prism:volume>75</prism:volume><prism:pageRange>44-48</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ypmed.2015.03.015</prism:doi><pii>S0091743515000870</pii><dc:description>© 2015 Elsevier Inc. Objective: To determine the influence of individual and area-level characteristics associated with suicide in older adults. Method: This study used two complementary data sources. The first used administrative data from the Quebec Coroner's office and included information on suicide deaths in older adults aged 65. years and over who died by suicide between 2000 and 2005 (n. = 903 persons). The second data source, which was used to identify the control group, came from a longitudinal study on seniors' health that was conducted in Quebec between 2004 and 2005 (n. = 2493 persons). Logistic regression analyses were used to test for associations between suicide and individual and area-level level characteristics. Results: Suicide was associated with male gender, age, the presence of a physical and mental disorder and the use of health services. At the area-level level, suicide was associated with a higher population density, concentration of men, lower rates of education and higher rate of unemployment. Gender specific analyses also showed different patterns of associations on suicide risk. Conclusions: Suicide in older adults is associated with area-level and individual characteristics. This suggests that policies targeting only one level of risk factors are less likely to significantly influence suicide among this population.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113020761</affiliation-url><afid>113020761</afid><affilname>Centre de réadaptation en dépendance de Montréal - Institut Universitaire</affilname><name-variant>Centre de Recherche Interdisciplinaire en Réadaptation de Montréal</name-variant><affiliation-city>Montreal</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60099961</affiliation-url><afid>60099961</afid><affilname>Hopital Charles LeMoyne</affilname><name-variant>Hôpital Charles LeMoyne</name-variant><affiliation-city>Greenfield Park</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011832</affiliation-url><afid>60011832</afid><affilname>Universite de Sherbrooke</affilname><name-variant>University of Sherbrooke</name-variant><affiliation-city>Sherbrooke</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027863</affiliation-url><afid>60027863</afid><affilname>Universite du Quebec a Montreal</affilname><name-variant>Université du Québec à Montréal</name-variant><affiliation-city>Montreal</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:52663960600</author-url><authid>52663960600</authid><authname>Ngamini Ngui A.</authname><surname>Ngamini Ngui</surname><given-name>André</given-name><initials>A.</initials><afid>113020761</afid><afid>60099961</afid><afid>60027863</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:52663960600</author-url><authid>52663960600</authid><authname>Ngamini Ngui A.</authname><surname>Ngamini Ngui</surname><given-name>André</given-name><initials>A.</initials><afid>113020761</afid><afid>60099961</afid><afid>60027863</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:52663960600</author-url><authid>52663960600</authid><authname>Ngamini Ngui A.</authname><surname>Ngamini Ngui</surname><given-name>André</given-name><initials>A.</initials><afid>113020761</afid><afid>60099961</afid><afid>60027863</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6602785434</author-url><authid>6602785434</authid><authname>Vasiliadis H.</authname><surname>Vasiliadis</surname><given-name>Helen Maria</given-name><initials>H.M.</initials><afid>60099961</afid><afid>60011832</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6602785434</author-url><authid>6602785434</authid><authname>Vasiliadis H.</authname><surname>Vasiliadis</surname><given-name>Helen Maria</given-name><initials>H.M.</initials><afid>60099961</afid><afid>60011832</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6602194225</author-url><authid>6602194225</authid><authname>Préville M.</authname><surname>Préville</surname><given-name>Michel</given-name><initials>M.</initials><afid>60099961</afid><afid>60011832</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6602194225</author-url><authid>6602194225</authid><authname>Préville M.</authname><surname>Préville</surname><given-name>Michel</given-name><initials>M.</initials><afid>60099961</afid><afid>60011832</afid></author><authkeywords>Area-level characteristics | Ecological study | Senior suicide | Suicide method</authkeywords><intid>1035426050</intid><source-id>17665</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928322281"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928322281?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928322281&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928322281&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0378595515000635"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928322281</prism:url><dc:identifier>SCOPUS_ID:84928322281</dc:identifier><eid>2-s2.0-84928322281</eid><dc:title>Infrared neural stimulation fails to evoke neural activity in the deaf guinea pig cochlea</dc:title><dc:creator>Thompson A.</dc:creator><prism:publicationName>Hearing Research</prism:publicationName><prism:issn>03785955</prism:issn><prism:eIssn>18785891</prism:eIssn><prism:volume>324</prism:volume><prism:pageRange>46-53</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.heares.2015.03.005</prism:doi><pii>S0378595515000635</pii><dc:description>© 2015 Elsevier B.V. At present there is some debate as to the processes by which infrared neural stimulation (INS) activates neurons in the cochlea, as the lasers used for INS can potentially generate a range of secondary stimuli e.g. an acoustic stimulus is produced when the light is absorbed by water. To clarify whether INS in the cochlea requires functioning hair cells and to explore the potential relevance to cochlear implants, experiments using INS were performed in the cochleae of both normal hearing and profoundly deaf guinea pigs. A response to laser stimulation was readily evoked in normal hearing cochlea. However, no response was evoked in any profoundly deaf cochleae, for either acute or chronic deafening, contrary to previous work where a response was observed after acute deafening with ototoxic drugs. A neural response to electrical stimulation was readily evoked in all cochleae after deafening. The absence of a response from optical stimuli in profoundly deaf cochleae suggests that the response from INS in the cochlea is hair cell mediated.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030804</affiliation-url><afid>60030804</afid><affilname>Swinburne University of Technology</affilname><name-variant>Swinburne University of Technology</name-variant><affiliation-city>Hawthorn</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:111168539</affiliation-url><afid>111168539</afid><affilname>Bionics Institute</affilname><name-variant>The Bionics Institute</name-variant><affiliation-city>Melbourne</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026553</affiliation-url><afid>60026553</afid><affilname>University of Melbourne</affilname><name-variant>University of Melbourne</name-variant><affiliation-city>Parkville</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026553</affiliation-url><afid>60026553</afid><affilname>University of Melbourne</affilname><name-variant>University of Melbourne</name-variant><affiliation-city>Parkville</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55534141236</author-url><authid>55534141236</authid><authname>Thompson A.</authname><surname>Thompson</surname><given-name>Alexander C.</given-name><initials>A.C.</initials><afid>60030804</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:9435651900</author-url><authid>9435651900</authid><authname>Fallon J.</authname><surname>Fallon</surname><given-name>James B.</given-name><initials>J.B.</initials><afid>111168539</afid><afid>60026553</afid><afid>60026553</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:9435651900</author-url><authid>9435651900</authid><authname>Fallon J.</authname><surname>Fallon</surname><given-name>James B.</given-name><initials>J.B.</initials><afid>111168539</afid><afid>60026553</afid><afid>60026553</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:9435651900</author-url><authid>9435651900</authid><authname>Fallon J.</authname><surname>Fallon</surname><given-name>James B.</given-name><initials>J.B.</initials><afid>111168539</afid><afid>60026553</afid><afid>60026553</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7102521034</author-url><authid>7102521034</authid><authname>Wise A.</authname><surname>Wise</surname><given-name>Andrew K.</given-name><initials>A.K.</initials><afid>111168539</afid><afid>60026553</afid><afid>60026553</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7102521034</author-url><authid>7102521034</authid><authname>Wise A.</authname><surname>Wise</surname><given-name>Andrew K.</given-name><initials>A.K.</initials><afid>111168539</afid><afid>60026553</afid><afid>60026553</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7102521034</author-url><authid>7102521034</authid><authname>Wise A.</authname><surname>Wise</surname><given-name>Andrew K.</given-name><initials>A.K.</initials><afid>111168539</afid><afid>60026553</afid><afid>60026553</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7102322178</author-url><authid>7102322178</authid><authname>Wade S.</authname><surname>Wade</surname><given-name>Scott A.</given-name><initials>S.A.</initials><afid>60030804</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7202338759</author-url><authid>7202338759</authid><authname>Shepherd R.</authname><surname>Shepherd</surname><given-name>Robert K.</given-name><initials>R.K.</initials><afid>111168539</afid><afid>60026553</afid><afid>60026553</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7202338759</author-url><authid>7202338759</authid><authname>Shepherd R.</authname><surname>Shepherd</surname><given-name>Robert K.</given-name><initials>R.K.</initials><afid>111168539</afid><afid>60026553</afid><afid>60026553</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7202338759</author-url><authid>7202338759</authid><authname>Shepherd R.</authname><surname>Shepherd</surname><given-name>Robert K.</given-name><initials>R.K.</initials><afid>111168539</afid><afid>60026553</afid><afid>60026553</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:8636425400</author-url><authid>8636425400</authid><authname>Stoddart P.</authname><surname>Stoddart</surname><given-name>Paul R.</given-name><initials>P.R.</initials><afid>60030804</afid></author><intid>35766555</intid><source-id>13707</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925240422"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925240422?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925240422&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925240422&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S2352250X15001050"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925240422</prism:url><dc:identifier>SCOPUS_ID:84925240422</dc:identifier><eid>2-s2.0-84925240422</eid><dc:title>Selectivity as an emotion regulation strategy: Lessons from older adults</dc:title><dc:creator>Sims T.</dc:creator><prism:publicationName>Current Opinion in Psychology</prism:publicationName><prism:issn>2352250X</prism:issn><prism:volume>3</prism:volume><prism:pageRange>80-84</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.copsyc.2015.02.012</prism:doi><pii>S2352250X15001050</pii><dc:description>© 2015 Elsevier Ltd. Findings based on studies of daily life consistently associate older ages with relatively positive emotional experience, suggesting that older adults may regulate emotions more effectively than younger adults. Findings from laboratory studies are equivocal, however, with mixed evidence for age-related improvements in use of emotion regulatory strategies. In the current paper, we propose that findings may reflect a failure of laboratory-based experiments to capture the regulatory strategies that older people use in their everyday lives. We argue that the advantages older people have are likely due to antecedent emotion regulation as opposed to response-focused strategies. Understanding the regulatory approaches that older people actually use may inform developmental models of emotion regulation throughout adulthood as well as interventions for improving emotional experience across the life span.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012708</affiliation-url><afid>60012708</afid><affilname>Stanford University</affilname><name-variant>Stanford University</name-variant><affiliation-city>Palo Alto</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8137448000</author-url><authid>8137448000</authid><authname>Sims T.</authname><surname>Sims</surname><given-name>Tamara</given-name><initials>T.</initials><afid>60012708</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55810041600</author-url><authid>55810041600</authid><authname>Hogan C.</authname><surname>Hogan</surname><given-name>Candice L.</given-name><initials>C.L.</initials><afid>60012708</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7004975365</author-url><authid>7004975365</authid><authname>Carstensen L.</authname><surname>Carstensen</surname><given-name>Laura L.</given-name><initials>L.L.</initials><afid>60012708</afid></author><intid>35277190</intid><source-id>21100372442</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926664035"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926664035?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926664035&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926664035&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0001879115000330"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926664035</prism:url><dc:identifier>SCOPUS_ID:84926664035</dc:identifier><eid>2-s2.0-84926664035</eid><dc:title>The protean career orientation as predictor of career outcomes: Evaluation of incremental validity and mediation effects</dc:title><dc:creator>Herrmann A.</dc:creator><prism:publicationName>Journal of Vocational Behavior</prism:publicationName><prism:issn>00018791</prism:issn><prism:volume>88</prism:volume><prism:pageRange>205-214</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jvb.2015.03.008</prism:doi><pii>S0001879115000330</pii><dc:description>© 2015 Elsevier Inc. A protean career orientation is assumed to be beneficial for career development but researchers have only recently started to empirically evaluate the concept. Conducting two studies based on three independent samples of university students and working professionals in Germany, we address issues of concurrent validity, predictive incremental validity and mechanisms linking the protean orientation to career outcomes. The first study showed that in a sample of 104 German employees different measures of the protean career orientation all correlated highly, but not identically, to a range of work and career attitudes. Using bootstrapping analysis, a second study with a six-month prospective examination among 419 German university students and a cross-sectional analysis among 526 German employees showed that a protean career orientation predicts proactive career behaviors and career satisfaction beyond a proactive disposition and core self-evaluations, respectively. Moreover, the protean career orientation was a significant mediator of these two personality constructs on both career outcomes. Cumulatively, the studies enrich our understanding of how and when a protean career orientation is related to important career outcomes.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011274</affiliation-url><afid>60011274</afid><affilname>Fachhochschule Nordwestschweiz</affilname><name-variant>University of Applied Sciences Northwestern Switzerland</name-variant><affiliation-city>Brugg</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020486</affiliation-url><afid>60020486</afid><affilname>Universitat Bern</affilname><name-variant>University of Berne</name-variant><affiliation-city>Bern</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60072202</affiliation-url><afid>60072202</afid><affilname>Leuphana Universitat Luneburg</affilname><name-variant>University of Lüneburg</name-variant><affiliation-city>Luneburg</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025225</affiliation-url><afid>60025225</afid><affilname>University of Southampton</affilname><name-variant>University of Southampton</name-variant><affiliation-city>Southampton</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55311884100</author-url><authid>55311884100</authid><authname>Herrmann A.</authname><surname>Herrmann</surname><given-name>Anne</given-name><initials>A.</initials><afid>60011274</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:24335241400</author-url><authid>24335241400</authid><authname>Hirschi A.</authname><surname>Hirschi</surname><given-name>Andreas</given-name><initials>A.</initials><afid>60020486</afid><afid>60072202</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:24335241400</author-url><authid>24335241400</authid><authname>Hirschi A.</authname><surname>Hirschi</surname><given-name>Andreas</given-name><initials>A.</initials><afid>60020486</afid><afid>60072202</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7005358901</author-url><authid>7005358901</authid><authname>Baruch Y.</authname><surname>Baruch</surname><given-name>Yehuda</given-name><initials>Y.</initials><afid>60025225</afid></author><authkeywords>Career engagement | Career satisfaction | Core self-evaluations | Proactivity | Protean career orientation</authkeywords><intid>2035478279</intid><source-id>12006</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929091197"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929091197?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929091197&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929091197&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929091197</prism:url><dc:identifier>SCOPUS_ID:84929091197</dc:identifier><eid>2-s2.0-84929091197</eid><dc:title>Large-scale mass spectrometry imaging investigation of consequences of cortical spreading depression in a transgenic mouse model of migraine</dc:title><dc:creator>Carreira R.</dc:creator><prism:publicationName>Journal of the American Society for Mass Spectrometry</prism:publicationName><prism:issn>10440305</prism:issn><prism:eIssn>18791123</prism:eIssn><prism:volume>26</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>853-861</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s13361-015-1136-8</prism:doi><dc:description>© 2015 The Author(s). Cortical spreading depression (CSD) is the electrophysiological correlate of migraine aura. Transgenic mice carrying the R192Q missense mutation in the Cacna1a gene, which in patients causes familial hemiplegic migraine type 1 (FHM1), exhibit increased propensity to CSD. Herein, mass spectrometry imaging (MSI) was applied for the first time to an animal cohort of transgenic and wild type mice to study the biomolecular changes following CSD in the brain. Ninety-six coronal brain sections from 32 mice were analyzed by MALDI-MSI. All MSI datasets were registered to the Allen Brain Atlas reference atlas of the mouse brain so that the molecular signatures of distinct brain regions could be compared. A number of metabolites and peptides showed substantial changes in the brain associated with CSD. Among those, different mass spectral features showed significant (t-test, P &lt; 0.05) changes in the cortex, 146 and 377 Da, and in the thalamus, 1820 and 1834 Da, of the CSD-affected hemisphere of FHM1 R192Q mice. Our findings reveal CSD- and genotype-specific molecular changes in the brain of FHM1 transgenic mice that may further our understanding about the role of CSD in migraine pathophysiology. The results also demonstrate the utility of aligning MSI datasets to a common reference atlas for large-scale MSI investigations. [Figure not available: see fulltext.]</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015618</affiliation-url><afid>60015618</afid><affilname>Leiden University Medical Center - LUMC</affilname><name-variant>University Hospital</name-variant><affiliation-city>Leiden</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015618</affiliation-url><afid>60015618</afid><affilname>Leiden University Medical Center - LUMC</affilname><name-variant>University Hospital</name-variant><affiliation-city>Leiden</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015618</affiliation-url><afid>60015618</afid><affilname>Leiden University Medical Center - LUMC</affilname><name-variant>University Hospital</name-variant><affiliation-city>Leiden</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015618</affiliation-url><afid>60015618</afid><affilname>Leiden University Medical Center - LUMC</affilname><name-variant>University Hospital</name-variant><affiliation-city>Leiden</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113974056</affiliation-url><afid>113974056</afid><affilname>Fondazione Pisana per la Scienza ONLUS</affilname><name-variant>Fondazione Pisana per la Scienza Onlus</name-variant><affiliation-city>Pisa</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">13</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:16023998900</author-url><authid>16023998900</authid><authname>Carreira R.</authname><surname>Carreira</surname><given-name>Ricardo J.</given-name><initials>R.J.</initials><afid>60015618</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:39362396800</author-url><authid>39362396800</authid><authname>Shyti R.</authname><surname>Shyti</surname><given-name>Reinald</given-name><initials>R.</initials><afid>60015618</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:26326152800</author-url><authid>26326152800</authid><authname>Balluff B.</authname><surname>Balluff</surname><given-name>Benjamin</given-name><initials>B.</initials><afid>60015618</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:53979374000</author-url><authid>53979374000</authid><authname>Abdelmoula W.</authname><surname>Abdelmoula</surname><given-name>Walid M.</given-name><initials>W.M.</initials><afid>60015618</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:26026535100</author-url><authid>26026535100</authid><authname>Van Heiningen S.</authname><surname>Van Heiningen</surname><given-name>Sandra H.</given-name><initials>S.H.</initials><afid>60015618</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:25121836700</author-url><authid>25121836700</authid><authname>Van Zeijl R.</authname><surname>Van Zeijl</surname><given-name>Rene J.</given-name><initials>R.J.</initials><afid>60015618</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7101611206</author-url><authid>7101611206</authid><authname>Dijkstra J.</authname><surname>Dijkstra</surname><given-name>Jouke</given-name><initials>J.</initials><afid>60015618</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:55349930200</author-url><authid>55349930200</authid><authname>Ferrari M.</authname><surname>Ferrari</surname><given-name>Michel D.</given-name><initials>M.D.</initials><afid>60015618</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:8973493300</author-url><authid>8973493300</authid><authname>Tolner E.</authname><surname>Tolner</surname><given-name>Else A.</given-name><initials>E.A.</initials><afid>60015618</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7004486150</author-url><authid>7004486150</authid><authname>McDonnell L.</authname><surname>McDonnell</surname><given-name>Liam A.</given-name><initials>L.A.</initials><afid>60015618</afid><afid>113974056</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7004486150</author-url><authid>7004486150</authid><authname>McDonnell L.</authname><surname>McDonnell</surname><given-name>Liam A.</given-name><initials>L.A.</initials><afid>60015618</afid><afid>113974056</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7003477455</author-url><authid>7003477455</authid><authname>Van Den Maagdenberg A.</authname><surname>Van Den Maagdenberg</surname><given-name>Arn M J M</given-name><initials>A.M.J.M.</initials><afid>60015618</afid><afid>60015618</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7003477455</author-url><authid>7003477455</authid><authname>Van Den Maagdenberg A.</authname><surname>Van Den Maagdenberg</surname><given-name>Arn M J M</given-name><initials>A.M.J.M.</initials><afid>60015618</afid><afid>60015618</afid></author><authkeywords>Cortical spreading depression | Familial hemiplegic migraine | MALDI | Mass spectrometry imaging | Preclinical studies</authkeywords><intid>1535902163</intid><source-id>29591</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924625312"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924625312?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924625312&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924625312&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1751616115000636"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924625312</prism:url><dc:identifier>SCOPUS_ID:84924625312</dc:identifier><eid>2-s2.0-84924625312</eid><dc:title>Experimental study on multi-step creep properties of rat skins</dc:title><dc:creator>Chen G.</dc:creator><prism:publicationName>Journal of the Mechanical Behavior of Biomedical Materials</prism:publicationName><prism:issn>17516161</prism:issn><prism:eIssn>18780180</prism:eIssn><prism:volume>46</prism:volume><prism:pageRange>49-58</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jmbbm.2015.02.020</prism:doi><pii>S1751616115000636</pii><dc:description>© 2015 Elsevier Ltd. Tension, single-step creep, and multi-step creep of rat skins at room temperature were experimentally studied. We studied the effects of loading histories of high stress creep, low stress creep, and stress relaxation on multi-step creep. Microstructure of rat skins after prescribed tests were observed microscopically with the help of standard hematoxylin and eosin (H&amp;E). The void ratios were also analyzed. The loading histories of high stress creep, low stress creep, and stress relaxation have significant influence on multi-step creep. We found that the creep strain and its rate in the steady-state stage and the creep-fatigue life of rat skins are sensitive to creep stress. Low stress creep after the loading history of high stress creep is characterized as a recovery of strain and a zero strain rate. Both the loading history of low stress creep and stress relaxation act as a recovery in multi-step creep, and they are driven by a same mechanism in the creep strain and the void ratio of rat skins. The loading history, of which sequence is as followings successively: low stress creep, stress relaxation, and high stress creep, helps to obtain the largest creep strain at the lowest void ratio.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019533</affiliation-url><afid>60019533</afid><affilname>Tianjin University</affilname><name-variant>Tianjin University</name-variant><affiliation-city>Tianjin</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009884</affiliation-url><afid>60009884</afid><affilname>Hebei Medical University</affilname><name-variant>Hebei Medical University</name-variant><affiliation-city>Shijiazhuang</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019533</affiliation-url><afid>60019533</afid><affilname>Tianjin University</affilname><name-variant>Tianjin University</name-variant><affiliation-city>Tianjin</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019533</affiliation-url><afid>60019533</afid><affilname>Tianjin University</affilname><name-variant>Tianjin University</name-variant><affiliation-city>Tianjin</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:10039149700</author-url><authid>10039149700</authid><authname>Chen G.</authname><surname>Chen</surname><given-name>Gang</given-name><initials>G.</initials><afid>60019533</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55977364400</author-url><authid>55977364400</authid><authname>Cui S.</authname><surname>Cui</surname><given-name>Shibo</given-name><initials>S.</initials><afid>60019533</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56479979100</author-url><authid>56479979100</authid><authname>You L.</authname><surname>You</surname><given-name>Lin</given-name><initials>L.</initials><afid>60019533</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56584806700</author-url><authid>56584806700</authid><authname>Li Y.</authname><surname>Li</surname><given-name>Yan</given-name><initials>Y.</initials><afid>60009884</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:41461442400</author-url><authid>41461442400</authid><authname>Mei Y.</authname><surname>Mei</surname><given-name>Yun Hui</given-name><initials>Y.H.</initials><afid>60019533</afid><afid>60019533</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:41461442400</author-url><authid>41461442400</authid><authname>Mei Y.</authname><surname>Mei</surname><given-name>Yun Hui</given-name><initials>Y.H.</initials><afid>60019533</afid><afid>60019533</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:24476451500</author-url><authid>24476451500</authid><authname>Chen X.</authname><surname>Chen</surname><given-name>Xu</given-name><initials>X.</initials><afid>60019533</afid></author><authkeywords>Creep | Microstructure | Multi-step | Rat skin</authkeywords><intid>35168627</intid><source-id>8000153139</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929144945"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929144945?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929144945&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929144945&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0018506X15000604"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929144945</prism:url><dc:identifier>SCOPUS_ID:84929144945</dc:identifier><eid>2-s2.0-84929144945</eid><dc:title>The association between affective psychopathic traits, time incarcerated, and cortisol response to psychosocial stress</dc:title><dc:creator>Johnson M.</dc:creator><prism:publicationName>Hormones and Behavior</prism:publicationName><prism:issn>0018506X</prism:issn><prism:eIssn>10956867</prism:eIssn><prism:volume>72</prism:volume><prism:pageRange>20-27</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yhbeh.2015.04.010</prism:doi><pii>S0018506X15000604</pii><dc:description>© 2015 Elsevier Inc. Previous research has demonstrated that psychopathic personality traits are significantly predictive of blunted cortisol reactivity to a performance-based stressor task (Trier Social Stress Test; TSST) in college students. However, the relationship between cortisol reactivity and psychopathy has not been explored in high risk samples such as incarcerated populations. Further, the role of imprisonment in relation to cortisol stress reactivity has not been previously explored, but could have practical and conceptual consequences in regard to rehabilitation and biological sensitivity to context, respectively. The current study tested the hypotheses that both psychopathic personality traits and amount of time incarcerated are related to cortisol blunting in response to stress among incarcerated young adults. A sample of 49 young adult male offenders was recruited to complete the TSST. Salivary hormone samples were taken just prior to and 20. min post-stressor, and participants were interviewed with the Psychopathy Checklist-Youth Version. Variables quantifying the amount of time at the present facility prior to the date of testing and number of commitments in juvenile facilities were also collected. Correlational analyses indicated that only number of incarcerations was related to blunted cortisol. Hierarchical Linear Modeling revealed that time incarcerated and number of commitments were related to a blunted cortisol response among responders and declining cortisol reactivity among nonresponders, respectively. Controlling for time incarcerated, psychopathic traits were significantly related to cortisol decline in response to the stressor among nonresponders, but were not related to blunted cortisol among responders. Results of this project highlight the potential biological effects of prolonged and repeated incarcerations, and extend our understanding about the relationship between psychopathic traits and cortisol reactivity in an incarcerated sample.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025038</affiliation-url><afid>60025038</afid><affilname>UC Berkeley</affilname><name-variant>University of California</name-variant><affiliation-city>Berkeley</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002092</affiliation-url><afid>60002092</afid><affilname>Florida State University</affilname><name-variant>Florida State University</name-variant><affiliation-city>Tallahassee</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004354</affiliation-url><afid>60004354</afid><affilname>Iowa State University</affilname><name-variant>Iowa State University</name-variant><affiliation-city>Ames</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55790240300</author-url><authid>55790240300</authid><authname>Johnson M.</authname><surname>Johnson</surname><given-name>Megan M.</given-name><initials>M.M.</initials><afid>60025038</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:24477624400</author-url><authid>24477624400</authid><authname>Mikolajewski A.</authname><surname>Mikolajewski</surname><given-name>Amy</given-name><initials>A.</initials><afid>60002092</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6507667153</author-url><authid>6507667153</authid><authname>Shirtcliff E.</authname><surname>Shirtcliff</surname><given-name>Elizabeth A.</given-name><initials>E.A.</initials><afid>60004354</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7007070975</author-url><authid>7007070975</authid><authname>Eckel L.</authname><surname>Eckel</surname><given-name>Lisa A.</given-name><initials>L.A.</initials><afid>60002092</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7405407942</author-url><authid>7405407942</authid><authname>Taylor J.</authname><surname>Taylor</surname><given-name>Jeanette</given-name><initials>J.</initials><afid>60002092</afid></author><authkeywords>Cortisol | Incarceration | Psychopathic traits | Psychopathy | Trier Social Stress Test | TSST</authkeywords><intid>2035912081</intid><source-id>26133</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924300028"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924300028?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924300028&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924300028&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0887233315000144"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924300028</prism:url><dc:identifier>SCOPUS_ID:84924300028</dc:identifier><eid>2-s2.0-84924300028</eid><dc:title>Deconjugation of soy isoflavone glucuronides needed for estrogenic activity</dc:title><dc:creator>Islam M.</dc:creator><prism:publicationName>Toxicology in Vitro</prism:publicationName><prism:issn>08872333</prism:issn><prism:eIssn>18793177</prism:eIssn><prism:volume>29</prism:volume><prism:issueIdentifier>4</prism:issueIdentifier><prism:pageRange>706715</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.tiv.2015.01.013</prism:doi><pii>S0887233315000144</pii><dc:description>© 2015 The Authors. Soy isoflavones (SIF) are present in the systemic circulation as conjugated forms of which the estrogenic potency is not yet clear. The present study provides evidence that the major SIF glucuronide metabolites in blood, genistein-7-O-glucuronide (GG) and daidzein-7-O-glucuronide (DG), only become estrogenic after deconjugation. The estrogenic potencies of genistein (Ge), daidzein (Da), GG and DG were determined using stably transfected U2OS-ERα, U2OS-ERβ reporter gene cells and proliferation was tested in T47D-ERβ cells mimicking the ERα/ERβ ratio of healthy breast cells and inT47D breast cancer cells. In all assays applied, the estrogenic potency of the aglycones was significantly higher than that of their corresponding glucuronides. UPLC analysis revealed that in U2OS and T47D cells, 0.2-1.6% of the glucuronides were deconjugated to their corresponding aglycones. The resulting aglycone concentrations can account for the estrogenicity observed upon glucuronide exposure. Interestingly, under similar experimental conditions, rat breast tissue S9 fraction was about 30 times more potent in deconjugating these glucuronides than human breast tissue S9 fraction. Our study confirms that SIF glucuronides are not estrogenic as such, and that the small % of deconjugation in the cell is enough to explain the slight bioactivity observed for the SIF-glucuronides. Species differences in deconjugation capacity should be taken into account when basing risk-benefit assessment of these SIF for the human population on animal data.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004156</affiliation-url><afid>60004156</afid><affilname>Wageningen University and Research Centre</affilname><name-variant>Wageningen University and Research Centre</name-variant><affiliation-city>Wageningen</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004156</affiliation-url><afid>60004156</afid><affilname>Wageningen University and Research Centre</affilname><name-variant>Wageningen University and Research Centre</name-variant><affiliation-city>Wageningen</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55946064200</author-url><authid>55946064200</authid><authname>Islam M.</authname><surname>Islam</surname><given-name>M. A.</given-name><initials>M.A.</initials><afid>60004156</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56541500000</author-url><authid>56541500000</authid><authname>Bekele R.</authname><surname>Bekele</surname><given-name>R.</given-name><initials>R.</initials><afid>60004156</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56541773300</author-url><authid>56541773300</authid><authname>vanden Berg J.</authname><surname>vanden Berg</surname><given-name>J. H J</given-name><initials>J.H.J.</initials><afid>60004156</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56541706100</author-url><authid>56541706100</authid><authname>Kuswanti Y.</authname><surname>Kuswanti</surname><given-name>Y.</given-name><initials>Y.</initials><afid>60004156</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56541758200</author-url><authid>56541758200</authid><authname>Thapa O.</authname><surname>Thapa</surname><given-name>O.</given-name><initials>O.</initials><afid>60004156</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:54685176600</author-url><authid>54685176600</authid><authname>Soltani S.</authname><surname>Soltani</surname><given-name>S.</given-name><initials>S.</initials><afid>60004156</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56489940300</author-url><authid>56489940300</authid><authname>van Leeuwen F.</authname><surname>van Leeuwen</surname><given-name>F. X R</given-name><initials>F.X.R.</initials><afid>60004156</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7005116412</author-url><authid>7005116412</authid><authname>Rietjens I.</authname><surname>Rietjens</surname><given-name>I. M C M</given-name><initials>I.M.C.M.</initials><afid>60004156</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7004084416</author-url><authid>7004084416</authid><authname>Murk A.</authname><surname>Murk</surname><given-name>A. J.</given-name><initials>A.J.</initials><afid>60004156</afid><afid>60004156</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7004084416</author-url><authid>7004084416</authid><authname>Murk A.</authname><surname>Murk</surname><given-name>A. J.</given-name><initials>A.J.</initials><afid>60004156</afid><afid>60004156</afid></author><authkeywords>Aglycones | Breast cell proliferation | Deconjugation | Estrogenicity | Glucuronides | Isoflavones</authkeywords><intid>1535119374</intid><source-id>25224</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930226140"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930226140?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930226140&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930226140&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930226140</prism:url><dc:identifier>SCOPUS_ID:84930226140</dc:identifier><eid>2-s2.0-84930226140</eid><dc:title>Hydrodynamic instabilities in the developing region of an axially rotating pipe flow</dc:title><dc:creator>Miranda-Barea A.</dc:creator><prism:publicationName>Fluid Dynamics Research</prism:publicationName><prism:issn>01695983</prism:issn><prism:volume>47</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1088/0169-5983/47/3/035514</prism:doi><dc:description>© 2015 The Japan Society of Fluid Mechanics and IOP Publishing Ltd. We conduct experiments in a rotating Hagen-Poiseuille flow (RHPF) through flow visualizations when the flow becomes convectively and absolutely unstable at low-to-moderate Reynolds numbers, Re. We characterize periodic patterns at a very high swirl parameter, L, when the flow overcomes the absolutely unstable region. These non-steady helical filaments wrapped around the axis appear in the developing region of the pipe. Experimentally, we compute the onset of these oscillations in the (L, Re)-plane finding that the rotation rate decreases as the Reynolds number increases in the process of achieving the time-dependent state. Additionally, we report information regarding frequencies and wavelengths that appear downstream of the rotating pipe for convectively and absolutely unstable flows, even for very high swirl parameters at which the flow becomes time-dependent in the developing region. We do not observe variations in the trends of these parameters, so these hydrodynamic instabilities in the developing region do not affect the unstable travelling waves downstream of the pipe.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003662</affiliation-url><afid>60003662</afid><affilname>Universidad de Malaga</affilname><name-variant>University of Málaga</name-variant><affiliation-city>Malaga</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56557119200</author-url><authid>56557119200</authid><authname>Miranda-Barea A.</authname><surname>Miranda-Barea</surname><given-name>A.</given-name><initials>A.</initials><afid>60003662</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56663285600</author-url><authid>56663285600</authid><authname>Fabrellas-García C.</authname><surname>Fabrellas-García</surname><given-name>C.</given-name><initials>C.</initials><afid>60003662</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6507210133</author-url><authid>6507210133</authid><authname>Parras L.</authname><surname>Parras</surname><given-name>L.</given-name><initials>L.</initials><afid>60003662</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:8876489600</author-url><authid>8876489600</authid><authname>Del Pino C.</authname><surname>Del Pino</surname><given-name>C.</given-name><initials>C.</initials><afid>60003662</afid></author><authkeywords>convective/absolute instabilities | hydrodynamic stability | rotating pipe</authkeywords><intid>1786088405</intid><article-number>035514</article-number><source-id>18465</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929708618"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929708618?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929708618&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929708618&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0965174815000181"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929708618</prism:url><dc:identifier>SCOPUS_ID:84929708618</dc:identifier><eid>2-s2.0-84929708618</eid><dc:title>Targeted mutagenesis and functional analysis of adipokinetic hormone-encoding gene in Drosophila</dc:title><dc:creator>Sajwan S.</dc:creator><prism:publicationName>Insect Biochemistry and Molecular Biology</prism:publicationName><prism:issn>09651748</prism:issn><prism:eIssn>18790240</prism:eIssn><prism:volume>61</prism:volume><prism:pageRange>79-86</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ibmb.2015.01.011</prism:doi><pii>S0965174815000181</pii><dc:description>© 2015 Elsevier Ltd. Adipokinetic hormones (Akhs) are small peptides (8-10 amino acid [aa] residues long) found in insects that regulate metabolic responses to stress by stimulating catabolic reactions and mobilizing energy stores. We employed Transcription activator-like effector nuclease (TALEN) mutagenesis and isolated an Akh&lt;sup&gt;1&lt;/sup&gt; mutant carrying a small deletion in the gene that resulted in a truncated peptide; the second aa (Leu) was missing from the functional octapeptide. This null Dmel/Akh mutant is suitable to study Akh function without any effect on the C-terminal associated peptide encoded by the same gene. The mutant flies were fully viable and compared to the control flies, had significantly low levels of hemolymph saccharides including trehalose and were resistant to starvation. These characteristics are similar to those obtained from the flies carrying targeted ablation of Akh-expressing neurons (reported earlier). We also found that the Akh&lt;sup&gt;1&lt;/sup&gt; mutants are slightly heavy and had a slow metabolic rate. Furthermore, we showed that the ectopic expression of Dmel\Akh reverses the Akh&lt;sup&gt;1&lt;/sup&gt; phenotype and restores the wild-type characteristics. Our results confirmed that Akh is an important regulator of metabolic homeostasis in Drosophila.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013029</affiliation-url><afid>60013029</afid><affilname>Institute of Entomology, Biology Centre of the Academy of Sciences of the Czech Republic</affilname><name-variant>Czech Academy of Sciences</name-variant><affiliation-city>Ceske Budejovice</affiliation-city><affiliation-country>Czech Republic</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009424</affiliation-url><afid>60009424</afid><affilname>Jihoceska Univerzita v Ceskuch Budejovicich</affilname><name-variant>University of South Bohemia</name-variant><affiliation-city>České Budějovice</affiliation-city><affiliation-country>Czech Republic</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031513</affiliation-url><afid>60031513</afid><affilname>National Institute of Agrobiological Sciences Tsukuba</affilname><name-variant>National Institute of Agrobiological Sciences</name-variant><affiliation-city>Tsukuba</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36451348600</author-url><authid>36451348600</authid><authname>Sajwan S.</authname><surname>Sajwan</surname><given-name>Suresh</given-name><initials>S.</initials><afid>60013029</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6602953038</author-url><authid>6602953038</authid><authname>Sidorov R.</authname><surname>Sidorov</surname><given-name>Roman</given-name><initials>R.</initials><afid>60013029</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55960763800</author-url><authid>55960763800</authid><authname>Stašková T.</authname><surname>Stašková</surname><given-name>Tereza</given-name><initials>T.</initials><afid>60013029</afid><afid>60009424</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55960763800</author-url><authid>55960763800</authid><authname>Stašková T.</authname><surname>Stašková</surname><given-name>Tereza</given-name><initials>T.</initials><afid>60013029</afid><afid>60009424</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56521748900</author-url><authid>56521748900</authid><authname>Žaloudíková A.</authname><surname>Žaloudíková</surname><given-name>Anna</given-name><initials>A.</initials><afid>60013029</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7005483492</author-url><authid>7005483492</authid><authname>Takasu Y.</authname><surname>Takasu</surname><given-name>Yoko</given-name><initials>Y.</initials><afid>60031513</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6603686806</author-url><authid>6603686806</authid><authname>Kodrík D.</authname><surname>Kodrík</surname><given-name>Dalibor</given-name><initials>D.</initials><afid>60013029</afid><afid>60009424</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6603686806</author-url><authid>6603686806</authid><authname>Kodrík D.</authname><surname>Kodrík</surname><given-name>Dalibor</given-name><initials>D.</initials><afid>60013029</afid><afid>60009424</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6602355318</author-url><authid>6602355318</authid><authname>Zurovec M.</authname><surname>Zurovec</surname><given-name>Michal</given-name><initials>M.</initials><afid>60013029</afid><afid>60009424</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6602355318</author-url><authid>6602355318</authid><authname>Zurovec M.</authname><surname>Zurovec</surname><given-name>Michal</given-name><initials>M.</initials><afid>60013029</afid><afid>60009424</afid></author><authkeywords>Carbohydrate metabolism | Drome-Akh | Neuropeptide | NHEJ | Stress | Trehalose</authkeywords><intid>1786001018</intid><source-id>20384</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924727485"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924727485?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924727485&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924727485&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0166432815001345"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924727485</prism:url><dc:identifier>SCOPUS_ID:84924727485</dc:identifier><eid>2-s2.0-84924727485</eid><dc:title>Time-dependent effects of rapamycin on consolidation of predator stress-induced hyperarousal</dc:title><dc:creator>Fifield K.</dc:creator><prism:publicationName>Behavioural Brain Research</prism:publicationName><prism:issn>01664328</prism:issn><prism:eIssn>18727549</prism:eIssn><prism:volume>286</prism:volume><prism:pageRange>104-111</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbr.2015.02.045</prism:doi><pii>S0166432815001345</pii><dc:description>© 2015 Elsevier B.V. Previous studies have indicated that rapamycin, a potent inhibitor of the mammalian target of rapamycin (mTOR) pathway, blocks consolidation of shock-induced associative fear memories. Moreover, rapamycin's block of associative fear memories is time-dependent. It is unknown, however, if rapamycin blocks consolidation of predator stress-induced non-associative fear memories. Furthermore, the temporal pattern of mTOR activation following predator stress is unknown. Thus, the goal of the current studies was to determine if rapamycin blocks consolidation of predator stress-induced fear memories and if so, whether rapamycin's effect is time-dependent. Male rats were injected systemically with rapamycin at various time points following predator stress. Predator stress involves an acute, unprotected exposure of a rat to a cat, which causes long-lasting non-associative fear memories manifested as generalized hyperarousal and increased anxiety-like behaviour. We show that rapamycin injected immediately after predator stress blocked consolidation of stress-induced startle. However, rapamycin injected 9, 24 or 48. h post predator stress potentiated stress-induced startle. Consistent with shock-induced associative fear memories, we show that mTOR signalling is essential for consolidation of predator stress-induced hyperarousal. However, unlike shock-induced fear memories, a second, persistent, late phase mTOR-dependent process following predator stress actually dampens startle. Consistent with previous findings, our data support the potential role for rapamycin in treatment of stress related disorders such as posttraumatic stress disorder. However, our data suggest timing of rapamycin administration is critical.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019000</affiliation-url><afid>60019000</afid><affilname>Memorial University of Newfoundland</affilname><name-variant>Memorial University</name-variant><affiliation-city>St John's</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55856936000</author-url><authid>55856936000</authid><authname>Fifield K.</authname><surname>Fifield</surname><given-name>Kathleen</given-name><initials>K.</initials><afid>60019000</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7102121804</author-url><authid>7102121804</authid><authname>Hebert M.</authname><surname>Hebert</surname><given-name>Mark</given-name><initials>M.</initials><afid>60019000</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56547891800</author-url><authid>56547891800</authid><authname>Williams K.</authname><surname>Williams</surname><given-name>Kimberly</given-name><initials>K.</initials><afid>60019000</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55369512300</author-url><authid>55369512300</authid><authname>Linehan V.</authname><surname>Linehan</surname><given-name>Victoria</given-name><initials>V.</initials><afid>60019000</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56548436200</author-url><authid>56548436200</authid><authname>Whiteman J.</authname><surname>Whiteman</surname><given-name>Jesse D.</given-name><initials>J.D.</initials><afid>60019000</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55853584300</author-url><authid>55853584300</authid><authname>Mac Callum P.</authname><surname>Mac Callum</surname><given-name>Phillip</given-name><initials>P.</initials><afid>60019000</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7103375351</author-url><authid>7103375351</authid><authname>Blundell J.</authname><surname>Blundell</surname><given-name>Jacqueline</given-name><initials>J.</initials><afid>60019000</afid></author><authkeywords>Consolidation | Hyperarousal | MTOR | Predator stress | Rapamycin | Startle</authkeywords><intid>1035184248</intid><source-id>14285</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924612323"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924612323?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924612323&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924612323&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0268005X15001034"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924612323</prism:url><dc:identifier>SCOPUS_ID:84924612323</dc:identifier><eid>2-s2.0-84924612323</eid><dc:title>Effect of barley and oat β-glucan concentrates on gluten-free rice-based doughs and bread characteristics</dc:title><dc:creator>Ronda F.</dc:creator><prism:publicationName>Food Hydrocolloids</prism:publicationName><prism:issn>0268005X</prism:issn><prism:volume>48</prism:volume><prism:pageRange>197-207</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.foodhyd.2015.02.031</prism:doi><pii>S0268005X15001034</pii><dc:description>© 2015 Elsevier Ltd. The impact of commercial oat or barley β-glucan concentrates incorporated at different levels (1.3-3.9 % actual β-glucan concentration, flour basis) into gluten-free (GF) rice-based dough formulations differing in water content (89-141%, flour basis) on dough rheology (empirical and fundamental tests) and breadmaking performance has been investigated. The effect of the baking process on the content and molecular weight of β-glucan in the final bread has been also evaluated. The rheological properties of the dough were dramatically influenced by dough water content; i.e. optimization of dough hydration is indeed of primary importance on improving GF bread quality. The bread specific volume was negatively correlated with the dough elastic modulus (G') and the viscosity (η0), and positively with the loss tangent. At optimum hydration, the rheological properties of barley β-glucans-enriched doughs and the quality attributes of breads derived therefrom were notably affected by the soluble fibre content; the G' at 1Hz increased up to ~100% and the bread volume decreased ~32% with respect to the values of the control dough and bread. In contrast, the impact of concentration of the oat-β-glucan preparation in the fortified doughs and bread was much less pronounced. These findings could be explained by the ability of the low molecular weight barley β-glucans to develop a gel network structure at higher concentrations, whereas the preparation of the high molecular weight oat β-glucan exhibits a more viscous-like rheological response. The added β-glucans to doughs were also quantitated in the bread crumbs, and a significant decrease in their molecular weight was noted, most likely due to the β-glucanase activity in the raw materials incorporated in the GF flour mixtures. Consequently, although the EFSA claims are achievable in gluten-free breads enriched with commercial β-glucans concentrates, control of β-glucanase activity in the raw materials may be a critical issue in exerting all the physiological benefits associated with the consumption of these bioactive polysaccharides.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024695</affiliation-url><afid>60024695</afid><affilname>Universidad de Valladolid</affilname><name-variant>Universidad de Valladolid</name-variant><affiliation-city>Valladolid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015331</affiliation-url><afid>60015331</afid><affilname>Aristoteleion Panepistimion Thessalonikis</affilname><name-variant>University of Thessaloniki</name-variant><affiliation-city>Thessaloniki</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6602530736</author-url><authid>6602530736</authid><authname>Ronda F.</authname><surname>Ronda</surname><given-name>Felicidad</given-name><initials>F.</initials><afid>60024695</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55599944300</author-url><authid>55599944300</authid><authname>Perez-Quirce S.</authname><surname>Perez-Quirce</surname><given-name>Sandra</given-name><initials>S.</initials><afid>60024695</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6602988519</author-url><authid>6602988519</authid><authname>Lazaridou A.</authname><surname>Lazaridou</surname><given-name>Athina</given-name><initials>A.</initials><afid>60015331</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7005416725</author-url><authid>7005416725</authid><authname>Biliaderis C.</authname><surname>Biliaderis</surname><given-name>Costas G.</given-name><initials>C.G.</initials><afid>60015331</afid></author><authkeywords>Barley β-glucans | Bread | Dough rheology | Gluten free formulations | Oat β-glucans | β-Glucan molecular weight</authkeywords><intid>1035162596</intid><source-id>22597</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928543286"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928543286?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928543286&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928543286&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928543286</prism:url><dc:identifier>SCOPUS_ID:84928543286</dc:identifier><eid>2-s2.0-84928543286</eid><dc:title>Glycaemic index and glycaemic load of sorghum products</dc:title><dc:creator>Prasad M.</dc:creator><prism:publicationName>Journal of the Science of Food and Agriculture</prism:publicationName><prism:issn>00225142</prism:issn><prism:eIssn>10970010</prism:eIssn><prism:volume>95</prism:volume><prism:issueIdentifier>8</prism:issueIdentifier><prism:pageRange>1626-1630</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1002/jsfa.6861</prism:doi><dc:description>© 2014 Society of Chemical Industry. BACKGROUND: Sorghum, a small-seeded grass, is an important food crop and chief energy source for the people of semi-arid regions of the world. In India, sorghum production/consumption decreased after the 'green revolution', but it is now regaining momentum owing to numerous health and nutritional benefits. An understanding of the glycaemic index (GI) and glycaemic load (GL) of staples can help in choosing suitable foods for the prevention and control of diabetes. In view of this, the present study was undertaken to evaluate the GI and GL of different sorghum foods and compare them with those of wheat/rice based foods. RESULTS: The GI of sorghum-based foods such as coarse semolina upma (P&lt;0.05), fine semolina upma (P&lt;0.01), flakes poha (P&lt;0.01) and pasta (P&lt;0.01) was significantly lower than that of their respective control (wheat/rice-based) foods. All sorghum-based foods showed significantly lower GL (P&lt;0.01) than their respective control (wheat/rice-based) foods. CONCLUSION: A few sorghum-based products have low GI (&lt;55; coarse semolina upma, fine semolina upma, flakes poha and pasta) and all sorghum-based products (with the exception of sorghum roti) tested in the present study have lower GL than their respective wheat/rice-based foods. Consumption of low-GI and low-GL sorghum-based foods may help in decreasing postprandial blood glucose levels.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017656</affiliation-url><afid>60017656</afid><affilname>National Institute of Nutrition India</affilname><name-variant>National Institute of Nutrition</name-variant><affiliation-city>Hyderabad</affiliation-city><affiliation-country>India</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:107870277</affiliation-url><afid>107870277</afid><affilname>Directorate of Sorghum Research</affilname><name-variant>Directorate of Sorghum Research</name-variant><affiliation-city>Hyderabad</affiliation-city><affiliation-country>India</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56339855500</author-url><authid>56339855500</authid><authname>Prasad M.</authname><surname>Prasad</surname><given-name>Madhrapakkam Pagadala Rajendra</given-name><initials>M.P.R.</initials><afid>60017656</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56340020000</author-url><authid>56340020000</authid><authname>Rao B.</authname><surname>Rao</surname><given-name>Benhur Dayakar</given-name><initials>B.D.</initials><afid>60017656</afid><afid>107870277</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56340020000</author-url><authid>56340020000</authid><authname>Rao B.</authname><surname>Rao</surname><given-name>Benhur Dayakar</given-name><initials>B.D.</initials><afid>60017656</afid><afid>107870277</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55332858400</author-url><authid>55332858400</authid><authname>Kalpana K.</authname><surname>Kalpana</surname><given-name>Kommi</given-name><initials>K.</initials><afid>107870277</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56339853900</author-url><authid>56339853900</authid><authname>Rao M.</authname><surname>Rao</surname><given-name>Mendu Vishuvardhana</given-name><initials>M.V.</initials><afid>60017656</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:25629989800</author-url><authid>25629989800</authid><authname>Patil J.</authname><surname>Patil</surname><given-name>Jagannath Vishnu</given-name><initials>J.V.</initials><afid>107870277</afid></author><authkeywords>Blood glucose | Glycaemic index | Glycaemic load | Serving size | Sorghum</authkeywords><intid>35803022</intid><source-id>33928</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84922981588"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84922981588?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84922981588&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84922981588&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0272494415000055"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84922981588</prism:url><dc:identifier>SCOPUS_ID:84922981588</dc:identifier><eid>2-s2.0-84922981588</eid><dc:title>Psychological and social factors associated with wastewater reuse emotional discomfort</dc:title><dc:creator>Wester J.</dc:creator><prism:publicationName>Journal of Environmental Psychology</prism:publicationName><prism:issn>02724944</prism:issn><prism:eIssn>15229610</prism:eIssn><prism:volume>42</prism:volume><prism:pageRange>16-23</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jenvp.2015.01.003</prism:doi><pii>S0272494415000055</pii><dc:description>© 2015 Elsevier Ltd. Wastewater reuse (WWR) technology has improved greatly in recent decades and may be an important solution to global water challenges. Nevertheless, several psychological and social barriers to widespread adoption still exist. Negative emotional reactions to WWR, known as the "yuck factor," have been identified as central to public acceptance. The present study used a large, context-neutral, web-based, U.S. sample (N=207), to examine factors underlying these negative emotions, here measured as discomfort felt toward WWR. We used a more nuanced measure to isolate what aspects of disgust sensitivity predict discomfort and then explored this relationship in the context of other individual and psychological differences. Being female, having less education, and being particularly sensitive to pathogen-related disgust stimuli, all were factors that were significantly and independently associated with reported discomfort. Mediation analysis showed that women felt greater discomfort because of higher levels of pathogen disgust sensitivity.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029251</affiliation-url><afid>60029251</afid><affilname>University of Miami</affilname><name-variant>University of Miami</name-variant><affiliation-city>Coral Gables</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029251</affiliation-url><afid>60029251</afid><affilname>University of Miami</affilname><name-variant>University of Miami</name-variant><affiliation-city>Coral Gables</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019600</affiliation-url><afid>60019600</afid><affilname>Nova Southeastern University</affilname><name-variant>Nova Southeastern University</name-variant><affiliation-city>Fort Lauderdale</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55067555500</author-url><authid>55067555500</authid><authname>Wester J.</authname><surname>Wester</surname><given-name>Julia</given-name><initials>J.</initials><afid>60029251</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:25930211600</author-url><authid>25930211600</authid><authname>Timpano K.</authname><surname>Timpano</surname><given-name>Kiara R.</given-name><initials>K.R.</initials><afid>60029251</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56518055200</author-url><authid>56518055200</authid><authname>Çek D.</authname><surname>Çek</surname><given-name>Demet</given-name><initials>D.</initials><afid>60029251</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7202460445</author-url><authid>7202460445</authid><authname>Lieberman D.</authname><surname>Lieberman</surname><given-name>Debra</given-name><initials>D.</initials><afid>60029251</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:36008729700</author-url><authid>36008729700</authid><authname>Fieldstone S.</authname><surname>Fieldstone</surname><given-name>Shaina C.</given-name><initials>S.C.</initials><afid>60019600</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7003578599</author-url><authid>7003578599</authid><authname>Broad K.</authname><surname>Broad</surname><given-name>Kenneth</given-name><initials>K.</initials><afid>60029251</afid></author><authkeywords>Disgust | Emotion ideology | Exposure | Wastewater reuse</authkeywords><intid>1034902802</intid><source-id>15470</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929462995"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929462995?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929462995&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929462995&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929462995</prism:url><dc:identifier>SCOPUS_ID:84929462995</dc:identifier><eid>2-s2.0-84929462995</eid><dc:title>A metabolomics approach to unravel the regulating role of phytohormones towards carotenoid metabolism in tomato fruit</dc:title><dc:creator>Van Meulebroek L.</dc:creator><prism:publicationName>Metabolomics</prism:publicationName><prism:issn>15733882</prism:issn><prism:eIssn>15733890</prism:eIssn><prism:volume>11</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:pageRange>667-683</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s11306-014-0728-9</prism:doi><dc:description>© 2014, Springer Science+Business Media New York. Carotenoids are important secondary metabolites, which have been recognized as an essential component of the human diet because of their valuable beneficial health effects. With this rationale, there is a continuous aim to define the distribution of these compounds in plants, to better understand their metabolism and to increase their concentration levels in fruits and vegetables. This study aimed at deepening the knowledge on the regulatory role of phytohormones in carotenoid metabolism. More specifically, it was envisaged to reveal the phytohormones involved in the metabolism of α-carotene, β-carotene, lycopene, lutein and zeaxanthin. To this purpose, the phytohormone profiles of 50 tomato fruits were determined by high-resolution Orbitrap mass spectrometry and evaluated towards the associated carotenoid levels. Data mining was performed by differential expression and orthogonal partial least squares analyses. This metabolomics approach revealed 5 phytohormonal metabolites, which significantly influenced (Variable Importance in Projection scores ≥0.80) carotenoid metabolism. These metabolites were identified as cis-12-oxo-phytodienoic acid, cucurbic acid, 2-oxindole-3-acetic acid, 1-acetylindole-3-carboxaldehyde, and cis-zeatin-O-glucoside. The involvement of the individual phytohormones towards carotenoid metabolism was investigated by regression analysis (P values ≤0.05, R&lt;sup&gt;2&lt;/sup&gt; varying between 0.280 and 0.760) and statistical correlation (P values ≤0.01, correlation varying between 0.403 and 0.846). It was concluded that these phytohormones all have significant contributing value in the regulation of carotenoid metabolism, thereby exhibiting down- and up-regulating influences. As a result, this knowledge encloses the potential for improving tomato fruit nutritional quality by targeted control of agronomic conditions, exogenous use of plant bioregulators, or genetic engineering.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033316</affiliation-url><afid>60033316</afid><affilname>Universiteit Gent</affilname><name-variant>Ghent University</name-variant><affiliation-city>Ghent</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033316</affiliation-url><afid>60033316</afid><affilname>Universiteit Gent</affilname><name-variant>Ghent University</name-variant><affiliation-city>Ghent</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:54901948700</author-url><authid>54901948700</authid><authname>Van Meulebroek L.</authname><surname>Van Meulebroek</surname><given-name>Lieven</given-name><initials>L.</initials><afid>60033316</afid><afid>60033316</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:54901948700</author-url><authid>54901948700</authid><authname>Van Meulebroek L.</authname><surname>Van Meulebroek</surname><given-name>Lieven</given-name><initials>L.</initials><afid>60033316</afid><afid>60033316</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35118704300</author-url><authid>35118704300</authid><authname>Bussche J.</authname><surname>Bussche</surname><given-name>Julie Vanden</given-name><initials>J.V.</initials><afid>60033316</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:26656611400</author-url><authid>26656611400</authid><authname>De Clercq N.</authname><surname>De Clercq</surname><given-name>Nathalie</given-name><initials>N.</initials><afid>60033316</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:8322375600</author-url><authid>8322375600</authid><authname>Steppe K.</authname><surname>Steppe</surname><given-name>Kathy</given-name><initials>K.</initials><afid>60033316</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:23092256600</author-url><authid>23092256600</authid><authname>Vanhaecke L.</authname><surname>Vanhaecke</surname><given-name>Lynn</given-name><initials>L.</initials><afid>60033316</afid></author><authkeywords>Carotenoids | Metabolism | Metabolomics | Phytohormones | Tomato</authkeywords><intid>2035957946</intid><source-id>130171</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84923319814"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84923319814?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84923319814&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84923319814&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0147651315000834"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84923319814</prism:url><dc:identifier>SCOPUS_ID:84923319814</dc:identifier><eid>2-s2.0-84923319814</eid><dc:title>Exposure of Daphnia magna to trichloroethylene (TCE) and vinyl chloride (VC): Evaluation of gene transcription, cellular activity, and life-history parameters</dc:title><dc:creator>Houde M.</dc:creator><prism:publicationName>Ecotoxicology and Environmental Safety</prism:publicationName><prism:issn>01476513</prism:issn><prism:eIssn>10902414</prism:eIssn><prism:volume>116</prism:volume><prism:pageRange>10-18</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ecoenv.2015.02.031</prism:doi><pii>S0147651315000834</pii><dc:description>© 2015. Trichloroethylene (TCE) is a ubiquitous contaminant classified as a human carcinogen. Vinyl chloride (VC) is primarily used to manufacture polyvinyl chloride and can also be a degradation product of TCE. Very few data exist on the toxicity of TCE and VC in aquatic organisms particularly at environmentally relevant concentrations. The aim of this study was to evaluate the sub-lethal effects (10. day exposure; 0.1; 1; 10. μg/L) of TCE and VC in Daphnia magna at the gene, cellular, and life-history levels. Results indicated impacts of VC on the regulation of genes related to glutathione-. S-transferase (. GST), juvenile hormone esterase (. JHE), and the vitelline outer layer membrane protein (. VMO1). On the cellular level, exposure to 0.1, 1, and 10. μg/L of VC significantly increased the activity of JHE in D. magna and TCE increased the activity of chitinase (at 1 and 10. μg/L). Results for life-history parameters indicated a possible tendency of TCE to affect the number of molts at the individual level in D. magna (. p=0.051). Measurement of VG-like proteins using the alkali-labile phosphates (ALP) assay did not show differences between TCE treated organisms and controls. However, semi-quantitative measurement using gradient gel electrophoresis (213-218. kDa) indicated significant decrease in VG-like protein levels following exposure to TCE at all three concentrations. Overall, results indicate effects of TCE and VC on genes and proteins related to metabolism, reproduction, and growth in D. magna.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100320701</affiliation-url><afid>100320701</afid><affilname>Centre Saint-Laurent</affilname><name-variant>Centre Saint-Laurent</name-variant><affiliation-city>Montreal</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115014962</affiliation-url><afid>115014962</afid><affilname>Prairie and Northern Laboratory for Environmental Testing</affilname><name-variant>Prairie and Northern Laboratory for Environmental Testing</name-variant><affiliation-city/><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115015105</affiliation-url><afid>115015105</afid><affilname>Environmental Protection Operations Directorate</affilname><name-variant>Environmental Protection Operations Directorate</name-variant><affiliation-city>Montreal</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8986698300</author-url><authid>8986698300</authid><authname>Houde M.</authname><surname>Houde</surname><given-name>Magali</given-name><initials>M.</initials><afid>100320701</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6507565990</author-url><authid>6507565990</authid><authname>Douville M.</authname><surname>Douville</surname><given-name>Mélanie</given-name><initials>M.</initials><afid>100320701</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7102161416</author-url><authid>7102161416</authid><authname>Gagnon P.</authname><surname>Gagnon</surname><given-name>Pierre</given-name><initials>P.</initials><afid>100320701</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6602081367</author-url><authid>6602081367</authid><authname>Sproull J.</authname><surname>Sproull</surname><given-name>Jim</given-name><initials>J.</initials><afid>115014962</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56526815600</author-url><authid>56526815600</authid><authname>Cloutier F.</authname><surname>Cloutier</surname><given-name>François</given-name><initials>F.</initials><afid>115015105</afid></author><authkeywords>Cellular activity | Daphnia magna | Gene transcription | Life-history parameters | Trichloroethylene | Vinyl chloride</authkeywords><intid>1034955638</intid><source-id>25076</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924386450"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924386450?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924386450&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924386450&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0305750X15000327"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924386450</prism:url><dc:identifier>SCOPUS_ID:84924386450</dc:identifier><eid>2-s2.0-84924386450</eid><dc:title>Unraveling the Notion of "Fair Carbon": Key Challenges for Standards Development</dc:title><dc:creator>Howard R.</dc:creator><prism:publicationName>World Development</prism:publicationName><prism:issn>0305750X</prism:issn><prism:eIssn>18735991</prism:eIssn><prism:volume>70</prism:volume><prism:pageRange>343-356</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.worlddev.2015.02.008</prism:doi><pii>S0305750X15000327</pii><dc:description>© 2015 The Authors. Standards organizations and NGOs have begun to refer to "fair carbon" projects, and "fairly traded" carbon credits. "Fairness" is a fuzzy notion, subject to multiple and competing interpretations. This paper draws on a framing used by standards organizations, which encompasses issues of access and benefits, to critically examine challenges and opportunities for achieving desired "fair" outcomes as discussed in the literature. Arising knowledge gaps are presented as a research agenda that explores what "fair carbon" means to multiple stakeholders; illuminates governance processes through which "fairness" is being standardized; and examines its implications within certified carbon projects.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012070</affiliation-url><afid>60012070</afid><affilname>University of Leeds</affilname><name-variant>University of Leeds</name-variant><affiliation-city>Leeds</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016418</affiliation-url><afid>60016418</afid><affilname>University of York</affilname><name-variant>University of York</name-variant><affiliation-city>York</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56542431600</author-url><authid>56542431600</authid><authname>Howard R.</authname><surname>Howard</surname><given-name>Rebecca Joy</given-name><initials>R.J.</initials><afid>60012070</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55897405300</author-url><authid>55897405300</authid><authname>Tallontire A.</authname><surname>Tallontire</surname><given-name>Anne</given-name><initials>A.</initials><afid>60012070</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:14018839600</author-url><authid>14018839600</authid><authname>Stringer L.</authname><surname>Stringer</surname><given-name>Lindsay</given-name><initials>L.</initials><afid>60012070</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7102843206</author-url><authid>7102843206</authid><authname>Marchant R.</authname><surname>Marchant</surname><given-name>Rob</given-name><initials>R.</initials><afid>60016418</afid></author><authkeywords>Access | Benefits | Carbon projects | Standard setting organizations | Sub Saharan Africa | Voluntary carbon market</authkeywords><intid>1785135660</intid><source-id>30060</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924659057"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924659057?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924659057&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924659057&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0306460315000179"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924659057</prism:url><dc:identifier>SCOPUS_ID:84924659057</dc:identifier><eid>2-s2.0-84924659057</eid><dc:title>Women and smoking - Prices and health warning messages: Evidence from Spain</dc:title><dc:creator>Gil-Lacruz A.</dc:creator><prism:publicationName>Addictive Behaviors</prism:publicationName><prism:issn>03064603</prism:issn><prism:eIssn>18736327</prism:eIssn><prism:volume>45</prism:volume><prism:pageRange>294-300</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.addbeh.2015.01.016</prism:doi><pii>S0306460315000179</pii><dc:description>© 2015 Elsevier Ltd. Objective: In Spain, fewer men are smoking every year yet the number of women smokers remains relatively high. This paper examines the impact of two anti-smoking policies (increased prices and obligatory pictorial health warning labels) on womens smoking decisions; generation cohorts are used to elucidate the determinants of those decisions. Data source: We have drawn 48,755 observations of women living in Spain from the Spanish National Health Surveys of 2001, 2003, 2006 and 2011. Data synthesis: Among the main results, we highlight that belonging to a particular generation modulates the manner in which individual characteristics and tobacco policies determine smoking decisions. For example, women's smoking was not considered as socially acceptable until the 1960s and therefore older women have lower smoking rates. However, for the younger female cohorts (generations X and Y) smoking was seen as an act of rebellion and modernity, so women belonging to these groups, irrespective of educational level, are more likely to smoke. Conclusions: The price of cigarettes and pictorial health warning labels on cigarette packets also influence the smoking behaviour of Spanish women.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016809</affiliation-url><afid>60016809</afid><affilname>Universidad de Zaragoza</affilname><name-variant>University of Zaragoza</name-variant><affiliation-city>Zaragoza</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016809</affiliation-url><afid>60016809</afid><affilname>Universidad de Zaragoza</affilname><name-variant>University of Zaragoza</name-variant><affiliation-city>Zaragoza</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025709</affiliation-url><afid>60025709</afid><affilname>University of Sydney</affilname><name-variant>University of Sydney</name-variant><affiliation-city>Sydney</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36138657700</author-url><authid>36138657700</authid><authname>Gil-Lacruz A.</authname><surname>Gil-Lacruz</surname><given-name>Ana Isabel</given-name><initials>A.I.</initials><afid>60016809</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:26664487500</author-url><authid>26664487500</authid><authname>Gil-Lacruz M.</authname><surname>Gil-Lacruz</surname><given-name>Marta</given-name><initials>M.</initials><afid>60016809</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56548361800</author-url><authid>56548361800</authid><authname>Leeder S.</authname><surname>Leeder</surname><given-name>Stephen</given-name><initials>S.</initials><afid>60025709</afid></author><authkeywords>Cigarette | Generations | Pictorial images | Prices | Women</authkeywords><intid>535189692</intid><source-id>24763</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928479349"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928479349?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928479349&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928479349&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0003986115001940"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928479349</prism:url><dc:identifier>SCOPUS_ID:84928479349</dc:identifier><eid>2-s2.0-84928479349</eid><dc:title>Oxidized low-density lipoprotein accelerates the destabilization of extracellular-superoxide dismutase mRNA during foam cell formation</dc:title><dc:creator>Makino J.</dc:creator><prism:publicationName>Archives of Biochemistry and Biophysics</prism:publicationName><prism:issn>00039861</prism:issn><prism:eIssn>10960384</prism:eIssn><prism:volume>575</prism:volume><prism:pageRange>54-60</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.abb.2015.04.001</prism:doi><pii>S0003986115001940</pii><dc:description>© 2015 Elsevier Inc. All rights reserved. Extracellular-superoxide dismutase (EC-SOD) is one of the main anti-oxidative enzymes that protect cells against the damaging effects of superoxide. In the present study, we investigated the regulation of EC-SOD expression during the oxidized low density lipoprotein (oxLDL)-induced foam cell formation of THP-1-derived macrophages. The uptake of oxLDL into THP-1-derived macrophages was increased and EC-SOD expression was decreased in a time-dependent manner by oxLDL. Furthermore, EC-SOD suppression by oxLDL was mediated by the binding to scavenger receptors, especially CD36, from the results with siRNA experience. EC-SOD expression is known to be regulated by histone acetylation and binding of the transcription factor Sp1/3 to the EC-SOD promoter region in human cell lines. However, oxLDL did not affect these processes. On the other hand, the stability of EC-SOD mRNA was decreased by oxLDL. Moreover, oxLDL promoted destabilization of ectopically expressed mRNA from EC-SOD or chimeric Cu,Zn-SOD gene with the sequence corresponding to 3′UTR of EC-SOD mRNA, whereas oxLDL had no effect on ectopic mRNA produced from EC-SOD gene lacking the sequence. These results suggested that oxLDL decreased the expression of EC-SOD, which, in turn, accelerated the destabilization of EC-SOD mRNA, leading to weaker protection against oxidative stress and atherosclerosis.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009011</affiliation-url><afid>60009011</afid><affilname>Gifu Pharmaceutical University</affilname><name-variant>Gifu Pharmaceutical University</name-variant><affiliation-city>Gifu</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:46062332500</author-url><authid>46062332500</authid><authname>Makino J.</authname><surname>Makino</surname><given-name>Junya</given-name><initials>J.</initials><afid>60009011</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56605998100</author-url><authid>56605998100</authid><authname>Nii M.</authname><surname>Nii</surname><given-name>Miyuki</given-name><initials>M.</initials><afid>60009011</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36150103700</author-url><authid>36150103700</authid><authname>Kamiya T.</authname><surname>Kamiya</surname><given-name>Tetsuro</given-name><initials>T.</initials><afid>60009011</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56457339800</author-url><authid>56457339800</authid><authname>Hara H.</authname><surname>Hara</surname><given-name>Hirokazu</given-name><initials>H.</initials><afid>60009011</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7401633116</author-url><authid>7401633116</authid><authname>Adachi T.</authname><surname>Adachi</surname><given-name>Tetsuo</given-name><initials>T.</initials><afid>60009011</afid></author><authkeywords>3′-Untranslated region | Destabilization | Extracellular-superoxide dismutase | mRNA | Oxidized low-density lipoprotein</authkeywords><intid>35793437</intid><source-id>16811</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928154344"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928154344?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928154344&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928154344&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0736574815000386"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928154344</prism:url><dc:identifier>SCOPUS_ID:84928154344</dc:identifier><eid>2-s2.0-84928154344</eid><dc:title>Hypoxic preconditioning can reduce injury-induced inflammatory processes in the neonatal rat brain</dc:title><dc:creator>Parmar J.</dc:creator><prism:publicationName>International Journal of Developmental Neuroscience</prism:publicationName><prism:issn>07365748</prism:issn><prism:eIssn>1873474X</prism:eIssn><prism:volume>43</prism:volume><prism:pageRange>35-42</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijdevneu.2015.03.010</prism:doi><pii>S0736574815000386</pii><dc:description>© 2015 Elsevier Ltd. Inflammation plays an important role in the pathophysiology of neonatal hypoxic-ischemic (HI) brain injury. Studies have shown that hypoxic preconditioning (HP) can ameliorate brain damage, but its effects on inflammation remain unknown. Postnatal day 6 (P6), Sprague-Dawley rats were divided into normoxia and hypoxia (8% oxygen, 3. h) groups. On P7, some pups underwent a right carotid artery occlusion followed by hypoxia (8% oxygen, 3. h) while under 1.5% isofluorane anesthesia and the remaining pups underwent sham surgery without occlusion. Animals were sacrificed 5 days later and fixed tissue was used to examine changes in neurons, astrocytes, and microglia in the cortex. Fresh tissue was collected to determine cortical levels of proinflammatory cytokines using ELISA. There was a significant loss in the number of NeuN positive cells in the cortex following HI injury, which was improved when HP was given prior to HI. There was an increase in cortical area of astrocyte staining after HI injury compared to control. HP before HI was able to reduce area of GFAP staining back to control levels. HI caused a large increase in the number of activated microglia compared to control and HP was able to significantly reduce this, although not back to control levels. HP alone increased microglial activation. Interleukin-1β levels were increased in the cortex 5 days after HI, but HP was not able to significantly reduce this change. The neuroprotective effects of HP appear to be mediated by affecting cellular inflammatory processes in the brain following HI injury.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:106580562</affiliation-url><afid>106580562</afid><affilname>School of Medical Sciences</affilname><name-variant>School of Medical Sciences</name-variant><affiliation-city>Sydney</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56600166700</author-url><authid>56600166700</authid><authname>Parmar J.</authname><surname>Parmar</surname><given-name>Jasneet</given-name><initials>J.</initials><afid>106580562</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7403398552</author-url><authid>7403398552</authid><authname>Jones N.</authname><surname>Jones</surname><given-name>Nicole M.</given-name><initials>N.M.</initials><afid>106580562</afid></author><authkeywords>Hypoxia-ischemia | Hypoxic preconditioning | Inflammation | Neonatal | Neuroprotection</authkeywords><intid>1535733496</intid><source-id>16147</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926443328"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926443328?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926443328&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926443328&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0010482515000979"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926443328</prism:url><dc:identifier>SCOPUS_ID:84926443328</dc:identifier><eid>2-s2.0-84926443328</eid><dc:title>A new machine learning approach for predicting the response to anemia treatment in a large cohort of End Stage Renal Disease patients undergoing dialysis</dc:title><dc:creator>Barbieri C.</dc:creator><prism:publicationName>Computers in Biology and Medicine</prism:publicationName><prism:issn>00104825</prism:issn><prism:eIssn>18790534</prism:eIssn><prism:volume>61</prism:volume><prism:pageRange>56-61</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.compbiomed.2015.03.019</prism:doi><pii>S0010482515000979</pii><dc:description>© 2015 Elsevier Ltd. Chronic Kidney Disease (CKD) anemia is one of the main common comorbidities in patients undergoing End Stage Renal Disease (ESRD). Iron supplement and especially Erythropoiesis Stimulating Agents (ESA) have become the treatment of choice for that anemia. However, it is very complicated to find an adequate treatment for every patient in each particular situation since dosage guidelines are based on average behaviors, and thus, they do not take into account the particular response to those drugs by different patients, although that response may vary enormously from one patient to another and even for the same patient in different stages of the anemia. This work proposes an advance with respect to previous works that have faced this problem using different methodologies (Machine Learning (ML), among others), since the diversity of the CKD population has been explicitly taken into account in order to produce a general and reliable model for the prediction of ESA/Iron therapy response. Furthermore, the ML model makes use of both human physiology and drug pharmacology to produce a model that outperforms previous approaches, yielding Mean Absolute Errors (MAE) of the Hemoglobin (Hb) prediction around or lower than 0.6. g/dl in the three countries analyzed in the study, namely, Spain, Italy and Portugal.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113660035</affiliation-url><afid>113660035</afid><affilname>Healthcare and Business Advanced Modeling</affilname><name-variant>Healthcare and Business Advanced Modeling</name-variant><affiliation-city>Bad Homburg</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:102053024</affiliation-url><afid>102053024</afid><affilname>University of Krems</affilname><name-variant>University of Krems</name-variant><affiliation-city>Krems</affiliation-city><affiliation-country>Austria</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002644</affiliation-url><afid>60002644</afid><affilname>Universitat de ValEncia</affilname><name-variant>Universitat de València</name-variant><affiliation-city>Valencia</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:54399977600</author-url><authid>54399977600</authid><authname>Barbieri C.</authname><surname>Barbieri</surname><given-name>Carlo</given-name><initials>C.</initials><afid>113660035</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:54400322800</author-url><authid>54400322800</authid><authname>Mari F.</authname><surname>Mari</surname><given-name>Flavio</given-name><initials>F.</initials><afid>113660035</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:15752090100</author-url><authid>15752090100</authid><authname>Stopper A.</authname><surname>Stopper</surname><given-name>Andrea</given-name><initials>A.</initials><afid>113660035</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7102127708</author-url><authid>7102127708</authid><authname>Gatti E.</authname><surname>Gatti</surname><given-name>Emanuele</given-name><initials>E.</initials><afid>113660035</afid><afid>102053024</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7102127708</author-url><authid>7102127708</authid><authname>Gatti E.</authname><surname>Gatti</surname><given-name>Emanuele</given-name><initials>E.</initials><afid>113660035</afid><afid>102053024</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:43460968000</author-url><authid>43460968000</authid><authname>Escandell-Montero P.</authname><surname>Escandell-Montero</surname><given-name>Pablo</given-name><initials>P.</initials><afid>60002644</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:43461774400</author-url><authid>43461774400</authid><authname>Martínez-Martínez J.</authname><surname>Martínez-Martínez</surname><given-name>José M.</given-name><initials>J.M.</initials><afid>60002644</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7004608452</author-url><authid>7004608452</authid><authname>Martín-Guerrero J.</authname><surname>Martín-Guerrero</surname><given-name>José D.</given-name><initials>J.D.</initials><afid>60002644</afid></author><authkeywords>Anemia | Chronic Kidney Disease | Hemoglobin | Machine learning | Prediction</authkeywords><intid>1535454564</intid><source-id>17957</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84923380348"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84923380348?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84923380348&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84923380348&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1567539414001145"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84923380348</prism:url><dc:identifier>SCOPUS_ID:84923380348</dc:identifier><eid>2-s2.0-84923380348</eid><dc:title>Nanosecond electric pulses: A mini-review of the present state of the art</dc:title><dc:creator>Chopinet L.</dc:creator><prism:publicationName>Bioelectrochemistry</prism:publicationName><prism:issn>15675394</prism:issn><prism:eIssn>1878562X</prism:eIssn><prism:volume>103</prism:volume><prism:pageRange>2-6</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bioelechem.2014.07.008</prism:doi><pii>S1567539414001145</pii><dc:description>© 2014 Elsevier B.V. Nanosecond electric pulses (nsEPs) are defined as very short high intensity electric pulses which present great potential for the destabilization of intracellular structures. Their theoretical descriptions first suggested specific effects on organelles that have been confirmed by various observations both in vitro and in vivo. However, due to their concomitant effects on the plasma membrane, nsEPs can also affect cell functions. In this mini-review, nsEP effects on cells are described following three topics: effects at the plasma membrane level, intracellular effects, and the impact on cell survival. Eventually, a short description of the major results obtained in vivo will be presented. This study shows that the use of nsEPs has evolved during the last decade to focus on low voltage for practical applications.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020129</affiliation-url><afid>60020129</afid><affilname>IPBS Institut de Pharmacologie et de Biologie Structurale</affilname><name-variant>CNRS</name-variant><affiliation-city>Toulouse</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60102124</affiliation-url><afid>60102124</afid><affilname>Universite de Toulouse</affilname><name-variant>University of Toulouse</name-variant><affiliation-city>Toulouse</affiliation-city><affiliation-country>France</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>sh</subtype><subtypeDescription>Short Survey</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:37561008200</author-url><authid>37561008200</authid><authname>Chopinet L.</authname><surname>Chopinet</surname><given-name>Louise</given-name><initials>L.</initials><afid>60020129</afid><afid>60102124</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:37561008200</author-url><authid>37561008200</authid><authname>Chopinet L.</authname><surname>Chopinet</surname><given-name>Louise</given-name><initials>L.</initials><afid>60020129</afid><afid>60102124</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7004153482</author-url><authid>7004153482</authid><authname>Rols M.</authname><surname>Rols</surname><given-name>Marie Pierre</given-name><initials>M.P.</initials><afid>60020129</afid><afid>60102124</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7004153482</author-url><authid>7004153482</authid><authname>Rols M.</authname><surname>Rols</surname><given-name>Marie Pierre</given-name><initials>M.P.</initials><afid>60020129</afid><afid>60102124</afid></author><authkeywords>Cell | Electropermeabilization | Electroporation | Gene therapy | NsEP</authkeywords><intid>2034956759</intid><source-id>16890</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924860643"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924860643?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924860643&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924860643&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S2214180415000069"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924860643</prism:url><dc:identifier>SCOPUS_ID:84924860643</dc:identifier><eid>2-s2.0-84924860643</eid><dc:title>Detection of S-nitrosylated protein by surface plasmon resonance</dc:title><dc:creator>Wang R.</dc:creator><prism:publicationName>Sensing and Bio-Sensing Research</prism:publicationName><prism:eIssn>22141804</prism:eIssn><prism:volume>4</prism:volume><prism:pageRange>30-36</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.sbsr.2015.02.001</prism:doi><pii>S2214180415000069</pii><dc:description>© 2015 The Authors. S-Nitrosylation has recently emerged as an important posttranslational modification of proteins and is becoming an intensive field of research in plants. Protein S-nitrosation, a reversible post-translation modification of cysteine, affects many cell signaling pathways and plays critical roles in redox-sensitive cell signaling. Changes in protein function effectively transmit biological signals and thus provide a framework for elucidating signaling networks. This paper presented a new, universal immunosensor for detection of S-nitrosylated proteins. Electrochemical impedance spectroscopy (EIS) and atomic force microscope (AFM) were used to estimate the formation of self-assembled film. This method was based on the specific binding characteristics of biotin-streptavidin, using Biotin-HPDP labeled protein sulfhydryl group as the substrate to detect proteins. The sensor was used to detect bovine serum albumin (BSA), nitrosylated BSA and denitrosylated BSA. The results showed that 90.61% of nitrosylated BSA were reduced, verifying that protein S-nitrosylation is a reversible and effective post-translation modification. This method was successfully applied to detect S-nitrosylated protein in Feicheng peach. The results showed good repeatability and precision. This method provided a molecular basis for further exploring the mechanism of S-nitrosylation of proteins in plants.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026852</affiliation-url><afid>60026852</afid><affilname>Shandong Agricultural University</affilname><name-variant>Shandong Agricultural University</name-variant><affiliation-city>Tainan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36072416400</author-url><authid>36072416400</authid><authname>Wang R.</authname><surname>Wang</surname><given-name>Ruirui</given-name><initials>R.</initials><afid>60026852</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56553697700</author-url><authid>56553697700</authid><authname>Kong Q.</authname><surname>Kong</surname><given-name>Qingnan</given-name><initials>Q.</initials><afid>60026852</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7405550459</author-url><authid>7405550459</authid><authname>Zhou J.</authname><surname>Zhou</surname><given-name>Jie</given-name><initials>J.</initials><afid>60026852</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56097934100</author-url><authid>56097934100</authid><authname>Zhang L.</authname><surname>Zhang</surname><given-name>Lili</given-name><initials>L.</initials><afid>60026852</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:35738328300</author-url><authid>35738328300</authid><authname>Zhu S.</authname><surname>Zhu</surname><given-name>Shuhua</given-name><initials>S.</initials><afid>60026852</afid></author><authkeywords>Biotin-streptavidin | Nitric oxide | S-Nitrosylated protein | Surface plasmon resonance</authkeywords><intid>535219852</intid><source-id>21100356802</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924692029"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924692029?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924692029&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924692029&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0166432815001114"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924692029</prism:url><dc:identifier>SCOPUS_ID:84924692029</dc:identifier><eid>2-s2.0-84924692029</eid><dc:title>Adenosine signaling in reserpine-induced depression in rats</dc:title><dc:creator>Minor T.</dc:creator><prism:publicationName>Behavioural Brain Research</prism:publicationName><prism:issn>01664328</prism:issn><prism:eIssn>18727549</prism:eIssn><prism:volume>286</prism:volume><prism:pageRange>184-191</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbr.2015.02.032</prism:doi><pii>S0166432815001114</pii><dc:description>© 2015. A single, 6mg/kg intraperitoneal injection of reserpine increased floating time during forced swim testing 24h after administration in rats in five experiments. Although such behavioral depression traditionally is attributed to drug-induced depletion of brain monoamines, we examined the potential contribution of adenosine signaling, which is plausibly activated by reserpine treatment and contributes to behavioral depression in other paradigms. Whereas peripheral administration of the highly selective A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (0.5, 1.0, or 5.0mg/kg i.p.) 15min before swim testing failed to improve performance in reserpine-treated rats, swim deficits were completely reversed by 7mg/kg of the nonselective receptor antagonist caffeine. Performance deficits were also reversed by the nonselective A2 antagonist 3,7-dimethylxanthine (0, 0.5, 1.0mg/kg i.p.), and the highly selective A2A receptor antagonist (CSC: 8-(3chlorostyral)caffeine) (0.01, 0.1, or 1.0mg/kg i.p.) in a dose-dependent manner. The highly selective A2B antagonist alloxazine had no beneficial effect on swim performance at any dose under study (0.1, 1.0, and 5.0mg/kg i.p.).</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031203</affiliation-url><afid>60031203</afid><affilname>University of California System</affilname><name-variant>Univ of California</name-variant><affiliation-city>Oakland</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35986009000</author-url><authid>35986009000</authid><authname>Minor T.</authname><surname>Minor</surname><given-name>Thomas R.</given-name><initials>T.R.</initials><afid>60031203</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:37011998400</author-url><authid>37011998400</authid><authname>Hanff T.</authname><surname>Hanff</surname><given-name>Thomas C.</given-name><initials>T.C.</initials><afid>60031203</afid></author><authkeywords>A2A receptor | Adenosine | Conservation-withdrawal | Major depression | Reserpine</authkeywords><intid>1785191826</intid><source-id>14285</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84923108955"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84923108955?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84923108955&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84923108955&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0197397515000077"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84923108955</prism:url><dc:identifier>SCOPUS_ID:84923108955</dc:identifier><eid>2-s2.0-84923108955</eid><dc:title>Social order, leisure, or tourist attraction? The changing planning missions for waterfront space in Hong Kong</dc:title><dc:creator>Cheung D.</dc:creator><prism:publicationName>Habitat International</prism:publicationName><prism:issn>01973975</prism:issn><prism:volume>47</prism:volume><prism:pageRange>231-240</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.habitatint.2015.01.006</prism:doi><pii>S0197397515000077</pii><dc:description>© 2015 Elsevier Ltd. Urban waterfronts gain more attention in the 21st century. While waterfront uses are often contested between the government and the community, the literature suggests that economic and property interests generally play significant roles in waterfront redevelopment. Relatively less emphasis is found in the literature to perceive the waterfront as a place for leisure and recreation. This study examines the changing missions for the Victoria Harbour waterfront in Hong Kong. Three epochs of harbour waterfront planning and development are discussed. It argues that leisure and recreational functions are provided in an auxiliary manner in all the three periods of waterfront development. The 19th century Praya aimed at enhancing social order, improving harbour appearance, and providing public access. The 20th century waterfront faced a competing demand between a place for tourism and a place for local people. The contemporary waterfront is further transformed under a selective logic, bringing tourists to the inner harbour waterfront and pushing local recreational needs to the outer harbour waterfront. The harbour waterfront is gradually emerging into a festival market type waterfront.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006541</affiliation-url><afid>60006541</afid><affilname>The University of Hong Kong</affilname><name-variant>University of Hong Kong</name-variant><affiliation-city>Pokfulam</affiliation-city><affiliation-country>Hong Kong</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56521054800</author-url><authid>56521054800</authid><authname>Cheung D.</authname><surname>Cheung</surname><given-name>Darren Man wai</given-name><initials>D.M.w.</initials><afid>60006541</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7402560881</author-url><authid>7402560881</authid><authname>Tang B.</authname><surname>Tang</surname><given-name>Bo sin</given-name><initials>B.s.</initials><afid>60006541</afid></author><authkeywords>Hong Kong | Open space | Recreation | Victoria harbour | Waterfront</authkeywords><intid>1534914064</intid><source-id>13760</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924184319"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924184319?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924184319&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924184319&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S2352250X15000937"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924184319</prism:url><dc:identifier>SCOPUS_ID:84924184319</dc:identifier><eid>2-s2.0-84924184319</eid><dc:title>The Affect Regulation Training (ART): A transdiagnostic approach to the prevention and treatment of mental disorders</dc:title><dc:creator>Berking M.</dc:creator><prism:publicationName>Current Opinion in Psychology</prism:publicationName><prism:issn>2352250X</prism:issn><prism:volume>3</prism:volume><prism:pageRange>64-69</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.copsyc.2015.02.002</prism:doi><pii>S2352250X15000937</pii><dc:description>© 2015 Elsevier Ltd. Deficits in emotion regulation skills likely contribute to the development and maintenance of various mental health problems. Thus, we developed the Affect Regulation Training (ART) as a transdiagnostic intervention that can be used to enhance such skills whenever a focus on emotion-regulation appears promising in preventing or treating mental health problems. In the present article we introduce the readers to the theoretical background, the aim and scope, and the procedure constituting ART. We will also present some research on the treatment's efficacy as well as perspectives for future treatment development and research.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000765</affiliation-url><afid>60000765</afid><affilname>Friedrich-Alexander-Universität Erlangen-Nürnberg</affilname><name-variant>University of Erlangen-Nuremberg</name-variant><affiliation-city>Erlangen</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:10039087200</author-url><authid>10039087200</authid><authname>Berking M.</authname><surname>Berking</surname><given-name>Matthias</given-name><initials>M.</initials><afid>60000765</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56538102900</author-url><authid>56538102900</authid><authname>Lukas C.</authname><surname>Lukas</surname><given-name>Christian A.</given-name><initials>C.A.</initials><afid>60000765</afid></author><intid>2035081027</intid><source-id>21100372442</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930206962"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930206962?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930206962&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930206962&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930206962</prism:url><dc:identifier>SCOPUS_ID:84930206962</dc:identifier><eid>2-s2.0-84930206962</eid><dc:title>Regular and chaotic vibration in a piezoelectric energy harvester with fractional damping</dc:title><dc:creator>Cao J.</dc:creator><prism:publicationName>European Physical Journal Plus</prism:publicationName><prism:issn>21905444</prism:issn><prism:eIssn>21905444</prism:eIssn><prism:volume>130</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1140/epjp/i2015-15103-8</prism:doi><dc:description>© 2015, The Author(s). We examine a vibrational energy harvester consisting of a mechanical resonator with a fractional damping and electrical circuit coupled by a piezoelectric converter. By comparing the bifurcation diagrams and the power output we show that the fractional order of damping changes the system response considerably and affects the power output. Various dynamic responses of the energy harvester are examined using phase trajectory, Fourier spectrum, Multi-scale entropy and 0–1 test. The numerical analysis shows that the fractionally damped energy harvesting system exhibits chaos, and periodic motion, as the fractional order changes. The observed bifurcations strongly influence the power output.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60089930</affiliation-url><afid>60089930</afid><affilname>State Key Laboratory for Manufacturing Systems Engineering</affilname><name-variant>Xi'An Jiaotong University</name-variant><affiliation-city>Xi'an</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011739</affiliation-url><afid>60011739</afid><affilname>Politechnika Lubelska</affilname><name-variant>Lublin University of Technology</name-variant><affiliation-city>Lublin</affiliation-city><affiliation-country>Poland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016253</affiliation-url><afid>60016253</afid><affilname>INSA Lyon</affilname><name-variant>INSA Lyon</name-variant><affiliation-city>Villeurbanne</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025778</affiliation-url><afid>60025778</afid><affilname>University Michigan Ann Arbor</affilname><name-variant>University of Michigan</name-variant><affiliation-city>Ann Arbor</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009164</affiliation-url><afid>60009164</afid><affilname>UC MERCED</affilname><name-variant>University of California, Merced</name-variant><affiliation-city>Merced</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:16548784600</author-url><authid>16548784600</authid><authname>Cao J.</authname><surname>Cao</surname><given-name>Junyi</given-name><initials>J.</initials><afid>60089930</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:14831952300</author-url><authid>14831952300</authid><authname>Syta A.</authname><surname>Syta</surname><given-name>Arkadiusz</given-name><initials>A.</initials><afid>60011739</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7003517944</author-url><authid>7003517944</authid><authname>Litak G.</authname><surname>Litak</surname><given-name>Grzegorz</given-name><initials>G.</initials><afid>60011739</afid><afid>60016253</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7003517944</author-url><authid>7003517944</authid><authname>Litak G.</authname><surname>Litak</surname><given-name>Grzegorz</given-name><initials>G.</initials><afid>60011739</afid><afid>60016253</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55443137600</author-url><authid>55443137600</authid><authname>Zhou S.</authname><surname>Zhou</surname><given-name>Shengxi</given-name><initials>S.</initials><afid>60089930</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7101824262</author-url><authid>7101824262</authid><authname>Inman D.</authname><surname>Inman</surname><given-name>Daniel J.</given-name><initials>D.J.</initials><afid>60025778</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7601439185</author-url><authid>7601439185</authid><authname>Chen Y.</authname><surname>Chen</surname><given-name>Yangquan</given-name><initials>Y.</initials><afid>60009164</afid></author><intid>36085882</intid><article-number>103</article-number><source-id>21100201754</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929208533"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929208533?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929208533&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929208533&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929208533</prism:url><dc:identifier>SCOPUS_ID:84929208533</dc:identifier><eid>2-s2.0-84929208533</eid><dc:title>Charlson comorbidity index: an additional prognostic parameter for preoperative glioblastoma patient stratification</dc:title><dc:creator>Ening G.</dc:creator><prism:publicationName>Journal of Cancer Research and Clinical Oncology</prism:publicationName><prism:issn>01715216</prism:issn><prism:eIssn>14321335</prism:eIssn><prism:volume>141</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>1131-1137</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s00432-014-1907-9</prism:doi><dc:description>© 2015, Springer-Verlag Berlin Heidelberg. Purpose: Dismal glioblastoma (GB) patient outcome calls for the elucidation of further reliable predictors of prognosis. Established “biomarkers,” age and functional status, employed in today’s patient stratification have limits in fingerprinting this heterogeneous tumor entity. We aimed at ascertaining additional prognostic factors that may facilitate patient stratification for surgery.Methods: A retrospective review of 233 consecutive adult patients operated on for newly diagnosed GB at a single tertiary institution over a 5-year period (2006–2011) was conducted. Modern defined outcome associating factors recorded included demographics (preoperative age, gender, signs, symptoms, comorbidity status quantified by the Charlson comorbidity index (CCI), functional status computed by the Karnofsky performance scale (KPS)), tumor characteristics (size, location, isocitrate dehydrogenase mutation, and O-6-methylguanine-DNA methyltransferase promoter methylation status), and treatment parameters (volumetrically quantified extent of resection and adjuvant therapy). Survival analysis was performed by the Kaplan–Maier method. Influence of variables was evaluated using log-rank test.Results: Median neuroradiographic evidence of tumor progression was 6 months after surgery (range 0–72). The median overall survival was 9.5 months (range 0–72). Age &gt; 65 years, KPS ≤ 70, and CCI &gt; 3 were significantly associated with both poor OS (each p &lt; 0.0001) and PFS (p &lt; 0.0001, p &lt; 0.001 and p &lt; 0.002), respectively. Also, patients older than 65 years significantly had a CCI &gt; 3 (p &lt; 0.0001).Conclusions: Our data evidence that aside established prognostic parameters (age and KPS) for GB patient outcome, the CCI additionally significantly impacts outcome and may be employed for preoperative patient stratification.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005322</affiliation-url><afid>60005322</afid><affilname>Universitat Bochum</affilname><name-variant>Ruhr-Universität Bochum</name-variant><affiliation-city>Bochum</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001972</affiliation-url><afid>60001972</afid><affilname>Universitatsklinikum Mannheim</affilname><name-variant>University of Heidelberg</name-variant><affiliation-city>Mannheim</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003280</affiliation-url><afid>60003280</afid><affilname>Universitatsklinikum Heidelberg</affilname><affiliation-city>Heidelberg</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56613451300</author-url><authid>56613451300</authid><authname>Ening G.</authname><surname>Ening</surname><given-name>G.</given-name><initials>G.</initials><afid>60005322</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56613427500</author-url><authid>56613427500</authid><authname>Osterheld F.</authname><surname>Osterheld</surname><given-name>F.</given-name><initials>F.</initials><afid>60001972</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:8547671300</author-url><authid>8547671300</authid><authname>Capper D.</authname><surname>Capper</surname><given-name>D.</given-name><initials>D.</initials><afid>60003280</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55208934800</author-url><authid>55208934800</authid><authname>Schmieder K.</authname><surname>Schmieder</surname><given-name>K.</given-name><initials>K.</initials><afid>60005322</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:9038712600</author-url><authid>9038712600</authid><authname>Brenke C.</authname><surname>Brenke</surname><given-name>C.</given-name><initials>C.</initials><afid>60005322</afid></author><authkeywords>Age | Charlson comorbidity index | Glioblastoma | Karnofsky performance score | Overall survival | Progression-free survival</authkeywords><intid>1035912763</intid><source-id>29930</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928156639"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928156639?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928156639&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928156639&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0272494415000316"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928156639</prism:url><dc:identifier>SCOPUS_ID:84928156639</dc:identifier><eid>2-s2.0-84928156639</eid><dc:title>Does perception of automation undermine pro-environmental behaviour? Findings from three everyday settings</dc:title><dc:creator>Murtagh N.</dc:creator><prism:publicationName>Journal of Environmental Psychology</prism:publicationName><prism:issn>02724944</prism:issn><prism:eIssn>15229610</prism:eIssn><prism:volume>42</prism:volume><prism:pageRange>139-148</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jenvp.2015.04.002</prism:doi><pii>S0272494415000316</pii><dc:description>© 2015 The Authors. The global deployment of technology to aid mitigation of climate change has great potential but the realisation of much of this potential depends on behavioural response. A culturally pervasive reliance on and belief in technology raises the risk that dependence on technology will hamper human actions of mitigation. Theory suggests that 'green' behaviour may be undermined by automated technology but empirical investigation has been lacking. We examined the effect of the prospect of automation on three everyday behaviours with environmental impact. Based on evidence from observational and experimental studies, we demonstrated that the prospect of automation can undermine even simple actions for sustainability. Further, we examined the process by which automated technology influences behaviour and suggest that automation may impair personal responsibility for action.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021097</affiliation-url><afid>60021097</afid><affilname>University of Surrey</affilname><name-variant>University of Surrey</name-variant><affiliation-city>Surrey</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:21733667800</author-url><authid>21733667800</authid><authname>Murtagh N.</authname><surname>Murtagh</surname><given-name>Niamh</given-name><initials>N.</initials><afid>60021097</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6602242116</author-url><authid>6602242116</authid><authname>Gatersleben B.</authname><surname>Gatersleben</surname><given-name>Birgitta</given-name><initials>B.</initials><afid>60021097</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56600171700</author-url><authid>56600171700</authid><authname>Cowen L.</authname><surname>Cowen</surname><given-name>Laura</given-name><initials>L.</initials><afid>60021097</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6603568290</author-url><authid>6603568290</authid><authname>Uzzell D.</authname><surname>Uzzell</surname><given-name>David</given-name><initials>D.</initials><afid>60021097</afid></author><authkeywords>Abdication of responsibility | Automation | Personal responsibility | Sustainable behaviour | Technology | Values</authkeywords><intid>1535733344</intid><source-id>15470</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84923587228"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84923587228?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84923587228&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84923587228&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S2352250X15001001"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84923587228</prism:url><dc:identifier>SCOPUS_ID:84923587228</dc:identifier><eid>2-s2.0-84923587228</eid><dc:title>Recent advances in laboratory assessment of emotion regulation</dc:title><dc:creator>Seeley S.</dc:creator><prism:publicationName>Current Opinion in Psychology</prism:publicationName><prism:issn>2352250X</prism:issn><prism:volume>3</prism:volume><prism:pageRange>58-63</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.copsyc.2015.02.009</prism:doi><pii>S2352250X15001001</pii><dc:description>© 2015 Elsevier Ltd. Over the past 15 years, the emotion regulation perspective has been widely integrated into theoretical and applied contexts in clinical psychology and beyond. Recent refinements to behavioral, subjective, psychophysiological and neuroimaging methods allow emotion regulation to be captured and assessed in the laboratory with greater precision. Technological advances enabling investigators to leverage information from multiple modalities are increasingly accessible, and as such, will further efforts to generate testable hypotheses about specific mechanisms implicated in emotion regulation and difficulties therein. In combination with theory-driven design, progressively sophisticated methods for laboratory assessment have potential to further emotion regulation as both a valid scientific construct and a useful paradigm for human emotion and behavior that has applicability to both clinical and non-clinical contexts.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002896</affiliation-url><afid>60002896</afid><affilname>Hunter College</affilname><name-variant>City University of New York</name-variant><affiliation-city>New York</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032373</affiliation-url><afid>60032373</afid><affilname>The Doctorate-Granting Institution of the City University of New York</affilname><name-variant>CUNY Graduate Center</name-variant><affiliation-city>New York</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56529254900</author-url><authid>56529254900</authid><authname>Seeley S.</authname><surname>Seeley</surname><given-name>Saren H.</given-name><initials>S.H.</initials><afid>60002896</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56528829500</author-url><authid>56528829500</authid><authname>Garcia E.</authname><surname>Garcia</surname><given-name>Emmanuel</given-name><initials>E.</initials><afid>60002896</afid><afid>60032373</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56528829500</author-url><authid>56528829500</authid><authname>Garcia E.</authname><surname>Garcia</surname><given-name>Emmanuel</given-name><initials>E.</initials><afid>60002896</afid><afid>60032373</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6602198674</author-url><authid>6602198674</authid><authname>Mennin D.</authname><surname>Mennin</surname><given-name>Douglas S.</given-name><initials>D.S.</initials><afid>60002896</afid><afid>60032373</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6602198674</author-url><authid>6602198674</authid><authname>Mennin D.</authname><surname>Mennin</surname><given-name>Douglas S.</given-name><initials>D.S.</initials><afid>60002896</afid><afid>60032373</afid></author><intid>1034998152</intid><source-id>21100372442</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925457477"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925457477?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925457477&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925457477&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0165032715001251"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925457477</prism:url><dc:identifier>SCOPUS_ID:84925457477</dc:identifier><eid>2-s2.0-84925457477</eid><dc:title>Emotional arousal modulation of right temporoparietal cortex in depression depends on parental depression status in women: First evidence</dc:title><dc:creator>Moratti S.</dc:creator><prism:publicationName>Journal of Affective Disorders</prism:publicationName><prism:issn>01650327</prism:issn><prism:eIssn>15732517</prism:eIssn><prism:volume>178</prism:volume><prism:pageRange>79-87</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jad.2015.02.031</prism:doi><pii>S0165032715001251</pii><dc:description>©2015 Elsevier Ltd. All rights reserved. Background Structural and Electroencephalography (EEG) abnormalities in right temporoparietal cortex have been associated with family history of depression (FH). Here we investigate if functional abnormalities in this area, indexed by attenuated responses to emotionally arousing stimuli, are also family-history-dependent. Methods Neuromagnetic activity for emotional and neutral complex scenes was recorded by Magnetoencephalography (MEG) in 20 depressed patients without, 8 depressed patients with FH, and 15 healthy controls. Emotion-sensitive neuronal steady state responses were cortical source localized and tested for group-by-emotion interactions. Results The group-by-emotion interaction (F(4, 80)=4.4, p=0.004) was explained by a significant modulation of right temporoparietal cortex activity by emotional arousal in controls and patients without FH. This effect was reduced in FH positive patients. The difference between patient groups remained when clinical variables such as symptom severity were accounted for. Limitations All patients were medicated, but differences between patient groups remained after accounting for medication dosage. Further, the sample size was limited, but data-driven resampling statistics showed the robustness of our effects. Finally, the sample consists of female patients only and we cannot generalize our results to male samples. Conclusions Patients with FH show impaired recruitment of attention-relevant cortical circuitry by emotional stimuli. The neuroanatomical locus of this effect accords with previous reports on structural abnormalities and electrophysiological deficits at rest in individuals with FH. Our results speak to the relevance of right temporoparietal dysfunction in emotional information processing as a potential endophenotype for depression with FH.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027282</affiliation-url><afid>60027282</afid><affilname>Universidad Complutense de Madrid</affilname><name-variant>Universidad Complutense</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028442</affiliation-url><afid>60028442</afid><affilname>Universidad Politecnica de Madrid</affilname><name-variant>Universidad Politécnica de Madrid</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028442</affiliation-url><afid>60028442</afid><affilname>Universidad Politecnica de Madrid</affilname><name-variant>Universidad Politécnica de Madrid</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004024</affiliation-url><afid>60004024</afid><affilname>Hospital 12 Octubre</affilname><name-variant>Hospital 12 de Octubre</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027282</affiliation-url><afid>60027282</afid><affilname>Universidad Complutense de Madrid</affilname><name-variant>Universidad Complutense</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7005290771</author-url><authid>7005290771</authid><authname>Moratti S.</authname><surname>Moratti</surname><given-name>Stephan</given-name><initials>S.</initials><afid>60027282</afid><afid>60028442</afid><afid>60028442</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7005290771</author-url><authid>7005290771</authid><authname>Moratti S.</authname><surname>Moratti</surname><given-name>Stephan</given-name><initials>S.</initials><afid>60027282</afid><afid>60028442</afid><afid>60028442</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7005290771</author-url><authid>7005290771</authid><authname>Moratti S.</authname><surname>Moratti</surname><given-name>Stephan</given-name><initials>S.</initials><afid>60027282</afid><afid>60028442</afid><afid>60028442</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6602104707</author-url><authid>6602104707</authid><authname>Strange B.</authname><surname>Strange</surname><given-name>Bryan</given-name><initials>B.</initials><afid>60028442</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35561145800</author-url><authid>35561145800</authid><authname>Rubio G.</authname><surname>Rubio</surname><given-name>Gabriel</given-name><initials>G.</initials><afid>60004024</afid><afid>60027282</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35561145800</author-url><authid>35561145800</authid><authname>Rubio G.</authname><surname>Rubio</surname><given-name>Gabriel</given-name><initials>G.</initials><afid>60004024</afid><afid>60027282</afid></author><authkeywords>Depression | Family history of depression | Magnetoencephalography | Oscillatory neuronal activity | Steady state visual evoked fields | Temporoparietal cortex</authkeywords><intid>535296387</intid><source-id>16245</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926643259"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926643259?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926643259&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926643259&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1750583615001449"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926643259</prism:url><dc:identifier>SCOPUS_ID:84926643259</dc:identifier><eid>2-s2.0-84926643259</eid><dc:title>Evolution of carbon capture and storage research: Trends of international collaborations and knowledge maps</dc:title><dc:creator>Karimi F.</dc:creator><prism:publicationName>International Journal of Greenhouse Gas Control</prism:publicationName><prism:issn>17505836</prism:issn><prism:volume>37</prism:volume><prism:pageRange>362-376</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijggc.2015.04.002</prism:doi><pii>S1750583615001449</pii><dc:description>© 2015 Elsevier Ltd. This study investigates the evolutionary trends of the international collaborations among the research community of carbon capture and storage (CCS) by looking at the collaboration network of countries publishing on CCS. The study also examines the evolution of major research topics in this field by exploring the co-occurrence network of keywords associated with CCS publications. The analysis is carried out based on the CCS related publications extracted from Scopus.com from 1980 to 2013. From the number of annual CCS publications, it seems that CCS research has closely followed the trend of international negotiations on climate change mitigation. The study elaborates how both international collaboration network and knowledge structure of the field have notably developed and interlinked over the years especially after 2005 during which almost 94% of the publications appeared.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025709</affiliation-url><afid>60025709</afid><affilname>University of Sydney</affilname><name-variant>University of Sydney</name-variant><affiliation-city>Sydney</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025709</affiliation-url><afid>60025709</afid><affilname>University of Sydney</affilname><name-variant>University of Sydney</name-variant><affiliation-city>Sydney</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56245433700</author-url><authid>56245433700</authid><authname>Karimi F.</authname><surname>Karimi</surname><given-name>Faezeh</given-name><initials>F.</initials><afid>60025709</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:23985049500</author-url><authid>23985049500</authid><authname>Khalilpour R.</authname><surname>Khalilpour</surname><given-name>Rajab</given-name><initials>R.</initials><afid>60025709</afid></author><authkeywords>Carbon capture and sequestration | Carbon capture and storage | Climate change mitigation | Social network analysis</authkeywords><intid>1785484707</intid><source-id>6200180161</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924404654"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924404654?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924404654&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924404654&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1383576914001330"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924404654</prism:url><dc:identifier>SCOPUS_ID:84924404654</dc:identifier><eid>2-s2.0-84924404654</eid><dc:title>Direct evidence for the atovaquone action on the Plasmodium cytochrome bc1 complex</dc:title><dc:creator>Siregar J.</dc:creator><prism:publicationName>Parasitology International</prism:publicationName><prism:issn>13835769</prism:issn><prism:eIssn>18730329</prism:eIssn><prism:volume>64</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:pageRange>295-300</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.parint.2014.09.011</prism:doi><pii>S1383576914001330</pii><dc:description>© 2014. Atovaquone, a coenzyme Q analogue has been indicated to specifically target the cytochrome bc1 complex of the mitochondrial respiratory chain in the malarial parasite and other protozoan. Various mutations in the quinone binding site of the cytochrome b gene of Plasmodium spp. such as M133I, L144S, L271V, K272R, Y268C, Y268S, Y268N, and V284F are suggesting to associate with resistance to atovaquone. There is no direct evidence of relation between the mutations and resistance to atovaquone in Plasmodium parasite that has been available. Technical difficulties in isolating active assayable mitochondria in the malarial parasite hinder us to obtain direct biochemical evidence to support the relation between the mutations and drug resistance.The establishment of a mitochondrial isolation method for the malaria parasite has allowed us to test the degree of resistance of Plasmodium berghei isolates to atovaquone directly. We have tested the activity of dihydroorotate (DHO)-cytochrome c reductase in various P. berghei atovaquone resistant clones in the presence of a wide concentration range of atovaquone. Our results show the IC50 of P. berghei atovaquone resistant clones is much higher (1.5 up to 40nM) in comparison to the atovaquone sensitive clones (0.132-0.465nM). The highest IC50 was revealed in clones carrying Y268C and Y268N mutations (which play an important role in atovaquone resistance in Plasmodium falciparum), with an approximately 100-fold increase. The findings indicate the importance of the mutation in the quinone binding site of the cytochrome b gene and that provide a direct evidence for the atovaquone inhibitory mechanism in the cytochrome bc1 complex of the parasite.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60069395</affiliation-url><afid>60069395</afid><affilname>Eijkman Institute for Molecular Biology</affilname><name-variant>Eijkman Inst. for Molecular Biology</name-variant><affiliation-city>Jakarta</affiliation-city><affiliation-country>Indonesia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024322</affiliation-url><afid>60024322</afid><affilname>Osaka University</affilname><name-variant>Osaka University</name-variant><affiliation-city>Suita</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002354</affiliation-url><afid>60002354</afid><affilname>University of Tokyo Faculty of Medicine</affilname><name-variant>University of Tokyo</name-variant><affiliation-city>Tokyo</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60102128</affiliation-url><afid>60102128</afid><affilname>Jichi Medical University</affilname><name-variant>Jichi Medical University</name-variant><affiliation-city>Kawachi District</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:21433379200</author-url><authid>21433379200</authid><authname>Siregar J.</authname><surname>Siregar</surname><given-name>Josephine E.</given-name><initials>J.E.</initials><afid>60069395</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6701675123</author-url><authid>6701675123</authid><authname>Kurisu G.</authname><surname>Kurisu</surname><given-name>Genji</given-name><initials>G.</initials><afid>60024322</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55540033000</author-url><authid>55540033000</authid><authname>Kobayashi T.</authname><surname>Kobayashi</surname><given-name>Tamaki</given-name><initials>T.</initials><afid>60002354</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56542667100</author-url><authid>56542667100</authid><authname>Matsuzaki M.</authname><surname>Matsuzaki</surname><given-name>Motomichi</given-name><initials>M.</initials><afid>60002354</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:35501195000</author-url><authid>35501195000</authid><authname>Sakamoto K.</authname><surname>Sakamoto</surname><given-name>Kimitoshi</given-name><initials>K.</initials><afid>60002354</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6505802130</author-url><authid>6505802130</authid><authname>Mi-ichi F.</authname><surname>Mi-ichi</surname><given-name>Fumika</given-name><initials>F.</initials><afid>60002354</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56542130300</author-url><authid>56542130300</authid><authname>Watanabe Y.</authname><surname>Watanabe</surname><given-name>Yoh ichi</given-name><initials>Y.i.</initials><afid>60002354</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:55625292400</author-url><authid>55625292400</authid><authname>Hirai M.</authname><surname>Hirai</surname><given-name>Makoto</given-name><initials>M.</initials><afid>60102128</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56542521700</author-url><authid>56542521700</authid><authname>Matsuoka H.</authname><surname>Matsuoka</surname><given-name>Hiroyuki</given-name><initials>H.</initials><afid>60102128</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:6602774565</author-url><authid>6602774565</authid><authname>Syafruddin D.</authname><surname>Syafruddin</surname><given-name>Din</given-name><initials>D.</initials><afid>60069395</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56231838700</author-url><authid>56231838700</authid><authname>Marzuki S.</authname><surname>Marzuki</surname><given-name>Sangkot</given-name><initials>S.</initials><afid>60069395</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7201529351</author-url><authid>7201529351</authid><authname>Kita K.</authname><surname>Kita</surname><given-name>Kiyoshi</given-name><initials>K.</initials><afid>60002354</afid></author><authkeywords>Atovaquone-resistance | Cytochrome bc1 complex | Malaria | Plasmodium</authkeywords><intid>1035129843</intid><source-id>22994</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924597586"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924597586?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924597586&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924597586&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0306261915002007"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924597586</prism:url><dc:identifier>SCOPUS_ID:84924597586</dc:identifier><eid>2-s2.0-84924597586</eid><dc:title>Progress in reliability of fast reactor operation and new trends to increased inherent safety</dc:title><dc:creator>Merk B.</dc:creator><prism:publicationName>Applied Energy</prism:publicationName><prism:issn>03062619</prism:issn><prism:volume>147</prism:volume><prism:pageRange>104-116</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.apenergy.2015.02.023</prism:doi><pii>S0306261915002007</pii><dc:description>© 2015 Elsevier Ltd. The reasons for the renewed interest in fast reactors and an overview of the progress in sodium cooled fast reactor operation in the last ten years are given. The excellent operational performance of sodium cooled fast reactors in this period is highlighted as a sound basis for the development of new fast reactors. The operational performance of the BN-600 is compared and evaluated against the performance of German light water reactors to assess the reliability. The relevance of feedback effects for safe reactor design is described, and a new method for the enhancement of feedback effects in fast reactors is proposed. Experimental reactors demonstrating the inherent safety of advanced sodium cooled fast reactor designs are described and the potential safety improvements resulting from the use of fine distributed moderating material are discussed. One sentence summary: Operating fast reactors have shown excellent in-service behavior within the last 10. years, new designs and methods are available to significantly improve safety.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112070361</affiliation-url><afid>112070361</afid><affilname>Helmholtz-Zentrum Dresden-Rossendorf (HZDR</affilname><name-variant>Helmholtz Zentrum Dresden-Rossendorf (HZDR</name-variant><affiliation-city/><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005120</affiliation-url><afid>60005120</afid><affilname>Idaho National Laboratory</affilname><name-variant>Idaho National Laboratory</name-variant><affiliation-city>Idaho Falls</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002881</affiliation-url><afid>60002881</afid><affilname>Indira Gandhi Centre for Atomic Research</affilname><name-variant>Indira Gandhi Centre for Atomic Research</name-variant><affiliation-city>Kalpakam</affiliation-city><affiliation-country>India</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028609</affiliation-url><afid>60028609</afid><affilname>Argonne National Laboratory</affilname><name-variant>Argonne National Laboratory</name-variant><affiliation-city>Argonne</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8947927900</author-url><authid>8947927900</authid><authname>Merk B.</authname><surname>Merk</surname><given-name>Bruno</given-name><initials>B.</initials><afid>112070361</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:23571037400</author-url><authid>23571037400</authid><authname>Stanculescu A.</authname><surname>Stanculescu</surname><given-name>Alexander</given-name><initials>A.</initials><afid>60005120</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:9635705100</author-url><authid>9635705100</authid><authname>Chellapandi P.</authname><surname>Chellapandi</surname><given-name>Perumal</given-name><initials>P.</initials><afid>60002881</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55451541500</author-url><authid>55451541500</authid><authname>Hill R.</authname><surname>Hill</surname><given-name>Robert</given-name><initials>R.</initials><afid>60028609</afid></author><authkeywords>Enhanced feedback | Fast reactors | Inherent safety | Nuclear | Nuclear reactors | Reliability</authkeywords><intid>35168498</intid><source-id>28801</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925605695"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925605695?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925605695&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925605695&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0925443914003111"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925605695</prism:url><dc:identifier>SCOPUS_ID:84925605695</dc:identifier><eid>2-s2.0-84925605695</eid><dc:title>The molecular targets of resveratrol</dc:title><dc:creator>Kulkarni S.</dc:creator><prism:publicationName>Biochimica et Biophysica Acta - Molecular Basis of Disease</prism:publicationName><prism:issn>09254439</prism:issn><prism:eIssn>1879260X</prism:eIssn><prism:volume>1852</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>1114-1123</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbadis.2014.10.005</prism:doi><pii>S0925443914003111</pii><dc:description>© 2014 Elsevier B.V. Resveratrol has emerged in recent years as a compound conferring strong protection against metabolic, cardiovascular and other age-related complications, including neurodegeneration and cancer. This has generated the notion that resveratrol treatment acts as a calorie-restriction mimetic, based on the many overlapping health benefits observed upon both interventions in diverse organisms, including yeast, worms, flies and rodents. Though studied for over a decade, the molecular mechanisms governing the therapeutic properties of resveratrol still remain elusive. Elucidating how resveratrol exerts its effects would provide not only new insights in its fundamental biological actions but also new avenues for the design and development of more potent drugs to efficiently manage metabolic disorders. In this review we will cover the most recent advances in the field, with special focus on the metabolic actions of resveratrol and the potential role of SIRT1 and AMPK. This article is part of a Special Issue entitled: Resveratrol: Challenges in translating pre-clinical findings to improved patient outcomes.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027886</affiliation-url><afid>60027886</afid><affilname>Nestle</affilname><name-variant>Nestec Ltd.</name-variant><affiliation-city>Vevey</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56465333500</author-url><authid>56465333500</authid><authname>Kulkarni S.</authname><surname>Kulkarni</surname><given-name>Sameer S.</given-name><initials>S.S.</initials><afid>60027886</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6602810525</author-url><authid>6602810525</authid><authname>Cantó C.</authname><surname>Cantó</surname><given-name>Carles</given-name><initials>C.</initials><afid>60027886</afid></author><authkeywords>AMPK | Metabolism | Mitochondria | Resveratrol | SIRT1</authkeywords><intid>35329399</intid><source-id>21722</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928666157"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928666157?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928666157&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928666157&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915015010138"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928666157</prism:url><dc:identifier>SCOPUS_ID:84928666157</dc:identifier><eid>2-s2.0-84928666157</eid><dc:title>A randomized controlled trial of the effects of vitamin D supplementation on arterial stiffness and aortic blood pressure in Native American women</dc:title><dc:creator>Gepner A.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>240</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>526-528</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2015.04.795</prism:doi><pii>S0021915015010138</pii><dc:description>© 2015 Elsevier Ireland Ltd. Objective: It is unclear if vitamin D supplementation improves central blood pressure or arterial stiffness in Native American (NA) women. Methods: Healthy postmenopausal NA women were randomized to receive 400 IU or 2500 IU of vitamin D for 6 months. Central systolic blood pressure (cSBP), central pulse pressure (cPP) and aortic augmentation index (AIx) were estimated by tonometry at baseline and after 6 months. Results: Study volunteers (n=98) were 61 (7.3) years old. 25(OH)D was 26.4 (11.0) ng/mL. 25(OH)D was similar between the two treatment groups (p=0.291), as were baseline cSBP, cPP, and CVD risk factors (all p&gt;0.1). Treatment with 2500 IU of daily vitamin D3 did not affect cSBP, cPP, or AIx (all p&gt;0.1) compared to 400 IU daily. Conclusions: Despite low serum 25(OH)D at baseline, 6 months of vitamin D supplementation did not improve central blood pressure parameters or arterial stiffness in NA women. Clinical trials. gov identifier: NCT01490333.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025553</affiliation-url><afid>60025553</afid><affilname>University of Wisconsin School of Medicine and Public Health</affilname><name-variant>University of Wisconsin</name-variant><affiliation-city>Madison</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:101048799</affiliation-url><afid>101048799</afid><affilname>Essentia Institute of Rural Health</affilname><name-variant>Essentia Institute of Rural Health</name-variant><affiliation-city>Duluth</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:12142211700</author-url><authid>12142211700</authid><authname>Gepner A.</authname><surname>Gepner</surname><given-name>Adam D.</given-name><initials>A.D.</initials><afid>60025553</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7003954235</author-url><authid>7003954235</authid><authname>Haller I.</authname><surname>Haller</surname><given-name>Irina V.</given-name><initials>I.V.</initials><afid>101048799</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7103337895</author-url><authid>7103337895</authid><authname>Krueger D.</authname><surname>Krueger</surname><given-name>Diane C.</given-name><initials>D.C.</initials><afid>60025553</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7004584135</author-url><authid>7004584135</authid><authname>Korcarz C.</authname><surname>Korcarz</surname><given-name>Claudia E.</given-name><initials>C.E.</initials><afid>60025553</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7004048242</author-url><authid>7004048242</authid><authname>Binkley N.</authname><surname>Binkley</surname><given-name>Neil</given-name><initials>N.</initials><afid>60025553</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7402750613</author-url><authid>7402750613</authid><authname>Stein J.</authname><surname>Stein</surname><given-name>James H.</given-name><initials>J.H.</initials><afid>60025553</afid></author><authkeywords>Arterial stiffness | Cardiovascular disease risk | Central blood pressure | Vitamin D</authkeywords><intid>2035817967</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930224815"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930224815?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930224815&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930224815&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930224815</prism:url><dc:identifier>SCOPUS_ID:84930224815</dc:identifier><eid>2-s2.0-84930224815</eid><dc:title>Proteomic analysis of human glioblastoma cell lines differently resistant to a nitric oxide releasing agent</dc:title><dc:creator>Leone R.</dc:creator><prism:publicationName>Molecular BioSystems</prism:publicationName><prism:issn>1742206X</prism:issn><prism:eIssn>17422051</prism:eIssn><prism:volume>11</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>1612-1621</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1039/c4mb00725e</prism:doi><dc:description>This journal is © The Royal Society of Chemistry. Glioblastoma multiforme is the most aggressive astrocytoma characterized by the development of resistant cells to various cytotoxic stimuli. Nitric oxide (NO) is able to overcome tumor resistance in PTEN mutated rat C6 glioma cells due to its ability to inhibit cell growth by influencing the intracellular distribution of ceramide. The aim of this study is to monitor the effects of NO donor PAPANONOate on ceramide trafficking in human glioma cell lines, CCF-STTG1 (PTEN-mutated, p53-wt) and T98G (PTEN-harboring, p53-mutated), together with the assessment of their differential molecular signature by 2D-DIGE and MALDI mass spectrometry. In the CCF-STTG1 cell line, the results indicate that treatment with PAPANONOate decreased cell proliferation (&lt;50%) and intracellular trafficking of ceramide, assessed by BODIPY-C5Cer, while these events were not observed in the T98G cell line. Proteomic results suggest that CCF-STTG1 cells are characterized by an increased expression of proteins involved in NO-associated ER stress (i.e. protein disulfide-isomerase A3, calreticulin, 78 kDa glucose-regulated protein), which could compromise ceramide delivery from ER to Golgi, leading to ceramide accumulation in ER and partial growth arrest. Conversely, T98G cell lines, resistant to NO exposure, are characterized by increased levels of cytosolic antioxidant proteins (i.e. glutathione-S-transferase P, peroxiredoxin 1), which might buffer intracellular NO. By providing differential ceramide distribution after NO exposure and differential protein expression of two high grade glioma cell lines, this study highlights specific proteins as possible markers for tumor aggressiveness. This study demonstrates that, in two different high grade glioma cell lines, NO exposure results in a different ceramide distribution and protein expression. Furthermore, this study highlights specific proteins as possible markers for tumor aggressiveness.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030318</affiliation-url><afid>60030318</afid><affilname>Universita degli Studi di Milano</affilname><name-variant>University of Milan</name-variant><affiliation-city>Milan</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030318</affiliation-url><afid>60030318</afid><affilname>Universita degli Studi di Milano</affilname><name-variant>University of Milan</name-variant><affiliation-city>Milan</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021199</affiliation-url><afid>60021199</afid><affilname>Consiglio Nazionale delle Ricerche</affilname><name-variant>CNR</name-variant><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60070490</affiliation-url><afid>60070490</afid><affilname>Gruppo Ospedaliero San Donato</affilname><name-variant>IRCCS Policlinico San Donato</name-variant><affiliation-city>San Donato Milanese</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">13</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55604782300</author-url><authid>55604782300</authid><authname>Leone R.</authname><surname>Leone</surname><given-name>Roberta</given-name><initials>R.</initials><afid>60030318</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6602878371</author-url><authid>6602878371</authid><authname>Giussani P.</authname><surname>Giussani</surname><given-name>Paola</given-name><initials>P.</initials><afid>60030318</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6505938583</author-url><authid>6505938583</authid><authname>De Palma S.</authname><surname>De Palma</surname><given-name>Sara</given-name><initials>S.</initials><afid>60021199</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:25027669300</author-url><authid>25027669300</authid><authname>Fania C.</authname><surname>Fania</surname><given-name>Chiara</given-name><initials>C.</initials><afid>60030318</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6603148410</author-url><authid>6603148410</authid><authname>Capitanio D.</authname><surname>Capitanio</surname><given-name>Daniele</given-name><initials>D.</initials><afid>60030318</afid><afid>60070490</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6603148410</author-url><authid>6603148410</authid><authname>Capitanio D.</authname><surname>Capitanio</surname><given-name>Daniele</given-name><initials>D.</initials><afid>60030318</afid><afid>60070490</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56536628200</author-url><authid>56536628200</authid><authname>Vasso M.</authname><surname>Vasso</surname><given-name>Michele</given-name><initials>M.</initials><afid>60021199</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6506138399</author-url><authid>6506138399</authid><authname>Brioschi L.</authname><surname>Brioschi</surname><given-name>Loredana</given-name><initials>L.</initials><afid>60030318</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7006232335</author-url><authid>7006232335</authid><authname>Riboni L.</authname><surname>Riboni</surname><given-name>Laura</given-name><initials>L.</initials><afid>60030318</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7003859174</author-url><authid>7003859174</authid><authname>Viani P.</authname><surname>Viani</surname><given-name>Paola</given-name><initials>P.</initials><afid>60030318</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7005211977</author-url><authid>7005211977</authid><authname>Gelfi C.</authname><surname>Gelfi</surname><given-name>Cecilia</given-name><initials>C.</initials><afid>60030318</afid><afid>60021199</afid><afid>60070490</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7005211977</author-url><authid>7005211977</authid><authname>Gelfi C.</authname><surname>Gelfi</surname><given-name>Cecilia</given-name><initials>C.</initials><afid>60030318</afid><afid>60021199</afid><afid>60070490</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7005211977</author-url><authid>7005211977</authid><authname>Gelfi C.</authname><surname>Gelfi</surname><given-name>Cecilia</given-name><initials>C.</initials><afid>60030318</afid><afid>60021199</afid><afid>60070490</afid></author><intid>1036082542</intid><source-id>145703</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929623146"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929623146?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929623146&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929623146&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0887618515000638"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929623146</prism:url><dc:identifier>SCOPUS_ID:84929623146</dc:identifier><eid>2-s2.0-84929623146</eid><dc:title>Cognitive-behavioral therapy for late-life anxiety: Similarities and differences between Veteran and community participants</dc:title><dc:creator>Barrera T.</dc:creator><prism:publicationName>Journal of Anxiety Disorders</prism:publicationName><prism:issn>08876185</prism:issn><prism:eIssn>18737897</prism:eIssn><prism:volume>33</prism:volume><prism:pageRange>72-80</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.janxdis.2015.04.005</prism:doi><pii>S0887618515000638</pii><dc:description>© 2015. Cognitive-behavioral therapy (CBT) is an evidence-based treatment for anxiety; however, a growing body of research suggests that CBT effect sizes are smaller in Veteran samples. The aim of this study was to perform secondary data analyses of a randomized controlled trial of CBT for late-life generalized anxiety disorder compared with treatment as usual (TAU) in a Veteran (n = 101) and community-based (n= 122) sample. Veterans had lower income and less education than community participants, greater severity on baseline measures of anxiety and depression, poorer physical health, and higher rates of psychiatric comorbidity. Treatment effects were statistically significant in the community sample (all ps&lt; 0.01), but not in Veterans (all ps&gt; 0.05). Further analyses in Veterans revealed that poorer perceived social support significantly predicted poorer outcomes (all ps&lt; 0.05). Our results underscore the complexity of treating Veterans with anxiety, and suggest that additional work is needed to improve the efficacy of CBT for Veterans, with particular attention to social support.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011641</affiliation-url><afid>60011641</afid><affilname>Michael E. DeBakey VA Medical Center</affilname><name-variant>Michael E. DeBakey VA Medical Center</name-variant><affiliation-city>Houston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002441</affiliation-url><afid>60002441</afid><affilname>Baylor College of Medicine</affilname><name-variant>Baylor College of Medicine</name-variant><affiliation-city>Houston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:105741360</affiliation-url><afid>105741360</afid><affilname>Education and Clinical Center</affilname><name-variant>Education and Clinical Center</name-variant><affiliation-city>Houston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011641</affiliation-url><afid>60011641</afid><affilname>Michael E. DeBakey VA Medical Center</affilname><name-variant>Michael E. DeBakey VA Medical Center</name-variant><affiliation-city>Houston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013847</affiliation-url><afid>60013847</afid><affilname>University of Texas Harris County Psychiatric Center</affilname><name-variant>Harris County Psychiatric Center</name-variant><affiliation-city>Houston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">28</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35315650200</author-url><authid>35315650200</authid><authname>Barrera T.</authname><surname>Barrera</surname><given-name>Terri L.</given-name><initials>T.L.</initials><afid>60011641</afid><afid>60002441</afid><afid>105741360</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35315650200</author-url><authid>35315650200</authid><authname>Barrera T.</authname><surname>Barrera</surname><given-name>Terri L.</given-name><initials>T.L.</initials><afid>60011641</afid><afid>60002441</afid><afid>105741360</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35315650200</author-url><authid>35315650200</authid><authname>Barrera T.</authname><surname>Barrera</surname><given-name>Terri L.</given-name><initials>T.L.</initials><afid>60011641</afid><afid>60002441</afid><afid>105741360</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603794475</author-url><authid>6603794475</authid><authname>Cully J.</authname><surname>Cully</surname><given-name>Jeffrey A.</given-name><initials>J.A.</initials><afid>60011641</afid><afid>60002441</afid><afid>105741360</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603794475</author-url><authid>6603794475</authid><authname>Cully J.</authname><surname>Cully</surname><given-name>Jeffrey A.</given-name><initials>J.A.</initials><afid>60011641</afid><afid>60002441</afid><afid>105741360</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603794475</author-url><authid>6603794475</authid><authname>Cully J.</authname><surname>Cully</surname><given-name>Jeffrey A.</given-name><initials>J.A.</initials><afid>60011641</afid><afid>60002441</afid><afid>105741360</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55539114400</author-url><authid>55539114400</authid><authname>Amspoker A.</authname><surname>Amspoker</surname><given-name>Amber B.</given-name><initials>A.B.</initials><afid>60011641</afid><afid>60002441</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55539114400</author-url><authid>55539114400</authid><authname>Amspoker A.</authname><surname>Amspoker</surname><given-name>Amber B.</given-name><initials>A.B.</initials><afid>60011641</afid><afid>60002441</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7402218288</author-url><authid>7402218288</authid><authname>Wilson N.</authname><surname>Wilson</surname><given-name>Nancy L.</given-name><initials>N.L.</initials><afid>60011641</afid><afid>60002441</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7402218288</author-url><authid>7402218288</authid><authname>Wilson N.</authname><surname>Wilson</surname><given-name>Nancy L.</given-name><initials>N.L.</initials><afid>60011641</afid><afid>60002441</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:36113544700</author-url><authid>36113544700</authid><authname>Kraus-Schuman C.</authname><surname>Kraus-Schuman</surname><given-name>Cynthia</given-name><initials>C.</initials><afid>60002441</afid><afid>60011641</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:36113544700</author-url><authid>36113544700</authid><authname>Kraus-Schuman C.</authname><surname>Kraus-Schuman</surname><given-name>Cynthia</given-name><initials>C.</initials><afid>60002441</afid><afid>60011641</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7004239129</author-url><authid>7004239129</authid><authname>Wagener P.</authname><surname>Wagener</surname><given-name>Paula D.</given-name><initials>P.D.</initials><afid>60011641</afid><afid>60002441</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7004239129</author-url><authid>7004239129</authid><authname>Wagener P.</authname><surname>Wagener</surname><given-name>Paula D.</given-name><initials>P.D.</initials><afid>60011641</afid><afid>60002441</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:24553992200</author-url><authid>24553992200</authid><authname>Calleo J.</authname><surname>Calleo</surname><given-name>Jessica S.</given-name><initials>J.S.</initials><afid>60011641</afid><afid>60002441</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:24553992200</author-url><authid>24553992200</authid><authname>Calleo J.</authname><surname>Calleo</surname><given-name>Jessica S.</given-name><initials>J.S.</initials><afid>60011641</afid><afid>60002441</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56651958300</author-url><authid>56651958300</authid><authname>Teng E.</authname><surname>Teng</surname><given-name>Ellen J.</given-name><initials>E.J.</initials><afid>60011641</afid><afid>60002441</afid><afid>105741360</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56651958300</author-url><authid>56651958300</authid><authname>Teng E.</authname><surname>Teng</surname><given-name>Ellen J.</given-name><initials>E.J.</initials><afid>60011641</afid><afid>60002441</afid><afid>105741360</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56651958300</author-url><authid>56651958300</authid><authname>Teng E.</authname><surname>Teng</surname><given-name>Ellen J.</given-name><initials>E.J.</initials><afid>60011641</afid><afid>60002441</afid><afid>105741360</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7006798290</author-url><authid>7006798290</authid><authname>Rhoades H.</authname><surname>Rhoades</surname><given-name>Howard M.</given-name><initials>H.M.</initials><afid>60013847</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:55649900200</author-url><authid>55649900200</authid><authname>Masozera N.</authname><surname>Masozera</surname><given-name>Nicholas</given-name><initials>N.</initials><afid>60002441</afid><afid>60011641</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:55649900200</author-url><authid>55649900200</authid><authname>Masozera N.</authname><surname>Masozera</surname><given-name>Nicholas</given-name><initials>N.</initials><afid>60002441</afid><afid>60011641</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:35550845400</author-url><authid>35550845400</authid><authname>Kunik M.</authname><surname>Kunik</surname><given-name>Mark E.</given-name><initials>M.E.</initials><afid>60011641</afid><afid>60002441</afid><afid>105741360</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:35550845400</author-url><authid>35550845400</authid><authname>Kunik M.</authname><surname>Kunik</surname><given-name>Mark E.</given-name><initials>M.E.</initials><afid>60011641</afid><afid>60002441</afid><afid>105741360</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:35550845400</author-url><authid>35550845400</authid><authname>Kunik M.</authname><surname>Kunik</surname><given-name>Mark E.</given-name><initials>M.E.</initials><afid>60011641</afid><afid>60002441</afid><afid>105741360</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7202498780</author-url><authid>7202498780</authid><authname>Stanley M.</authname><surname>Stanley</surname><given-name>Melinda A.</given-name><initials>M.A.</initials><afid>60011641</afid><afid>60002441</afid><afid>105741360</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7202498780</author-url><authid>7202498780</authid><authname>Stanley M.</authname><surname>Stanley</surname><given-name>Melinda A.</given-name><initials>M.A.</initials><afid>60011641</afid><afid>60002441</afid><afid>105741360</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7202498780</author-url><authid>7202498780</authid><authname>Stanley M.</authname><surname>Stanley</surname><given-name>Melinda A.</given-name><initials>M.A.</initials><afid>60011641</afid><afid>60002441</afid><afid>105741360</afid></author><authkeywords>Anxiety | Cognitive-behavioral therapy | Psychotherapy | Randomized controlled trial | Veterans</authkeywords><intid>1035984458</intid><source-id>15375</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929579535"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929579535?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929579535&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929579535&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929579535</prism:url><dc:identifier>SCOPUS_ID:84929579535</dc:identifier><eid>2-s2.0-84929579535</eid><dc:title>Comparative efficacies of tedizolid phosphate, vancomycin, and daptomycin in a rabbit model of methicillin-resistant Staphylococcus aureus endocarditis</dc:title><dc:creator>Chan L.</dc:creator><prism:publicationName>Antimicrobial Agents and Chemotherapy</prism:publicationName><prism:issn>00664804</prism:issn><prism:eIssn>10986596</prism:eIssn><prism:volume>59</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>3252-3256</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1128/AAC.04376-14</prism:doi><dc:description>Copyright © 2015, American Society for Microbiology. All Rights Reserved. Tedizolid, the active component of the prodrug tedizolid phosphate, is a novel oxazolidinone that is approximately 4 times more active by weight than linezolid against Staphylococcus aureus in vitro. The in vivo efficacy of tedizolid phosphate (15 mg/kg body weight intravenous [i.v.] twice a day [b.i.d.]) was compared to those of vancomycin (30 mg/kg i.v. b.i.d.) and daptomycin (18 mg/kg i.v. once a day [q.d.]) in a rabbit model of aortic valve endocarditis (AVE) caused by methicillin-resistant S. aureus strain COL (infection inoculum of 10&lt;sup&gt;7&lt;/sup&gt; CFU). Median vegetation titers of daptomycin-treated rabbits were significantly lower than those of rabbits treated with tedizolid phosphate (15 mg/kg b.i.d.) (P = 0.016), whereas titers for vancomycin-treated compared to tedizolid-treated rabbits were not different (P = 0.984). The numbers of organisms in spleen and kidney tissues were similar for all treatment groups. A dose-ranging experiment was performed with tedizolid phosphate (2, 4, and 8 mg/kg b.i.d.) compared to vancomycin (30 mg/kg b.i.d.), using a higher infecting inoculum (10&lt;sup&gt;8&lt;/sup&gt; CFU) to determine the lowest efficacious dose of tedizolid phosphate. Tedizolid phosphate (2 mg/kg) (equivalent to 60% of the area under the concentration-time curve from 0 to 24 h (AUC&lt;inf&gt;0-24&lt;/inf&gt; ) for the human 200-mg dose approved by the U.S. Food and Drug Administration) was not efficacious. Tedizolid phosphate at 4 mg/kg (equivalent to 75% of the AUC&lt;inf&gt;0-24&lt;/inf&gt; for the human 400-mg dose) and 8 mg/kg produced lower vegetation titers than the control, but neither was as efficacious as vancomycin.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003214</affiliation-url><afid>60003214</afid><affilname>San Francisco General Hospital and Trauma Center</affilname><name-variant>San Francisco General Hospital</name-variant><affiliation-city>San Francisco</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016081</affiliation-url><afid>60016081</afid><affilname>Los Angeles County Harbor-UCLA Med Center</affilname><name-variant>Harbor-UCLA Medical Center</name-variant><affiliation-city>Torrance</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56650495900</author-url><authid>56650495900</authid><authname>Chan L.</authname><surname>Chan</surname><given-name>Liana C.</given-name><initials>L.C.</initials><afid>60003214</afid><afid>60016081</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56650495900</author-url><authid>56650495900</authid><authname>Chan L.</authname><surname>Chan</surname><given-name>Liana C.</given-name><initials>L.C.</initials><afid>60003214</afid><afid>60016081</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8721453600</author-url><authid>8721453600</authid><authname>Basuino L.</authname><surname>Basuino</surname><given-name>Li</given-name><initials>L.</initials><afid>60003214</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6504170599</author-url><authid>6504170599</authid><authname>Dip E.</authname><surname>Dip</surname><given-name>Etyene C.</given-name><initials>E.C.</initials><afid>60003214</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:24777834900</author-url><authid>24777834900</authid><authname>Chambers H.</authname><surname>Chambers</surname><given-name>Henry F.</given-name><initials>H.F.</initials><afid>60003214</afid></author><intid>1035977290</intid><source-id>19615</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928406173"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928406173?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928406173&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928406173&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0163725815000091"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928406173</prism:url><dc:identifier>SCOPUS_ID:84928406173</dc:identifier><eid>2-s2.0-84928406173</eid><dc:title>Anti-tumor activities of lipids and lipid analogues and their development as potential anticancer drugs</dc:title><dc:creator>Murray M.</dc:creator><prism:publicationName>Pharmacology and Therapeutics</prism:publicationName><prism:issn>01637258</prism:issn><prism:eIssn>1879016X</prism:eIssn><prism:volume>150</prism:volume><prism:pageRange>109-128</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.pharmthera.2015.01.008</prism:doi><pii>S0163725815000091</pii><dc:description>© 2015 Elsevier Inc. All rights reserved. Lipids have the potential for development as anticancer agents. Endogenous membrane lipids, such as ceramides and certain saturated fatty acids, have been found to modulate the viability of tumor cells. In addition, many tumors over-express cyclooxygenase, lipoxygenase or cytochrome P450 enzymes that mediate the biotransformation of ω-6 polyunsaturated fatty acids (PUFAs) to potent eicosanoid regulators of tumor cell proliferation and cell death. In contrast, several analogous products from the biotransformation of ω-3 PUFAs impair particular tumorigenic pathways. For example, the ω-3 17,18-epoxide of eicosapentaenoic acid activates anti-proliferative and proapoptotic signaling cascades in tumor cells and the lipoxygenase-derived resolvins are effective inhibitors of inflammatory pathways that may drive tumor expansion. However, the development of potential anti-cancer drugs based on these molecules is complex, with in vivo stability a major issue. Nevertheless, recent successes with the antitumor alkyl phospholipids, which are synthetic analogues of naturally-occurring membrane phospholipid esters, have provided the impetus for development of further molecules. The alkyl phospholipids have been tested against a range of cancers and show considerable activity against skin cancers and certain leukemias. Very recently, it has been shown that combination strategies, in which alkyl phospholipids are used in conjunction with established anticancer agents, are promising new therapeutic approaches. In future, the evaluation of new lipid-based molecules in single-agent and combination treatments may also be assessed. This could provide a range of important treatment options in the management of advanced and metastatic cancer.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025709</affiliation-url><afid>60025709</afid><affilname>University of Sydney</affilname><name-variant>University of Sydney</name-variant><affiliation-city>Sydney</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100610106</affiliation-url><afid>100610106</afid><affilname>University of Technology</affilname><name-variant>University of Technology</name-variant><affiliation-city/><affiliation-country>Australia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35378413600</author-url><authid>35378413600</authid><authname>Murray M.</authname><surname>Murray</surname><given-name>Michael</given-name><initials>M.</initials><afid>60025709</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56605105500</author-url><authid>56605105500</authid><authname>Hraiki A.</authname><surname>Hraiki</surname><given-name>Adam</given-name><initials>A.</initials><afid>60025709</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6506211522</author-url><authid>6506211522</authid><authname>Bebawy M.</authname><surname>Bebawy</surname><given-name>Mary</given-name><initials>M.</initials><afid>100610106</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56605043400</author-url><authid>56605043400</authid><authname>Pazderka C.</authname><surname>Pazderka</surname><given-name>Curtis</given-name><initials>C.</initials><afid>100610106</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:15849655700</author-url><authid>15849655700</authid><authname>Rawling T.</authname><surname>Rawling</surname><given-name>Tristan</given-name><initials>T.</initials><afid>100610106</afid></author><authkeywords>Alkyl phospholipid | Epoxide isostere | Lipid-based anticancer agent | PUFA epoxide | Tumor apoptosis | Tumor proliferation</authkeywords><intid>2035773356</intid><source-id>21195</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924709480"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924709480?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924709480&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924709480&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924709480</prism:url><dc:identifier>SCOPUS_ID:84924709480</dc:identifier><eid>2-s2.0-84924709480</eid><dc:title>The flow behavior of a biofluid in a separated and reattached flow region</dc:title><dc:creator>Hammad K.</dc:creator><prism:publicationName>Journal of Fluids Engineering, Transactions of the ASME</prism:publicationName><prism:issn>00982202</prism:issn><prism:eIssn>1528901X</prism:eIssn><prism:volume>137</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1115/1.4029727</prism:doi><dc:description>© 2015 by ASME. The flow behavior of human blood in a separated and reattached flow region is investigated. Hemorheological data that account for the yield stress and shear-thinning non-Newtonian characteristics of blood are used. The governing mass and momentum conservation equations along with the Herschel-Bulkley constitutive equation are solved numerically using a finite-difference scheme. Two inflow velocity profiles are considered, uniform and fully developed (fd) ones. A parametric study is performed to reveal the impact of inflow velocity profile, upstream flow restriction, and rheology on the recirculation strength and reattachment characteristics of the flow field. Uniform inflow conditions result in larger relative recirculation intensity, in comparison with the fd ones, only for a moderate upstream flow restriction. The separated flow region size in the case of a fd inflow is always larger than the one observed for uniform inflow. Larger separated flow regions with stronger flow recirculation, are predicted by the Newtonian (N) model in comparison with the yield shear-thinning (HB) model for all studied inflow and upstream restriction conditions. The separated flow region size displays a stronger dependency on the inflow velocity profile and upstream flow restriction, in comparison with the observed dependency on the used hemorheological model.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032058</affiliation-url><afid>60032058</afid><affilname>Central Connecticut State University</affilname><name-variant>Central Connecticut State University</name-variant><affiliation-city>New Britain</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7004221673</author-url><authid>7004221673</authid><authname>Hammad K.</authname><surname>Hammad</surname><given-name>Khaled J.</given-name><initials>K.J.</initials><afid>60032058</afid></author><intid>535190814</intid><article-number>061104</article-number><source-id>18538</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925423999"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925423999?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925423999&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925423999&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0166432815001564"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925423999</prism:url><dc:identifier>SCOPUS_ID:84925423999</dc:identifier><eid>2-s2.0-84925423999</eid><dc:title>Plasmalogen precursor analog treatment reduces levodopa-induced dyskinesias in parkinsonian monkeys</dc:title><dc:creator>Grégoire L.</dc:creator><prism:publicationName>Behavioural Brain Research</prism:publicationName><prism:issn>01664328</prism:issn><prism:eIssn>18727549</prism:eIssn><prism:volume>286</prism:volume><prism:pageRange>328-337</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbr.2015.03.012</prism:doi><pii>S0166432815001564</pii><dc:description>© 2015 Elsevier B.V. l-DOPA-induced dyskinesias (LID) remain a serious obstacle in the treatment of Parkinson's disease (PD). The objective of this study was to test a new target for treatment of dyskinesias, ethanolamine plasmalogens (PlsEtn). PlsEtn play critical roles in membrane structure mediated functions and as a storage depot of polyunsaturated fatty acids such as docosahexaenoic acid (DHA, omega-3) known to reduce dyskinesias. The motor effect of a daily treatment for 12 days of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Macaca fascicularis monkeys with DHA (100. mg/kg) was compared to the DHA-PlsEtn precursor PPI-1011 (50. mg/kg). PPI-1011 and DHA reduced LID while maintaining the antiparkinsonian activity of l-DOPA, however the PPI-1011 effect was observed at the first behavioral time point analyzed following drug administration (day 2) whereas the effect of DHA was not observed until after 10 days of administration. DHA treatment increased plasma DHA levels 2-3× whereas PPI-1011 had no effect. DHA and PPI-1011 increased DHA-PlsEtn levels by 1.5-2× while DHA-phosphatidylethanolamine (PtdEtn) levels remained unaffected. DHA treatment also elevated very long chain fatty acid containing PtdEtn and reduced non-DHA containing PtdEtn and PlsEtn levels. PPI-1011 had no effect on these systems. LID scores were inversely correlated with serum DHA-PlsEtn/total PlsEtn ratios levels in DHA and PPI-1011 treated monkeys. Hence, the antidyskinetic activity of DHA and PPI-1011 in MPTP monkeys appears to be associated with the increase of serum DHA-PlsEtn concentrations. This is the first study reporting an antidyskinetic response to augmentation of DHA-PlsEtn using a plasmalogen precursor thus providing a novel drug target for dyskinesias.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113695033</affiliation-url><afid>113695033</afid><affilname>Centre de Recherche du CHU de Québec</affilname><name-variant>Centre de Recherche du CHU de Québec-CHUL</name-variant><affiliation-city/><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100406808</affiliation-url><afid>100406808</afid><affilname>Phenomenome Discoveries Inc.</affilname><name-variant>Phenomenome Discoveries Inc</name-variant><affiliation-city>Saskatoon</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002787</affiliation-url><afid>60002787</afid><affilname>Chiba University</affilname><name-variant>Chiba University</name-variant><affiliation-city>Chiba</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032619</affiliation-url><afid>60032619</afid><affilname>Universite Laval</affilname><name-variant>Université Laval</name-variant><affiliation-city>Quebec</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7006932563</author-url><authid>7006932563</authid><authname>Grégoire L.</authname><surname>Grégoire</surname><given-name>Laurent</given-name><initials>L.</initials><afid>113695033</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55482157100</author-url><authid>55482157100</authid><authname>Smith T.</authname><surname>Smith</surname><given-name>Tara</given-name><initials>T.</initials><afid>100406808</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:25947766000</author-url><authid>25947766000</authid><authname>Senanayake V.</authname><surname>Senanayake</surname><given-name>Vijitha</given-name><initials>V.</initials><afid>100406808</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56567619800</author-url><authid>56567619800</authid><authname>Mochizuki A.</authname><surname>Mochizuki</surname><given-name>Asuka</given-name><initials>A.</initials><afid>100406808</afid><afid>60002787</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56567619800</author-url><authid>56567619800</authid><authname>Mochizuki A.</authname><surname>Mochizuki</surname><given-name>Asuka</given-name><initials>A.</initials><afid>100406808</afid><afid>60002787</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56568406300</author-url><authid>56568406300</authid><authname>Miville-Godbout E.</authname><surname>Miville-Godbout</surname><given-name>Edith</given-name><initials>E.</initials><afid>113695033</afid><afid>60032619</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56568406300</author-url><authid>56568406300</authid><authname>Miville-Godbout E.</authname><surname>Miville-Godbout</surname><given-name>Edith</given-name><initials>E.</initials><afid>113695033</afid><afid>60032619</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6507001775</author-url><authid>6507001775</authid><authname>Goodenowe D.</authname><surname>Goodenowe</surname><given-name>Dayan</given-name><initials>D.</initials><afid>100406808</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7006090281</author-url><authid>7006090281</authid><authname>Di Paolo T.</authname><surname>Di Paolo</surname><given-name>Thérèse</given-name><initials>T.</initials><afid>113695033</afid><afid>60032619</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7006090281</author-url><authid>7006090281</authid><authname>Di Paolo T.</authname><surname>Di Paolo</surname><given-name>Thérèse</given-name><initials>T.</initials><afid>113695033</afid><afid>60032619</afid></author><authkeywords>Bioavailable plasmalogen precursor | DHA | MPTP | Parkinson | PPI-1011</authkeywords><intid>535296420</intid><source-id>14285</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928035214"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928035214?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928035214&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928035214&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0891584915000957"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928035214</prism:url><dc:identifier>SCOPUS_ID:84928035214</dc:identifier><eid>2-s2.0-84928035214</eid><dc:title>Pterostilbene and allopurinol reduce fructose-induced podocyte oxidative stress and inflammation via microRNA-377</dc:title><dc:creator>Wang W.</dc:creator><prism:publicationName>Free Radical Biology and Medicine</prism:publicationName><prism:issn>08915849</prism:issn><prism:eIssn>18734596</prism:eIssn><prism:volume>83</prism:volume><prism:pageRange>214-226</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.freeradbiomed.2015.02.029</prism:doi><pii>S0891584915000957</pii><dc:description>© 2015 Elsevier Inc. All rights reserved. Abstract High dietary fructose is an important causative factor in the development of metabolic syndrome-associated glomerular podocyte oxidative stress and injury. Here, we identified microRNA-377 (miR-377) as a biomarker of oxidative stress in renal cortex of fructose-fed rats, which correlated with podocyte injury and albuminuria in metabolic syndrome. Fructose feeding increased miR-377 expression, decreased superoxide dismutase (SOD) expression and activity, and caused O&lt;inf&gt;2&lt;/inf&gt;&lt;sup&gt;-&lt;/sup&gt; and H&lt;inf&gt;2&lt;/inf&gt;O&lt;inf&gt;2&lt;/inf&gt; overproduction in kidney cortex or glomeruli of rats. This reactive oxygen species induction increased p38 MAPK phosphorylation and thioredoxin-interacting protein (TXNIP) expression and activated the NOD-like receptor pyrin domain-containing 3 (NLRP3) inflammasome to produce interleukin-1β in kidney glomeruli of fructose-fed rats. These pathological processes were further evaluated in cultured differentiated podocytes exposed to 5 mM fructose, or transfected with miR-377 mimic/inhibitor and TXNIP siRNA, or co-incubated with p38 MAPK inhibitor, demonstrating that miR-377 overexpression activates the O&lt;inf&gt;2&lt;/inf&gt;&lt;sup&gt;-&lt;/sup&gt;/p38 MAPK/TXNIP/NLRP3 inflammasome pathway to promote oxidative stress and inflammation in fructose-induced podocyte injury. Antioxidants pterostilbene and allopurinol were found to ameliorate fructose-induced hyperuricemia, podocyte injury, and albuminuria in rats. More importantly, pterostilbene and allopurinol inhibited podocyte miR-377 overexpression to increase SOD1 and SOD2 levels and suppress the O&lt;inf&gt;2&lt;/inf&gt;&lt;sup&gt;-&lt;/sup&gt;/p38 MAPK/TXNIP/NLRP3 inflammasome pathway activation in vivo and in vitro, consistent with the reduction of oxidative stress and inflammation. These findings suggest that miR-377 plays an important role in glomerular podocyte oxidative stress, inflammation, and injury driven by high fructose. Inhibition of miR-377 by antioxidants may be a promising therapeutic strategy for the prevention of metabolic syndrome-associated glomerular podocyte injury.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033100</affiliation-url><afid>60033100</afid><affilname>Nanjing University</affilname><name-variant>Nanjing University</name-variant><affiliation-city>Nanjing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56419023900</author-url><authid>56419023900</authid><authname>Wang W.</authname><surname>Wang</surname><given-name>Wei</given-name><initials>W.</initials><afid>60033100</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55207231400</author-url><authid>55207231400</authid><authname>Ding X.</authname><surname>Ding</surname><given-name>Xiao Qin</given-name><initials>X.Q.</initials><afid>60033100</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55773749100</author-url><authid>55773749100</authid><authname>Gu T.</authname><surname>Gu</surname><given-name>Ting Ting</given-name><initials>T.T.</initials><afid>60033100</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56597259400</author-url><authid>56597259400</authid><authname>Song L.</authname><surname>Song</surname><given-name>Lin</given-name><initials>L.</initials><afid>60033100</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55958055200</author-url><authid>55958055200</authid><authname>Li J.</authname><surname>Li</surname><given-name>Jian Mei</given-name><initials>J.M.</initials><afid>60033100</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56018983600</author-url><authid>56018983600</authid><authname>Xue Q.</authname><surname>Xue</surname><given-name>Qiao Chu</given-name><initials>Q.C.</initials><afid>60033100</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7201533047</author-url><authid>7201533047</authid><authname>Kong L.</authname><surname>Kong</surname><given-name>Ling Dong</given-name><initials>L.D.</initials><afid>60033100</afid></author><authkeywords>Allopurinol | Free radicals | Fructose | MiR-377 | NLRP3 inflammasome | Oxidative stress | Podocyte injury | Pterostilbene | TXNIP</authkeywords><intid>1785717366</intid><article-number>12332</article-number><source-id>15095</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928687569"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928687569?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928687569&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928687569&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0169433215000045"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928687569</prism:url><dc:identifier>SCOPUS_ID:84928687569</dc:identifier><eid>2-s2.0-84928687569</eid><dc:title>Grip performance affected by water-induced wrinkling of fingers</dc:title><dc:creator>Lin H.</dc:creator><prism:publicationName>Tribology Letters</prism:publicationName><prism:issn>10238883</prism:issn><prism:volume>58</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:pageRange>1-9</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s11249-015-0515-4</prism:doi><dc:description>© Springer Science+Business Media New York 2015. Abstract Gripping an object is one of the most common actions in our daily lives. The hairless human fingers and toes become wrinkled after interacting with water for a period of time. This wrinkling phenomenon affects finger grip performance and influences the safety and convenience of everyday life. In order to study the impact of wrinkled fingers on grip performance, the moisture of the finger was measured using a Corneometer® CM825; the real-time fingertip contact area on the moving surfaces was captured via the ink method and a high-speed camera; and the coefficient of friction between the fingertip and the contact surfaces in the dry, wet and water-submerged states was evaluated using a tribometer (UMT-2). In particular, a simple compressed spring grip experiment was designed to quantify and verify the relationship between the gripping force and the friction force of an unwrinkled/wrinkled fingertip and contact PET surfaces. The experimental results revealed that how finger wrinkles affect grip action.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014982</affiliation-url><afid>60014982</afid><affilname>National Cheng Kung University</affilname><name-variant>National Cheng Kung University</name-variant><affiliation-city>Tainan</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006082</affiliation-url><afid>60006082</afid><affilname>National Pingtung University of Science and Technology</affilname><name-variant>National Pingtung University of Science and Technology</name-variant><affiliation-city>Pingtung</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56609468200</author-url><authid>56609468200</authid><authname>Lin H.</authname><surname>Lin</surname><given-name>Hsin Ta</given-name><initials>H.T.</initials><afid>60014982</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56609682800</author-url><authid>56609682800</authid><authname>Hong T.</authname><surname>Hong</surname><given-name>Ting Fu</given-name><initials>T.F.</initials><afid>60006082</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56453735400</author-url><authid>56453735400</authid><authname>Li W.</authname><surname>Li</surname><given-name>Wang Long</given-name><initials>W.L.</initials><afid>60014982</afid></author><authkeywords>Biotribology | Contact area | Friction mechanisms | Reciprocating sliding | Skin hydration</authkeywords><intid>1785824347</intid><article-number>515</article-number><source-id>18380</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927726186"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927726186?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927726186&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927726186&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915015002154"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927726186</prism:url><dc:identifier>SCOPUS_ID:84927726186</dc:identifier><eid>2-s2.0-84927726186</eid><dc:title>FABP4 inhibition suppresses PPARγ activity and VLDL-induced foam cell formation in IL-4-polarized human macrophages</dc:title><dc:creator>Boß M.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>240</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>424-430</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2015.03.042</prism:doi><pii>S0021915015002154</pii><dc:description>© 2015 Elsevier Ireland Ltd. Objective: Macrophages, converted to lipid-loaded foam cells, accumulate in atherosclerotic lesions. Macrophage lipid metabolism is transcriptionally regulated by peroxisome proliferator-activated receptor gamma (PPARγ), and its target gene fatty acid binding protein 4 (FABP4) accelerates the progression of atherosclerosis in mouse models. Since expression of PPARγ and FABP4 is increased upon interleukin-4 (IL-4)-induced macrophage polarization, we aimed to investigate the role of FABP4 in human IL-4-polarized macrophages. Methods and results: We investigated the impact of FABP4 on PPARγ-dependent gene expression in primary human monocytes differentiated to macrophages in the presence of IL-4. IL-4 increased PPARγ and its target genes lipoprotein lipase (LPL) and FABP4 compared to non-polarized or LPS/interferon γ-stimulated macrophages. LPL expression correlated with increased very low density lipoprotein (VLDL)-induced triglyceride accumulation in IL-4-polarized macrophages, which was sensitive to inhibition of lipolysis or PPARγ antagonism. Inhibition of FABP4 during differentiation using chemical inhibitors BMS309403 and HTS01037 or FABP4 siRNA decreased the expression of FABP4 and LPL, and reduced lipid accumulation in macrophages treated with VLDL. FABP4 or LPL inhibition also reduced the expression of inflammatory mediators chemokine (C-C motif) ligand 2 (CCL2) and IL-1β in response to VLDL in IL-4-polarized macrophages. PPARγ luciferase reporter assays confirmed that FABP4 supports fatty acid-induced PPARγ activation. Conclusion: Our findings suggest that IL-4 induces a lipid-accumulating macrophage phenotype by activating PPARγ and subsequent LPL expression. Inhibition of FABP4 decreases VLDL-induced foam cell formation, indicating that anti-atherosclerotic effects achieved by FABP4 inhibition in mouse models may be feasible in the human system as well.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007762</affiliation-url><afid>60007762</afid><affilname>Johann Wolfgang Goethe Universitat Frankfurt am Main</affilname><affiliation-city>Frankfurt am Main</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56594654000</author-url><authid>56594654000</authid><authname>Boß M.</authname><surname>Boß</surname><given-name>Marcel</given-name><initials>M.</initials><afid>60007762</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55734908900</author-url><authid>55734908900</authid><authname>Kemmerer M.</authname><surname>Kemmerer</surname><given-name>Marina</given-name><initials>M.</initials><afid>60007762</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7102115323</author-url><authid>7102115323</authid><authname>Brüne B.</authname><surname>Brüne</surname><given-name>Bernhard</given-name><initials>B.</initials><afid>60007762</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6602227461</author-url><authid>6602227461</authid><authname>Namgaladze D.</authname><surname>Namgaladze</surname><given-name>Dmitry</given-name><initials>D.</initials><afid>60007762</afid></author><authkeywords>Fatty acid binding proteins | Foam cell formation | Lipoprotein lipase | PPARγ</authkeywords><intid>1535665665</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924980074"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924980074?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924980074&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924980074&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0278691515000587"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924980074</prism:url><dc:identifier>SCOPUS_ID:84924980074</dc:identifier><eid>2-s2.0-84924980074</eid><dc:title>The good and bad of antioxidant foods: An immunological perspective</dc:title><dc:creator>Gostner J.</dc:creator><prism:publicationName>Food and Chemical Toxicology</prism:publicationName><prism:issn>02786915</prism:issn><prism:eIssn>18736351</prism:eIssn><prism:volume>80</prism:volume><prism:pageRange>72-79</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.fct.2015.02.012</prism:doi><pii>S0278691515000587</pii><dc:description>© 2015 Elsevier Ltd. Maintenance of redox homeostasis plays a central role in health and disease prevention, and antioxidant foods are thought to exert protective effects by counteracting oxidative stress. The term "dietary antioxidant" implies a classical reducing or radical-scavenging capacity, but more data on the in vivo bioactivity of such compounds are needed. Indeed, several dietary antioxidants activate signaling cascades that lead to effects that extend beyond radical scavenging, such as the induction of endogenous cytoprotective mechanisms and detoxification. Currently, the overall uptake of antioxidants with diet exceeds actual needs, as food additives that include vitamins, colorants, flavoring agents, and preservatives are often also relatively strong antioxidants. Chronic antioxidative stress favors adverse effects, such as the suppression of T helper (Th) type 1 immune responses and consequent activation of Th2 reactions that support the development of asthma, allergies, and obesity. In this context, we discuss the immunoregulatory pathway of tryptophan breakdown by enzyme indoleamine 2,3-dioxygenase (IDO), which represents a central regulatory hub for immune, metabolic, and neuroendocrine processes. Activation of IDO-mediated tryptophan metabolism is strongly redox-sensitive and is therefore susceptible to modulation by dietary components, phytochemicals, preservatives, and drugs.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008222</affiliation-url><afid>60008222</afid><affilname>Medizinische Universitat Innsbruck</affilname><name-variant>Medical University Innsbruck</name-variant><affiliation-city>Innsbruck</affiliation-city><affiliation-country>Austria</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008222</affiliation-url><afid>60008222</afid><affilname>Medizinische Universitat Innsbruck</affilname><name-variant>Medical University Innsbruck</name-variant><affiliation-city>Innsbruck</affiliation-city><affiliation-country>Austria</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:16636147200</author-url><authid>16636147200</authid><authname>Gostner J.</authname><surname>Gostner</surname><given-name>Johanna M.</given-name><initials>J.M.</initials><afid>60008222</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36089011800</author-url><authid>36089011800</authid><authname>Becker K.</authname><surname>Becker</surname><given-name>Kathrin</given-name><initials>K.</initials><afid>60008222</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6508289567</author-url><authid>6508289567</authid><authname>Ueberall F.</authname><surname>Ueberall</surname><given-name>Florian</given-name><initials>F.</initials><afid>60008222</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35414205100</author-url><authid>35414205100</authid><authname>Fuchs D.</authname><surname>Fuchs</surname><given-name>Dietmar</given-name><initials>D.</initials><afid>60008222</afid></author><authkeywords>Allergy | Antioxidative stress | Dietary antioxidant | Indoleamine 2,3-dioxygenase | Preservative | Tryptophan</authkeywords><intid>2035227179</intid><source-id>25096</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926625909"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926625909?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926625909&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926625909&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926625909</prism:url><dc:identifier>SCOPUS_ID:84926625909</dc:identifier><eid>2-s2.0-84926625909</eid><dc:title>Thiol redox chemistry: Role of protein cysteine oxidation and altered redox homeostasis in allergic inflammation and asthma</dc:title><dc:creator>Hoffman S.</dc:creator><prism:publicationName>Journal of Cellular Biochemistry</prism:publicationName><prism:issn>07302312</prism:issn><prism:eIssn>10974644</prism:eIssn><prism:volume>116</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>884-892</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1002/jcb.25017</prism:doi><dc:description>© 2015 Wiley Periodicals, Inc. Asthma is a pulmonary disorder, with an estimated 300 million people affected worldwide. While it is thought that endogenous reactive oxygen species (ROS) and reactive nitrogen species (RNS) such as hydrogen peroxide and nitric oxide, are important mediators of natural physiological processes, inflammatory cells recruited to the asthmatic airways have an exceptional capacity for producing a variety of highly reactive ROS and RNS believed to contribute to tissue damage and chronic airways inflammation. Antioxidant defense systems form a tightly regulated network that maintains the redox environment of the intra- as well as extracellular environment. Evidence for an oxidant-antioxidant imbalance in asthmatic airways is demonstrated in a number of studies, revealing decreased total antioxidant capacity as well as lower levels of individual antioxidants. Thiols in the form of GSH and sulfhydryl groups of proteins are among the most susceptible oxidant-sensitive targets, and hence, studies investigating protein thiol redox modifications in biology and disease have emerged. This perspective offers an overview of the combined efforts aimed at the elucidation of mechanisms whereby cysteine oxidations contribute to chronic inflammation and asthma, as well as insights into potential cysteine thiol-based therapeutic strategies.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009500</affiliation-url><afid>60009500</afid><affilname>University of Vermont</affilname><name-variant>University of Vermont</name-variant><affiliation-city>Burlington</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018869</affiliation-url><afid>60018869</afid><affilname>Maastricht University</affilname><name-variant>University of Limburg</name-variant><affiliation-city>Maastricht</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55359075100</author-url><authid>55359075100</authid><authname>Hoffman S.</authname><surname>Hoffman</surname><given-name>Sidra</given-name><initials>S.</initials><afid>60009500</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:37031647500</author-url><authid>37031647500</authid><authname>Nolin J.</authname><surname>Nolin</surname><given-name>James</given-name><initials>J.</initials><afid>60009500</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56585401400</author-url><authid>56585401400</authid><authname>McMillan D.</authname><surname>McMillan</surname><given-name>David</given-name><initials>D.</initials><afid>60009500</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35395980800</author-url><authid>35395980800</authid><authname>Wouters E.</authname><surname>Wouters</surname><given-name>Emiel</given-name><initials>E.</initials><afid>60018869</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6701619434</author-url><authid>6701619434</authid><authname>Janssen-Heininger Y.</authname><surname>Janssen-Heininger</surname><given-name>Yvonne</given-name><initials>Y.</initials><afid>60009500</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6602896916</author-url><authid>6602896916</authid><authname>Reynaert N.</authname><surname>Reynaert</surname><given-name>Niki</given-name><initials>N.</initials><afid>60018869</afid></author><authkeywords>asthma | cysteine | oxidation</authkeywords><intid>1535483808</intid><source-id>17598</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84923061319"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84923061319?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84923061319&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84923061319&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1095643315000021"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84923061319</prism:url><dc:identifier>SCOPUS_ID:84923061319</dc:identifier><eid>2-s2.0-84923061319</eid><dc:title>Reversible brain swelling in crucian carp (Carassius carassius) and goldfish (Carassius auratus) in response to high external ammonia and anoxia</dc:title><dc:creator>Wilkie M.</dc:creator><prism:publicationName>Comparative Biochemistry and Physiology -Part A : Molecular and Integrative Physiology</prism:publicationName><prism:issn>10956433</prism:issn><prism:eIssn>15314332</prism:eIssn><prism:volume>184</prism:volume><prism:pageRange>65-75</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cbpa.2014.12.038</prism:doi><pii>S1095643315000021</pii><dc:description>© 2014 Elsevier Inc. Increased internal ammonia (hyperammonemia) and ischemic/anoxic insults are known to result in a cascade of deleterious events that can culminate in potentially fatal brain swelling in mammals. It is less clear, however, if the brains of fishes respond to ammonia in a similar manner. The present study demonstrated that the crucian carp (Carassius carassius) was not only able to endure high environmental ammonia exposure (HEA; 2 to 22mmolL-1) but that they experienced 30% increases in brain water content at the highest ammonia concentrations. This swelling was accompanied by 4-fold increases in plasma total ammonia (TAmm) concentration, but both plasma TAmm and brain water content were restored to pre-exposure levels following depuration in ammonia-free water. The closely related, ammonia-tolerant goldfish (Carassius auratus) responded similarly to HEA (up to 3.6mmolL-1), which was accompanied by 4-fold increases in brain glutamine. Subsequent administration of the glutamine synthetase inhibitor, methionine sulfoximine (MSO), reduced brain glutamine accumulation by 80% during HEA. However, MSO failed to prevent ammonia-induced increases in brain water content suggesting that glutamine may not be directly involved in initiating ammonia-induced brain swelling in fishes. Although the mechanisms of brain swelling are likely different, exposure to anoxia for 96h caused similar, but lesser (10%) increases in brain water content in crucian carp. We conclude that brain swelling in some fishes may be a common response to increased internal ammonia or lower oxygen but further research is needed to deduce the underlying mechanisms behind such responses.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000521</affiliation-url><afid>60000521</afid><affilname>Wilfrid Laurier University</affilname><name-variant>Wilfrid Laurier University</name-variant><affiliation-city>Waterloo</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010348</affiliation-url><afid>60010348</afid><affilname>Universitetet i Oslo</affilname><name-variant>University of Oslo</name-variant><affiliation-city>Oslo</affiliation-city><affiliation-country>Norway</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029489</affiliation-url><afid>60029489</afid><affilname>University of Alaska Anchorage</affilname><name-variant>University of Alaska</name-variant><affiliation-city>Anchorage</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7005667832</author-url><authid>7005667832</authid><authname>Wilkie M.</authname><surname>Wilkie</surname><given-name>Michael P.</given-name><initials>M.P.</initials><afid>60000521</afid><afid>60010348</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7005667832</author-url><authid>7005667832</authid><authname>Wilkie M.</authname><surname>Wilkie</surname><given-name>Michael P.</given-name><initials>M.P.</initials><afid>60000521</afid><afid>60010348</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603260427</author-url><authid>6603260427</authid><authname>Stecyk J.</authname><surname>Stecyk</surname><given-name>Jonathan A W</given-name><initials>J.A.W.</initials><afid>60010348</afid><afid>60029489</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603260427</author-url><authid>6603260427</authid><authname>Stecyk J.</authname><surname>Stecyk</surname><given-name>Jonathan A W</given-name><initials>J.A.W.</initials><afid>60010348</afid><afid>60029489</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:54405417300</author-url><authid>54405417300</authid><authname>Couturier C.</authname><surname>Couturier</surname><given-name>Christine S.</given-name><initials>C.S.</initials><afid>60010348</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56519311100</author-url><authid>56519311100</authid><authname>Sidhu S.</authname><surname>Sidhu</surname><given-name>Sanya</given-name><initials>S.</initials><afid>60000521</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:23502395100</author-url><authid>23502395100</authid><authname>Sandvik G.</authname><surname>Sandvik</surname><given-name>Guro K.</given-name><initials>G.K.</initials><afid>60010348</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56519241000</author-url><authid>56519241000</authid><authname>Nilsson G.</authname><surname>Nilsson</surname><given-name>Göran E.</given-name><initials>G.E.</initials><afid>60010348</afid></author><authkeywords>Ammonia toxicity | Astrocyte | Brain | Encephalopathy | Ethanol | Glutamine | Glutamine synthetase | Hyperammonemia | Methionine sulfoximine | Neurotoxicity</authkeywords><intid>2034902635</intid><source-id>3500148021</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930198107"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930198107?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930198107&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930198107&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930198107</prism:url><dc:identifier>SCOPUS_ID:84930198107</dc:identifier><eid>2-s2.0-84930198107</eid><dc:title>Influence of voltage balancing on the temperature distribution of a Li-ion battery module</dc:title><dc:creator>Iraola U.</dc:creator><prism:publicationName>IEEE Transactions on Energy Conversion</prism:publicationName><prism:issn>08858969</prism:issn><prism:volume>30</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>507-514</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1109/TEC.2014.2366375</prism:doi><dc:description>© 1986-2012 IEEE. Temperature is one of the key factors when working with lithium-ion battery modules due to its influence in safety, performance, and lifespan concerns in these devices. High working temperatures reduce the available capacity of each cell within the module after several cycles due to aging; nonuniform temperature distributions in the module lead to different aging processes in each cell, and thus it will be impossible to take advantage of all the energy available in the Li-ion storage system, because the most aged cell will limit the available energy. This paper is focused on the minimization of the maximum temperature gradient of a battery module for high depth of discharge applications to avoid different aging processes of the cells within the module. Voltage balancing is proposed as a solution for this purpose, and different strategies and their results are presented in this paper.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60080988</affiliation-url><afid>60080988</afid><affilname>Mondragon Unibertsitatea</affilname><name-variant>Mondragon University</name-variant><affiliation-city>Mondragon</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:105909105</affiliation-url><afid>105909105</afid><affilname>ORONA Elevator Innovation Centre</affilname><name-variant>ORONA Elevator Innovation Centre</name-variant><affiliation-city>Hernani</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:54892033300</author-url><authid>54892033300</authid><authname>Iraola U.</authname><surname>Iraola</surname><given-name>Unai</given-name><initials>U.</initials><afid>60080988</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55582171200</author-url><authid>55582171200</authid><authname>Aizpuru I.</authname><surname>Aizpuru</surname><given-name>Iosu</given-name><initials>I.</initials><afid>60080988</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56340162400</author-url><authid>56340162400</authid><authname>Gorrotxategi L.</authname><surname>Gorrotxategi</surname><given-name>Lorea</given-name><initials>L.</initials><afid>60080988</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:54891846700</author-url><authid>54891846700</authid><authname>Segade J.</authname><surname>Segade</surname><given-name>Jose Maria Canales</given-name><initials>J.M.C.</initials><afid>60080988</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56423707900</author-url><authid>56423707900</authid><authname>Larrazabal A.</authname><surname>Larrazabal</surname><given-name>Ander Etxeberria</given-name><initials>A.E.</initials><afid>60080988</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55520939800</author-url><authid>55520939800</authid><authname>Gil I.</authname><surname>Gil</surname><given-name>Inigo</given-name><initials>I.</initials><afid>105909105</afid></author><authkeywords>Aging | battery modules | lithium-ion | temperature distribution | voltage balancing</authkeywords><intid>36086140</intid><source-id>28824</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930181870"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930181870?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930181870&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930181870&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0927776515002131"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930181870</prism:url><dc:identifier>SCOPUS_ID:84930181870</dc:identifier><eid>2-s2.0-84930181870</eid><dc:title>Combined nitric oxide-releasing poly(vinyl alcohol) film/F127 hydrogel for accelerating wound healing</dc:title><dc:creator>Schanuel F.</dc:creator><prism:publicationName>Colloids and Surfaces B: Biointerfaces</prism:publicationName><prism:issn>09277765</prism:issn><prism:eIssn>18734367</prism:eIssn><prism:volume>130</prism:volume><prism:pageRange>182-191</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.colsurfb.2015.04.007</prism:doi><pii>S0927776515002131</pii><dc:description>© 2015 Elsevier B.V. Nitric oxide (NO) releasing biomaterials represent a potential strategy for use as active wound dressings capable of accelerating wound healing. Topical NO-releasing poly(vinyl alcohol) (PVA) films and Pluronic F127 hydrogels (F127) have already exhibited effective skin vasodilation and wound healing actions. In this study, we functionalized PVA films with SNO groups via esterification with a mixture of mercaptosucinic acid (MSA) and thiolactic acid (TLA) followed by S-nitrosation of the SH moieties. These films were combined with an underlying layer of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide), i.e., PEO-PPO-PEO (Pluronic F127) hydrogel and used for the topical treatment of skin lesions in an animal model. The mixed esterification of PVA with MSA and TLA led to chemically crosslinked PVA-SNO films with a high swelling capacity capable of spontaneously releasing NO. Real time NO-release measurements revealed that the hydrogel layer reduces the initial NO burst from the PVA-SNO films. We demonstrate that the combination of PVA-SNO films with F127 hydrogel accelerates wound contraction, decreases wound gap and cellular density and accelerates the inflammatory phase of the lesion. These results were reflected in an increase in myofibroblastic differentiation and collagen type III expression in the cicatricial tissue. Therefore, PVA-SNO films combined with F127 hydrogel may represent a new approach for active wound dressings capable of accelerating wound healing.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005499</affiliation-url><afid>60005499</afid><affilname>Universidade do Estado do Rio de Janeiro</affilname><name-variant>Universidade do Estado do Rio de Janeiro</name-variant><affiliation-city>Rio de Janeiro</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029570</affiliation-url><afid>60029570</afid><affilname>Universidade Estadual de Campinas</affilname><name-variant>State University of Campinas</name-variant><affiliation-city>Campinas</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56597978300</author-url><authid>56597978300</authid><authname>Schanuel F.</authname><surname>Schanuel</surname><given-name>Fernanda Seabra</given-name><initials>F.S.</initials><afid>60005499</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56598090100</author-url><authid>56598090100</authid><authname>Raggio Santos K.</authname><surname>Raggio Santos</surname><given-name>Karen Slis</given-name><initials>K.S.</initials><afid>60029570</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55534606300</author-url><authid>55534606300</authid><authname>Monte-Alto-Costa A.</authname><surname>Monte-Alto-Costa</surname><given-name>Andréa</given-name><initials>A.</initials><afid>60005499</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7202819763</author-url><authid>7202819763</authid><authname>de Oliveira M.</authname><surname>de Oliveira</surname><given-name>Marcelo G.</given-name><initials>M.G.</initials><afid>60029570</afid></author><authkeywords>F127 hydrogel | Nitric oxide | Poly(vinyl alcohol) | S-nitrosoglutathione | Wound dressing | Wound healing</authkeywords><intid>36078084</intid><source-id>26590</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929650126"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929650126?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929650126&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929650126&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0887618515000754"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929650126</prism:url><dc:identifier>SCOPUS_ID:84929650126</dc:identifier><eid>2-s2.0-84929650126</eid><dc:title>Metacognitions, worry and sleep in everyday life: Studying bidirectional pathways using Ecological Momentary Assessment in GAD patients</dc:title><dc:creator>Thielsch C.</dc:creator><prism:publicationName>Journal of Anxiety Disorders</prism:publicationName><prism:issn>08876185</prism:issn><prism:eIssn>18737897</prism:eIssn><prism:volume>33</prism:volume><prism:pageRange>53-61</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.janxdis.2015.04.007</prism:doi><pii>S0887618515000754</pii><dc:description>© 2015 Elsevier Ltd. Background: The metacognitive model of generalized anxiety disorder proposes that negative metacognitive beliefs are crucial in the maintenance of excessive worry. Furthermore, according to the cognitive model of insomnia, worry leads to problems falling or staying asleep and poor sleep quality. In order to test the assumed causal relationships, the present study examined the time-dependent course of negative metacognition and worry as well as worry and sleep quality, using Ecological Momentary Assessment (EMA). Method: Negative metacognitions, worry and sleep were assessed by self-report questionnaires as well as EMA in 56 GAD patients who carried a portable device for 1 week and logged sleep quality, negative metacognition and worry processes four times a day. Results: Metacognitions, worry and sleep were significantly correlated. Structural equation modeling using multilevel analyses showed a unidirectional relationship of negative metacognitions leading to prolonged worry processes and a bidirectional relationship of worry and sleep quality. Conclusions: These findings support the theoretically derived assumptions on the relationship between negative metacognitions, worry and sleep. Implications for further research as well as clinical implications are discussed.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000401</affiliation-url><afid>60000401</afid><affilname>Westfalische Wilhelms-Universitat Munster</affilname><name-variant>University of Münster</name-variant><affiliation-city>Munster</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028717</affiliation-url><afid>60028717</afid><affilname>Ludwig-Maximilians-Universitat Munchen</affilname><name-variant>University of Munich</name-variant><affiliation-city>Munich</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024025</affiliation-url><afid>60024025</afid><affilname>Universitat zu Koln</affilname><name-variant>Universität zu Köln</name-variant><affiliation-city>Koln</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56401175400</author-url><authid>56401175400</authid><authname>Thielsch C.</authname><surname>Thielsch</surname><given-name>Carolin</given-name><initials>C.</initials><afid>60000401</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603589721</author-url><authid>6603589721</authid><authname>Ehring T.</authname><surname>Ehring</surname><given-name>Thomas</given-name><initials>T.</initials><afid>60000401</afid><afid>60028717</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603589721</author-url><authid>6603589721</authid><authname>Ehring T.</authname><surname>Ehring</surname><given-name>Thomas</given-name><initials>T.</initials><afid>60000401</afid><afid>60028717</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56652049900</author-url><authid>56652049900</authid><authname>Nestler S.</authname><surname>Nestler</surname><given-name>Steffen</given-name><initials>S.</initials><afid>60000401</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56651948200</author-url><authid>56651948200</authid><authname>Wolters J.</authname><surname>Wolters</surname><given-name>Janina</given-name><initials>J.</initials><afid>60000401</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56652228700</author-url><authid>56652228700</authid><authname>Kopei I.</authname><surname>Kopei</surname><given-name>Ina</given-name><initials>I.</initials><afid>60000401</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7003322909</author-url><authid>7003322909</authid><authname>Rist F.</authname><surname>Rist</surname><given-name>Fred</given-name><initials>F.</initials><afid>60000401</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55550755600</author-url><authid>55550755600</authid><authname>Gerlach A.</authname><surname>Gerlach</surname><given-name>Alexander L.</given-name><initials>A.L.</initials><afid>60024025</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:23567709800</author-url><authid>23567709800</authid><authname>Andor T.</authname><surname>Andor</surname><given-name>Tanja</given-name><initials>T.</initials><afid>60000401</afid></author><authkeywords>Ecological Momentary Assessment | Generalized anxiety disorder | Insomnia | Metacognitions | Sleep | Worry</authkeywords><intid>1535989744</intid><source-id>15375</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926629056"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926629056?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926629056&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926629056&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1050464815001187"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926629056</prism:url><dc:identifier>SCOPUS_ID:84926629056</dc:identifier><eid>2-s2.0-84926629056</eid><dc:title>Fat-associated lymphoid cluster in Cyprinus carpio: Characterisation and its relation with peritoneal haemangiosarcoma</dc:title><dc:creator>Madera-Sandoval R.</dc:creator><prism:publicationName>Fish and Shellfish Immunology</prism:publicationName><prism:issn>10504648</prism:issn><prism:eIssn>10959947</prism:eIssn><prism:volume>44</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>633-641</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.fsi.2015.03.019</prism:doi><pii>S1050464815001187</pii><dc:description>© 2015 Elsevier Ltd. FALC cells are natural helper cells producing Th2-type cytokines, which express c-kit, Sca-1, IL7R and CD45 in mouse and human. These cells are involved in allergic responses and contribute to the inflammatory reactions of adipose tissue; however, a lack of information prevails about the presence of these cells in other species. The aim of the study was to identify and characterise FALC cells in the common carp (. Cyprinus carpio) using immunohistochemistry and molecular biology techniques as well as to explore their relationships with their microenvironment. Histological description of the FALC was performed using H&amp;E and polyclonal antibodies were used against cell-surface markers such as c-kit, Sca-1 and CD45. Furthermore, gene expression of c-kit, Sca-1 and IL7R was assessed. C.carpio FALC cells express the same surface markers reported in FALC of the mouse at both the pre- and post-transcriptional level. By exposure to the soluble fraction of helminths, FALC cells produce abundant Th2 cytokines (IL-5, IL-6 and IL-13) but do not synthesise IL-1α. Additionally, FALC cells probably participate in vascular remodelling of the intestine vessels, inducing tumours because a malignant haemangiosarcoma in the peritoneal cavity was found. In this tumour, abundant FALC with their characteristic cell-surface markers were detected. The findings of this study suggest the involvement of some proto-oncogenes such as c-kit and Sca-1, and the deregulation of Src kinases modulated by CD45 present in C. carpio FALC with the ontogeny of peritoneal haemangiosarcoma in this fish species.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112075620</affiliation-url><afid>112075620</afid><affilname>Departamento de Ingeniería en Sistemas Ambientales</affilname><name-variant>Departamento de Ingeniería en Sistemas Ambientales</name-variant><affiliation-city>San Pedro Zacatenco</affiliation-city><affiliation-country>Mexico</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019176</affiliation-url><afid>60019176</afid><affilname>Instituto Politecnico Nacional</affilname><name-variant>IPN</name-variant><affiliation-city>Mexico City</affiliation-city><affiliation-country>Mexico</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019176</affiliation-url><afid>60019176</afid><affilname>Instituto Politecnico Nacional</affilname><name-variant>IPN</name-variant><affiliation-city>Mexico City</affiliation-city><affiliation-country>Mexico</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56479361000</author-url><authid>56479361000</authid><authname>Madera-Sandoval R.</authname><surname>Madera-Sandoval</surname><given-name>Ruth L.</given-name><initials>R.L.</initials><afid>112075620</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603184009</author-url><authid>6603184009</authid><authname>Reyes-Maldonado E.</authname><surname>Reyes-Maldonado</surname><given-name>Elba</given-name><initials>E.</initials><afid>60019176</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55317830700</author-url><authid>55317830700</authid><authname>Dzul-Caamal R.</authname><surname>Dzul-Caamal</surname><given-name>Ricardo</given-name><initials>R.</initials><afid>112075620</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56586141900</author-url><authid>56586141900</authid><authname>Gallegos-Rangel E.</authname><surname>Gallegos-Rangel</surname><given-name>Esperanza</given-name><initials>E.</initials><afid>112075620</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6507901115</author-url><authid>6507901115</authid><authname>Domínguez-López M.</authname><surname>Domínguez-López</surname><given-name>María Lilia</given-name><initials>M.L.</initials><afid>60019176</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56479073500</author-url><authid>56479073500</authid><authname>García-Latorre E.</authname><surname>García-Latorre</surname><given-name>Ethel</given-name><initials>E.</initials><afid>60019176</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:12784429500</author-url><authid>12784429500</authid><authname>Vega-López A.</authname><surname>Vega-López</surname><given-name>Armando</given-name><initials>A.</initials><afid>112075620</afid></author><authkeywords>C-kit | CD45 | FALC cells | IL7R | Proto-oncogenes | Sca-1 | Th-2 cytokines</authkeywords><intid>2035480070</intid><source-id>15066</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928017551"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928017551?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928017551&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928017551&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928017551</prism:url><dc:identifier>SCOPUS_ID:84928017551</dc:identifier><eid>2-s2.0-84928017551</eid><dc:title>Perspectives on thyroid hormone action in adult neurogenesis</dc:title><dc:creator>Kapoor R.</dc:creator><prism:publicationName>Journal of Neurochemistry</prism:publicationName><prism:issn>00223042</prism:issn><prism:eIssn>14714159</prism:eIssn><prism:volume>133</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:pageRange>599-616</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1111/jnc.13093</prism:doi><dc:description>© 2015 International Society for Neurochemistry. Thyroid hormone exhibits profound effects on neural progenitor turnover, survival, maturation, and differentiation during perinatal development. Studies over the past decade have revealed that thyroid hormone continues to retain an important influence on progenitors within the neurogenic niches of the adult mammalian brain. The focus of the current review is to critically examine and summarize the current state of understanding of the role of thyroid hormone in regulating adult neurogenesis within the major neurogenic niches of the subgranular zone in the hippocampus and the subventricular zone lining the lateral ventricles. We review in depth the studies that highlight a role for thyroid hormone, in particular the TRa1 receptor isoform, in regulating progenitor survival and commitment to a neuronal fate. We also discuss putative models for the mechanism of action of thyroid hormone/TRa1 on specific stages of subgranular zone and subventricular zone progenitor development, and highlight potential thyroid hormone responsive target genes that may contribute to the neurogenic effects of thyroid hormone. The effects of thyroid hormone on adult neurogenesis are discussed in the context of a potential role of these effects in the cognitive- and moodrelated consequences of thyroid hormone dysfunction. Finally, we detail hitherto unexplored aspects of the effects of thyroid hormone on adult neurogenesis that provide impetus for future studies to gain a deeper mechanistic insight into the neurogenic effects of thyroid hormone.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031855</affiliation-url><afid>60031855</afid><affilname>Tata Institute of Fundamental Research</affilname><name-variant>Tata Institute of Fundamental Research</name-variant><affiliation-city>Mumbai</affiliation-city><affiliation-country>India</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36606265300</author-url><authid>36606265300</authid><authname>Kapoor R.</authname><surname>Kapoor</surname><given-name>Richa</given-name><initials>R.</initials><afid>60031855</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:24821187500</author-url><authid>24821187500</authid><authname>Fanibunda S.</authname><surname>Fanibunda</surname><given-name>Sashaina E.</given-name><initials>S.E.</initials><afid>60031855</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:24780351700</author-url><authid>24780351700</authid><authname>Desouza L.</authname><surname>Desouza</surname><given-name>Lynette A.</given-name><initials>L.A.</initials><afid>60031855</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56244220200</author-url><authid>56244220200</authid><authname>Guha S.</authname><surname>Guha</surname><given-name>Suman K.</given-name><initials>S.K.</initials><afid>60031855</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7006043990</author-url><authid>7006043990</authid><authname>Vaidya V.</authname><surname>Vaidya</surname><given-name>Vidita A.</given-name><initials>V.A.</initials><afid>60031855</afid></author><authkeywords>hippocampus | neural stem cell | progenitor | subgranular zone | subventricular zone | thyroid hormone receptor</authkeywords><intid>1035712167</intid><source-id>17620</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928804994"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928804994?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928804994&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928804994&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928804994</prism:url><dc:identifier>SCOPUS_ID:84928804994</dc:identifier><eid>2-s2.0-84928804994</eid><dc:title>Infant motor development and cognitive performance in early old age: the Helsinki Birth Cohort Study</dc:title><dc:creator>Poranen-Clark T.</dc:creator><prism:publicationName>Age</prism:publicationName><prism:issn>01619152</prism:issn><prism:eIssn>15744647</prism:eIssn><prism:volume>37</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s11357-015-9785-x</prism:doi><dc:description>© 2015, American Aging Association. Motor development and cognitive development in childhood have been found to be fundamentally interrelated, but less is known about the association extending over the life course. The aim of this study was to examine the association between early motor development and cognitive performance in early old age. From men and women belonging to the Helsinki Birth Cohort Study, who were born between 1934 and 1944 and resided in Finland in 1971, 1279 participated in cognitive performance tests (CogState®, version 3.0.5) between 2001 and 2006 at an average age of 64.2 years (SD 3.0). Of these, age at first walking extracted from child welfare clinic records was available for 398 participants. Longer reaction times in cognitive tasks measuring simple reaction time (SRT), choice reaction time (CRT), working memory (WM), divided attention (DA), and associated learning (AL) indicated poorer cognitive performance. Adjustment was made for sex, age at testing, father’s occupational status and own highest attained education, and occupation in adulthood. Average age of learning to walk was 12.2 months (SD 2.1). After adjusting for covariates, earlier attainment of learning to walk was associated with shorter reaction times in cognitive performance tasks (SRT 10.32 % per month, 95 % CI 0.48–21.12, p = 0.039; CRT 14.17 % per month, 95 % CI 3.75–25.63, p = 0.007; WM 15.14 % per month, 95 % CI 4.95–26.32, p = 0.003). People who learned to walk earlier had better cognitive performance in early old age. The earlier attainment of motor skills may track over to early old age and possibly reflect greater cognitive reserve in older age.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032398</affiliation-url><afid>60032398</afid><affilname>Jyvaskylan Yliopisto</affilname><name-variant>University of Jyväskylä</name-variant><affiliation-city>Jyvaskyla</affiliation-city><affiliation-country>Finland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002952</affiliation-url><afid>60002952</afid><affilname>Helsingin Yliopisto</affilname><name-variant>University of Helsinki</name-variant><affiliation-city>Helsinki</affiliation-city><affiliation-country>Finland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002952</affiliation-url><afid>60002952</afid><affilname>Helsingin Yliopisto</affilname><name-variant>University of Helsinki</name-variant><affiliation-city>Helsinki</affiliation-city><affiliation-country>Finland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025225</affiliation-url><afid>60025225</afid><affilname>University of Southampton</affilname><name-variant>University of Southampton</name-variant><affiliation-city>Southampton</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60104546</affiliation-url><afid>60104546</afid><affilname>National Institute for Health and Welfare</affilname><name-variant>National Institute for Health and Welfare</name-variant><affiliation-city>Helsinki</affiliation-city><affiliation-country>Finland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016987</affiliation-url><afid>60016987</afid><affilname>Helsinki University Central Hospital</affilname><name-variant>Helsinki University Central Hospital</name-variant><affiliation-city>Helsinki</affiliation-city><affiliation-country>Finland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016622</affiliation-url><afid>60016622</afid><affilname>Oulu University Hospital</affilname><name-variant>Oulu University Central Hospital</name-variant><affiliation-city>Oulu</affiliation-city><affiliation-country>Finland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016987</affiliation-url><afid>60016987</afid><affilname>Helsinki University Central Hospital</affilname><name-variant>Helsinki University Central Hospital</name-variant><affiliation-city>Helsinki</affiliation-city><affiliation-country>Finland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002952</affiliation-url><afid>60002952</afid><affilname>Helsingin Yliopisto</affilname><name-variant>University of Helsinki</name-variant><affiliation-city>Helsinki</affiliation-city><affiliation-country>Finland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">72</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56613398300</author-url><authid>56613398300</authid><authname>Poranen-Clark T.</authname><surname>Poranen-Clark</surname><given-name>Taina</given-name><initials>T.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56613398300</author-url><authid>56613398300</authid><authname>Poranen-Clark T.</authname><surname>Poranen-Clark</surname><given-name>Taina</given-name><initials>T.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56613398300</author-url><authid>56613398300</authid><authname>Poranen-Clark T.</authname><surname>Poranen-Clark</surname><given-name>Taina</given-name><initials>T.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56613398300</author-url><authid>56613398300</authid><authname>Poranen-Clark T.</authname><surname>Poranen-Clark</surname><given-name>Taina</given-name><initials>T.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56613398300</author-url><authid>56613398300</authid><authname>Poranen-Clark T.</authname><surname>Poranen-Clark</surname><given-name>Taina</given-name><initials>T.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56613398300</author-url><authid>56613398300</authid><authname>Poranen-Clark T.</authname><surname>Poranen-Clark</surname><given-name>Taina</given-name><initials>T.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56613398300</author-url><authid>56613398300</authid><authname>Poranen-Clark T.</authname><surname>Poranen-Clark</surname><given-name>Taina</given-name><initials>T.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56613398300</author-url><authid>56613398300</authid><authname>Poranen-Clark T.</authname><surname>Poranen-Clark</surname><given-name>Taina</given-name><initials>T.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56613398300</author-url><authid>56613398300</authid><authname>Poranen-Clark T.</authname><surname>Poranen-Clark</surname><given-name>Taina</given-name><initials>T.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:15051198900</author-url><authid>15051198900</authid><authname>von Bonsdorff M.</authname><surname>von Bonsdorff</surname><given-name>Mikaela B.</given-name><initials>M.B.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:15051198900</author-url><authid>15051198900</authid><authname>von Bonsdorff M.</authname><surname>von Bonsdorff</surname><given-name>Mikaela B.</given-name><initials>M.B.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:15051198900</author-url><authid>15051198900</authid><authname>von Bonsdorff M.</authname><surname>von Bonsdorff</surname><given-name>Mikaela B.</given-name><initials>M.B.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:15051198900</author-url><authid>15051198900</authid><authname>von Bonsdorff M.</authname><surname>von Bonsdorff</surname><given-name>Mikaela B.</given-name><initials>M.B.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:15051198900</author-url><authid>15051198900</authid><authname>von Bonsdorff M.</authname><surname>von Bonsdorff</surname><given-name>Mikaela B.</given-name><initials>M.B.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:15051198900</author-url><authid>15051198900</authid><authname>von Bonsdorff M.</authname><surname>von Bonsdorff</surname><given-name>Mikaela B.</given-name><initials>M.B.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:15051198900</author-url><authid>15051198900</authid><authname>von Bonsdorff M.</authname><surname>von Bonsdorff</surname><given-name>Mikaela B.</given-name><initials>M.B.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:15051198900</author-url><authid>15051198900</authid><authname>von Bonsdorff M.</authname><surname>von Bonsdorff</surname><given-name>Mikaela B.</given-name><initials>M.B.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:15051198900</author-url><authid>15051198900</authid><authname>von Bonsdorff M.</authname><surname>von Bonsdorff</surname><given-name>Mikaela B.</given-name><initials>M.B.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35290361500</author-url><authid>35290361500</authid><authname>Lahti J.</authname><surname>Lahti</surname><given-name>Jari</given-name><initials>J.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35290361500</author-url><authid>35290361500</authid><authname>Lahti J.</authname><surname>Lahti</surname><given-name>Jari</given-name><initials>J.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35290361500</author-url><authid>35290361500</authid><authname>Lahti J.</authname><surname>Lahti</surname><given-name>Jari</given-name><initials>J.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35290361500</author-url><authid>35290361500</authid><authname>Lahti J.</authname><surname>Lahti</surname><given-name>Jari</given-name><initials>J.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35290361500</author-url><authid>35290361500</authid><authname>Lahti J.</authname><surname>Lahti</surname><given-name>Jari</given-name><initials>J.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35290361500</author-url><authid>35290361500</authid><authname>Lahti J.</authname><surname>Lahti</surname><given-name>Jari</given-name><initials>J.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35290361500</author-url><authid>35290361500</authid><authname>Lahti J.</authname><surname>Lahti</surname><given-name>Jari</given-name><initials>J.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35290361500</author-url><authid>35290361500</authid><authname>Lahti J.</authname><surname>Lahti</surname><given-name>Jari</given-name><initials>J.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35290361500</author-url><authid>35290361500</authid><authname>Lahti J.</authname><surname>Lahti</surname><given-name>Jari</given-name><initials>J.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7003281795</author-url><authid>7003281795</authid><authname>Räikkönen K.</authname><surname>Räikkönen</surname><given-name>Katri</given-name><initials>K.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7003281795</author-url><authid>7003281795</authid><authname>Räikkönen K.</authname><surname>Räikkönen</surname><given-name>Katri</given-name><initials>K.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7003281795</author-url><authid>7003281795</authid><authname>Räikkönen K.</authname><surname>Räikkönen</surname><given-name>Katri</given-name><initials>K.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7003281795</author-url><authid>7003281795</authid><authname>Räikkönen K.</authname><surname>Räikkönen</surname><given-name>Katri</given-name><initials>K.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7003281795</author-url><authid>7003281795</authid><authname>Räikkönen K.</authname><surname>Räikkönen</surname><given-name>Katri</given-name><initials>K.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7003281795</author-url><authid>7003281795</authid><authname>Räikkönen K.</authname><surname>Räikkönen</surname><given-name>Katri</given-name><initials>K.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7003281795</author-url><authid>7003281795</authid><authname>Räikkönen K.</authname><surname>Räikkönen</surname><given-name>Katri</given-name><initials>K.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7003281795</author-url><authid>7003281795</authid><authname>Räikkönen K.</authname><surname>Räikkönen</surname><given-name>Katri</given-name><initials>K.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7003281795</author-url><authid>7003281795</authid><authname>Räikkönen K.</authname><surname>Räikkönen</surname><given-name>Katri</given-name><initials>K.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56397757000</author-url><authid>56397757000</authid><authname>Osmond C.</authname><surname>Osmond</surname><given-name>Clive</given-name><initials>C.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56397757000</author-url><authid>56397757000</authid><authname>Osmond C.</authname><surname>Osmond</surname><given-name>Clive</given-name><initials>C.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56397757000</author-url><authid>56397757000</authid><authname>Osmond C.</authname><surname>Osmond</surname><given-name>Clive</given-name><initials>C.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56397757000</author-url><authid>56397757000</authid><authname>Osmond C.</authname><surname>Osmond</surname><given-name>Clive</given-name><initials>C.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56397757000</author-url><authid>56397757000</authid><authname>Osmond C.</authname><surname>Osmond</surname><given-name>Clive</given-name><initials>C.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56397757000</author-url><authid>56397757000</authid><authname>Osmond C.</authname><surname>Osmond</surname><given-name>Clive</given-name><initials>C.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56397757000</author-url><authid>56397757000</authid><authname>Osmond C.</authname><surname>Osmond</surname><given-name>Clive</given-name><initials>C.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56397757000</author-url><authid>56397757000</authid><authname>Osmond C.</authname><surname>Osmond</surname><given-name>Clive</given-name><initials>C.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56397757000</author-url><authid>56397757000</authid><authname>Osmond C.</authname><surname>Osmond</surname><given-name>Clive</given-name><initials>C.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7006330833</author-url><authid>7006330833</authid><authname>Rantanen T.</authname><surname>Rantanen</surname><given-name>Taina</given-name><initials>T.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7006330833</author-url><authid>7006330833</authid><authname>Rantanen T.</authname><surname>Rantanen</surname><given-name>Taina</given-name><initials>T.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7006330833</author-url><authid>7006330833</authid><authname>Rantanen T.</authname><surname>Rantanen</surname><given-name>Taina</given-name><initials>T.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7006330833</author-url><authid>7006330833</authid><authname>Rantanen T.</authname><surname>Rantanen</surname><given-name>Taina</given-name><initials>T.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7006330833</author-url><authid>7006330833</authid><authname>Rantanen T.</authname><surname>Rantanen</surname><given-name>Taina</given-name><initials>T.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7006330833</author-url><authid>7006330833</authid><authname>Rantanen T.</authname><surname>Rantanen</surname><given-name>Taina</given-name><initials>T.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7006330833</author-url><authid>7006330833</authid><authname>Rantanen T.</authname><surname>Rantanen</surname><given-name>Taina</given-name><initials>T.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7006330833</author-url><authid>7006330833</authid><authname>Rantanen T.</authname><surname>Rantanen</surname><given-name>Taina</given-name><initials>T.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7006330833</author-url><authid>7006330833</authid><authname>Rantanen T.</authname><surname>Rantanen</surname><given-name>Taina</given-name><initials>T.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7004275338</author-url><authid>7004275338</authid><authname>Kajantie E.</authname><surname>Kajantie</surname><given-name>Eero</given-name><initials>E.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7004275338</author-url><authid>7004275338</authid><authname>Kajantie E.</authname><surname>Kajantie</surname><given-name>Eero</given-name><initials>E.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7004275338</author-url><authid>7004275338</authid><authname>Kajantie E.</authname><surname>Kajantie</surname><given-name>Eero</given-name><initials>E.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7004275338</author-url><authid>7004275338</authid><authname>Kajantie E.</authname><surname>Kajantie</surname><given-name>Eero</given-name><initials>E.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7004275338</author-url><authid>7004275338</authid><authname>Kajantie E.</authname><surname>Kajantie</surname><given-name>Eero</given-name><initials>E.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7004275338</author-url><authid>7004275338</authid><authname>Kajantie E.</authname><surname>Kajantie</surname><given-name>Eero</given-name><initials>E.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7004275338</author-url><authid>7004275338</authid><authname>Kajantie E.</authname><surname>Kajantie</surname><given-name>Eero</given-name><initials>E.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7004275338</author-url><authid>7004275338</authid><authname>Kajantie E.</authname><surname>Kajantie</surname><given-name>Eero</given-name><initials>E.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7004275338</author-url><authid>7004275338</authid><authname>Kajantie E.</authname><surname>Kajantie</surname><given-name>Eero</given-name><initials>E.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56092048900</author-url><authid>56092048900</authid><authname>Eriksson J.</authname><surname>Eriksson</surname><given-name>Johan G.</given-name><initials>J.G.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56092048900</author-url><authid>56092048900</authid><authname>Eriksson J.</authname><surname>Eriksson</surname><given-name>Johan G.</given-name><initials>J.G.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56092048900</author-url><authid>56092048900</authid><authname>Eriksson J.</authname><surname>Eriksson</surname><given-name>Johan G.</given-name><initials>J.G.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56092048900</author-url><authid>56092048900</authid><authname>Eriksson J.</authname><surname>Eriksson</surname><given-name>Johan G.</given-name><initials>J.G.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56092048900</author-url><authid>56092048900</authid><authname>Eriksson J.</authname><surname>Eriksson</surname><given-name>Johan G.</given-name><initials>J.G.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56092048900</author-url><authid>56092048900</authid><authname>Eriksson J.</authname><surname>Eriksson</surname><given-name>Johan G.</given-name><initials>J.G.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56092048900</author-url><authid>56092048900</authid><authname>Eriksson J.</authname><surname>Eriksson</surname><given-name>Johan G.</given-name><initials>J.G.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56092048900</author-url><authid>56092048900</authid><authname>Eriksson J.</authname><surname>Eriksson</surname><given-name>Johan G.</given-name><initials>J.G.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56092048900</author-url><authid>56092048900</authid><authname>Eriksson J.</authname><surname>Eriksson</surname><given-name>Johan G.</given-name><initials>J.G.</initials><afid>60032398</afid><afid>60002952</afid><afid>60002952</afid><afid>60025225</afid><afid>60104546</afid><afid>60016987</afid><afid>60016622</afid><afid>60016987</afid><afid>60002952</afid></author><authkeywords>Age at first walking | Cognitive performance | Cognitive reserve | Infant motor development | Older age</authkeywords><intid>35851953</intid><source-id>40283</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926319156"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926319156?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926319156&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926319156&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0010945215000763"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926319156</prism:url><dc:identifier>SCOPUS_ID:84926319156</dc:identifier><eid>2-s2.0-84926319156</eid><dc:title>Amnesia in an actor: Learning and re-learning of play passages despite severe autobiographical amnesia</dc:title><dc:creator>Kopelman M.</dc:creator><prism:publicationName>Cortex</prism:publicationName><prism:issn>00109452</prism:issn><prism:eIssn>19738102</prism:eIssn><prism:volume>67</prism:volume><prism:pageRange>1-14</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cortex.2015.03.001</prism:doi><pii>S0010945215000763</pii><dc:description>© 2015. We describe the case of an accomplished actor, whom we term AB, who suffered severe amnesia following a cardiac arrest and hypoxic brain damage, affecting medial temporal and thalamic structures. His performance on standard episodic memory tests, and on measures of retrograde amnesia, including autobiographical memory, was severely impaired. When presented with passages from plays he had not appeared in, AB showed a severe impairment at the first learning trial, but thereafter showed a 'normal' learning curve for this semantically and syntactically complex material. On being presented with passages from plays he had performed in the past, AB did not show any recognition of them whatsoever, as one might expect from his severe episodic memory impairment. However, AB showed a striking benefit (savings score) in relearning passages he had previously performed, compared with new passages, despite not having any autobiographical recall of having performed the relearned passages before. Moreover, although his initial recall performance in learning these passages was impaired compared with healthy control actors of similar age and experience, AB demonstrated the same incremental learning rate on subsequent learning trials of the passages as did the controls. We conclude that, although severely impaired at the first learning trial (on both 'new' and 'old' passages), AB was able to employ his long-established semantic and procedural skills to attempt the task, and that thereafter he showed a 'normal' rate of incremental learning from a lower baseline.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004111</affiliation-url><afid>60004111</afid><affilname>St Thomas' Hospital</affilname><name-variant>St Thomas' Hospital</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019953</affiliation-url><afid>60019953</afid><affilname>UCL Institute of Neurology</affilname><name-variant>UCL Institute of Neurology</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7006593707</author-url><authid>7006593707</authid><authname>Kopelman M.</authname><surname>Kopelman</surname><given-name>Michael D.</given-name><initials>M.D.</initials><afid>60004111</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8410455200</author-url><authid>8410455200</authid><authname>Morton J.</authname><surname>Morton</surname><given-name>John</given-name><initials>J.</initials><afid>60019953</afid></author><authkeywords>Actor | Autobiographical amnesia | Episodic memory | Semantic learning</authkeywords><intid>535432288</intid><source-id>14945</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929991244"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929991244?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929991244&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929991244&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929991244</prism:url><dc:identifier>SCOPUS_ID:84929991244</dc:identifier><eid>2-s2.0-84929991244</eid><dc:title>Biocatalytic approach for the synthesis of enantiopure acebutolol as a β&lt;inf&gt;1&lt;/inf&gt;-selective blocker</dc:title><dc:creator>Banoth L.</dc:creator><prism:publicationName>Chirality</prism:publicationName><prism:issn>08990042</prism:issn><prism:eIssn>1520636X</prism:eIssn><prism:volume>27</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>382-391</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1002/chir.22444</prism:doi><dc:description>© 2015 Wiley Periodicals, Inc. Abstract A new chemoenzymatic route is reported to synthesize acebutolol, a selective β&lt;inf&gt;1&lt;/inf&gt; adrenergic receptor blocking agent in enantiopure (R and S) forms. The enzymatic kinetic resolution strategy was used to synthesize enantiopure intermediates (R)- and (S)-N-(3-acetyl-4-(3-chloro-2-hydroxypropoxy)phenyl)butyramide from the corresponding racemic alcohols. The results showed that out of eleven commercially available lipase preparations, two enzyme preparations (Lipase A, Candida antarctica, CLEA [CAL CLEA] and Candida rugosa lipase, 62316 [CRL 62316]) act in enantioselective manner. Under optimized conditions the enantiomeric excess of both (R)- and (S)-N-(3-acetyl-4-(3-chloro-2-hydroxypropoxy)phenyl)butyramide were 99.9 and 96.8%, respectively. N-alkylation of both the (R) and (S) intermediates with isopropylamine gave enantiomerically pure (R and S)- acebutolol with a yield 68 and 72%, respectively. This study suggests a high yielding, easy and environmentally green approach to synthesize enantiopure acebutolol. Chirality 27:382-391, 2015.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001411</affiliation-url><afid>60001411</afid><affilname>National Institute of Pharmaceutical Education and Research India</affilname><name-variant>National Institute of Pharmaceutical Education and Research</name-variant><affiliation-city>Mohali</affiliation-city><affiliation-country>India</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:32067543200</author-url><authid>32067543200</authid><authname>Banoth L.</authname><surname>Banoth</surname><given-name>Linga</given-name><initials>L.</initials><afid>60001411</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56645996700</author-url><authid>56645996700</authid><authname>Thakur N.</authname><surname>Thakur</surname><given-name>Neeraj Singh</given-name><initials>N.S.</initials><afid>60001411</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:8925201200</author-url><authid>8925201200</authid><authname>Bhaumik J.</authname><surname>Bhaumik</surname><given-name>Jayeeta</given-name><initials>J.</initials><afid>60001411</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35499190200</author-url><authid>35499190200</authid><authname>Banerjee U.</authname><surname>Banerjee</surname><given-name>Uttam Chand</given-name><initials>U.C.</initials><afid>60001411</afid></author><authkeywords>enantiopure drug | enantioselectivity | lipase | transesterification | β-blockers</authkeywords><intid>1036045323</intid><source-id>16948</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925111390"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925111390?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925111390&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925111390&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0165032715000877"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925111390</prism:url><dc:identifier>SCOPUS_ID:84925111390</dc:identifier><eid>2-s2.0-84925111390</eid><dc:title>Long-term morbidity in bipolar-I, bipolar-II, and unipolar major depressive disorders</dc:title><dc:creator>Forte A.</dc:creator><prism:publicationName>Journal of Affective Disorders</prism:publicationName><prism:issn>01650327</prism:issn><prism:eIssn>15732517</prism:eIssn><prism:volume>178</prism:volume><prism:pageRange>71-78</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jad.2015.02.011</prism:doi><pii>S0165032715000877</pii><dc:description>© 2015 Elsevier B.V. Background Long-term symptomatic status in persons with major depressive and bipolar disorders treated clinically is not well established, although mood disorders are leading causes of disability worldwide. Aims To pool data on long-term morbidity, by type and as a proportion of time-at-risk, based on published studies and previously unreported data. Methods We carried out systematic, computerized literature searches for information on percentage of time in specific morbid states in persons treated clinically and diagnosed with recurrent major depressive or bipolar I or II disorders, and incorporated new data from one of our centers. Results We analyzed data from 25 samples involving 2479 unipolar depressive and 3936 bipolar disorder subjects (total N=6415) treated clinically for 9.4 years. Proportions of time ill were surprisingly and similarly high across diagnoses: unipolar depressive (46.0%), bipolar I (43.7%), and bipolar II (43.2%) disorders, and morbidity was predominantly depressive: unipolar (100%), bipolar-II (81.2%), bipolar-I (69.6%). Percent-time-ill did not differ between UP and BD subjects, but declined significantly with longer exposure times. Conclusions The findings indicate that depressive components of all major affective disorders accounted for 86% of the 43-46% of time in affective morbidity that occurred despite availability of effective treatments. These results encourage redoubled efforts to improve treatments for depression and adherence to their long-term use.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002746</affiliation-url><afid>60002746</afid><affilname>Harvard Medical School</affilname><name-variant>Harvard Medical School</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100333594</affiliation-url><afid>100333594</afid><affilname>Mailman Research Center</affilname><name-variant>Mailman Res. Cent.</name-variant><affiliation-city>Belmont</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032350</affiliation-url><afid>60032350</afid><affilname>Universita degli Studi di Roma La Sapienza</affilname><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112655830</affiliation-url><afid>112655830</afid><affilname>Lucio Bini Mood Disorder Center</affilname><name-variant>Centro Lucio Bini Mood Disorders Center</name-variant><affiliation-city>Cagliari</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112665101</affiliation-url><afid>112665101</afid><affilname>Lucio Bini Mood Disorder Center</affilname><name-variant>Lucio Bini Mood Disorder Centers</name-variant><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:109655004</affiliation-url><afid>109655004</afid><affilname>Palermo University</affilname><name-variant>Palermo University</name-variant><affiliation-city>Buenos Aires</affiliation-city><affiliation-country>Argentina</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">13</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35740318700</author-url><authid>35740318700</authid><authname>Forte A.</authname><surname>Forte</surname><given-name>Alberto</given-name><initials>A.</initials><afid>60002746</afid><afid>100333594</afid><afid>60032350</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35740318700</author-url><authid>35740318700</authid><authname>Forte A.</authname><surname>Forte</surname><given-name>Alberto</given-name><initials>A.</initials><afid>60002746</afid><afid>100333594</afid><afid>60032350</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35740318700</author-url><authid>35740318700</authid><authname>Forte A.</authname><surname>Forte</surname><given-name>Alberto</given-name><initials>A.</initials><afid>60002746</afid><afid>100333594</afid><afid>60032350</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55945905600</author-url><authid>55945905600</authid><authname>Baldessarini R.</authname><surname>Baldessarini</surname><given-name>Ross J.</given-name><initials>R.J.</initials><afid>60002746</afid><afid>100333594</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55945905600</author-url><authid>55945905600</authid><authname>Baldessarini R.</authname><surname>Baldessarini</surname><given-name>Ross J.</given-name><initials>R.J.</initials><afid>60002746</afid><afid>100333594</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7006585733</author-url><authid>7006585733</authid><authname>Tondo L.</authname><surname>Tondo</surname><given-name>Leonardo</given-name><initials>L.</initials><afid>60002746</afid><afid>100333594</afid><afid>112655830</afid><afid>112665101</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7006585733</author-url><authid>7006585733</authid><authname>Tondo L.</authname><surname>Tondo</surname><given-name>Leonardo</given-name><initials>L.</initials><afid>60002746</afid><afid>100333594</afid><afid>112655830</afid><afid>112665101</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7006585733</author-url><authid>7006585733</authid><authname>Tondo L.</authname><surname>Tondo</surname><given-name>Leonardo</given-name><initials>L.</initials><afid>60002746</afid><afid>100333594</afid><afid>112655830</afid><afid>112665101</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7006585733</author-url><authid>7006585733</authid><authname>Tondo L.</authname><surname>Tondo</surname><given-name>Leonardo</given-name><initials>L.</initials><afid>60002746</afid><afid>100333594</afid><afid>112655830</afid><afid>112665101</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:15758576600</author-url><authid>15758576600</authid><authname>Vázquez G.</authname><surname>Vázquez</surname><given-name>Gustavo H.</given-name><initials>G.H.</initials><afid>100333594</afid><afid>109655004</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:15758576600</author-url><authid>15758576600</authid><authname>Vázquez G.</authname><surname>Vázquez</surname><given-name>Gustavo H.</given-name><initials>G.H.</initials><afid>100333594</afid><afid>109655004</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7005882312</author-url><authid>7005882312</authid><authname>Pompili M.</authname><surname>Pompili</surname><given-name>Maurizio</given-name><initials>M.</initials><afid>60032350</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7004181693</author-url><authid>7004181693</authid><authname>Girardi P.</authname><surname>Girardi</surname><given-name>Paolo</given-name><initials>P.</initials><afid>60032350</afid></author><authkeywords>Bipolar -Rfis1 | Bipolar II | Long-term | Major depression | Morbidity | Percent-time ill</authkeywords><intid>1535265027</intid><source-id>16245</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927137672"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927137672?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927137672&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927137672&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0955598615000278"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927137672</prism:url><dc:identifier>SCOPUS_ID:84927137672</dc:identifier><eid>2-s2.0-84927137672</eid><dc:title>Generalized adaptive neuro-fuzzy based method for wind speed distribution prediction</dc:title><dc:creator>Petković D.</dc:creator><prism:publicationName>Flow Measurement and Instrumentation</prism:publicationName><prism:issn>09555986</prism:issn><prism:volume>43</prism:volume><prism:pageRange>47-52</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.flowmeasinst.2015.03.003</prism:doi><pii>S0955598615000278</pii><dc:description>© 2015 Elsevier Ltd. The probabilistic distribution of wind speed is one of the important wind characteristics for the assessment of wind energy potential and for the performance of wind energy conversion systems. When the wind speed probability distribution is known, the wind energy distribution can easily be obtained. Therefore, the probability distribution of wind speed is a very important piece of information needed in the assessment of wind energy potential. For this reason, a large number of studies have been published concerning the use of a variety of probability density functions to describe wind speed frequency distributions. Two parameter Weibull distribution is widely used and accepted method. Artificial neural networks (ANN) can be used as an alternative to analytical approach as ANN offers advantages such as no required knowledge of internal system parameters, compact solution for multi-variable problems. In this investigation adaptive neuro-fuzzy inference system (ANFIS), which is a specific type of the ANN family, was used to predict the annual probability density distribution of wind speed. The simulation results presented in this paper show the effectiveness of the developed method.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Deparment for Mechatronics and Control</affilname><name-variant>University of Niš</name-variant><name-variant>Faculty of Mechanical Engineering</name-variant><affiliation-city>Niš</affiliation-city><affiliation-country>Serbia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>University of Malaya</affilname><name-variant>Department of Computer System and Technology</name-variant><name-variant>Faculty of Computer Science and Information Technology</name-variant><affiliation-city>Kuala Lumpur</affiliation-city><affiliation-country>Malaysia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>University of Malaya</affilname><name-variant>Department of Mechanical Engineering</name-variant><name-variant>Faculty of Engineering</name-variant><affiliation-city>Kuala Lumpur</affiliation-city><affiliation-country>Malaysia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Kuwait University</affilname><name-variant>Information Science Department</name-variant><name-variant>College of Computing Sciences and Engineering</name-variant><affiliation-city/><affiliation-country>Kuwait</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:37461848600</author-url><authid>37461848600</authid><authname>Petković D.</authname><surname>Petković</surname><given-name>Dalibor</given-name><initials>D.</initials><afid/></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36643049500</author-url><authid>36643049500</authid><authname>Shamshirband S.</authname><surname>Shamshirband</surname><given-name>Shahaboddin</given-name><initials>S.</initials><afid/></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56462088100</author-url><authid>56462088100</authid><authname>Tong C.</authname><surname>Tong</surname><given-name>Chong Wen</given-name><initials>C.W.</initials><afid/></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:25921742000</author-url><authid>25921742000</authid><authname>Al-Shammari E.</authname><surname>Al-Shammari</surname><given-name>Eiman Tamah</given-name><initials>E.T.</initials><afid/></author><authkeywords>Adaptive neuro-fuzzy system (ANFIS) | Maximum likelihood method | Weibull distribution | Wind energy | Wind speed distribution</authkeywords><intid>1035565535</intid><source-id>15026</source-id></entry></search-results>
